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■ Summary
An investigation into the physico-chemical and molecular mechanical 
properties of tertiary amines which predispose them to rapid metabolism by 
cytochrome P-450 has been undertaken.
A series of tertiary amines based on the common 2-(2,4- 
dichlorophenoxy)-N~methylethanamine moiety was synthesised with different 
substituent groups which changed the lipophilicity, size, polarity and 
electronic configuration. The substituent groups employed included n -  
alkyl, branched alkyl, aromatic, unsaturated, and oxygenated moieties. 
The design of the molecules was c e n t r e d  around an N-methyl group which 
was shown to be the major site of metabolism in a selected series of the 
molecules. The rates of N-demethylation were used as the index by which 
the effect of changing the s u b s t i t u e n t  group was assessed.
Studies using chemical inducers and inhibitors of cytochrome P-450 
indicated that the hepatic microsomal fraction obtained from rats that had 
been pretreated with phenobarbital was the most effective biological system 
for the study of the rate of metabolism of these compounds. Further investig­
ations using purified cytochrome P450 IIB4 in a reconstituted system 
showed that this particular isozyme of cytochrome P-450 was capable of 
supporting the metabolism of these compounds indicating that in the rat 
hepatic microsomes it was cytochrome P450 IIB1 which was mediating the 
compounds' metabolism.
Various physico-chemical properties including lipophilicity, pKa and 
the octanol/water partition coefficient at pH 7.4 (log D) were determined 
for each of the compounds. The X-ray crystal structures of two of the 
molecules were solved to provide co-ordinates that were used in the 
determination of various molecular mechanical parameters such as the 
partial charges on the atoms in the molecules.
The physico-chemical parameters were correlated with biological
parameters obtained from both hepatic microsomal and purified cytochrome 
P450 IXB4 in a reconstituted system. The biological parameters determined 
were the binding affinity (Ks, K3 and K4), the substrate-induced 
cytochrome P-450 spin state change (% HS and K2), Vmaoc and Km. No 
correlation was found between these parameters derived from the different 
biological systems. This may have been a result of changes in the tertiary 
structure of the enzyme brought about- as a result of the purification 
process or it may have been due to differences in the primary structures 
of cytochrome P450 IIB1 and IIB4.
Quantitative structure-activity relationships derived between these 
sets of parameters for the microsomal system indicated that increasing 
size and lipophilicity produced stronger binding of the substrate to the 
enzyme, however, this gave no information about the orientation of the 
molecule in the enzyme’s active site. A correlation was found for Km which 
indicated that the electronic structure of the molecules may influence the 
orientation that the molecule adopts in the active site of the enzyme. No 
correlations were found for Vmax, however the ratio Vmax/Km produced a 
number of correlations which indicated that this parameter was dependent 
on the electron density on the nitrogen atom and the electronic influence 
of the substituent group on the nitrogen atom.
Very few correlations were found for the biological parameters 
determined using purified cytochrome P450 IIB4 in a reconstituted system. 
Those that were obtained went a little way in supporting the suggestion 
that compounds bind to cytochrome P-450 via a hydrophobic interaction.
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1Chapter 1
Introduction
2To gain a full understanding of the action of drugs requires not only 
the examination of the way the drug exerts its effect on the target 
receptor and the way in which the drug is distributed around the body by 
the plasma, but also a knowledge of the way that the body metabolises the 
drug prior to its excretion. This latter point may be of great interest 
since if a drug is rapidly metabolised, the concentration of the parent 
compound at the target receptor may not be sufficient to exert the effect 
seen in an i n  v i t r o  system. These facets of a drug's interaction with the 
organism are represented in fig 1.1.
The interaction of drugs with receptors has been extensively studied 
using both structure-activity and quantitative structure-activity 
relationships. These studies have attempted to relate the way that 
different drugs interact with receptors to various chemical and physico­
chemical properties of the compounds. This approach has also been applied 
to the pharmacokinetic properties of compounds (Caccia et  a l ., 1987) and
to the metabolism of drugs by an organism (Martin and Hansch, 1971).
The advent of computers and molecular mechanics in the world of drug 
design has allowed these quantitative structure-activity relationships now 
to be examined in terms of the atoms in a molecule rather than in terms of 
the molecule as a whole. Assessments may now be made of which atoms may 
are interacting with a receptor. The application of this system to drug 
metabolism, although in its infancy, may lead to the identification of 
chemical groups that are more metabolically stable and hence lead to new 
and more potent drugs.
1.1 Introduction.
3Drug Molecule
Quantitative descriptors 
Lipophilicityi steric & 
electronic paraneters.
QSMR
Intrinsic activity
Quantitative descriptors! 
Biological response in 
isolated systens
hetabolisn Fate in the body
Quantitative descriptors! Quantitative Descriptors! 
Rate constants Rate constants! ciearence
volune of distribution
Pharnacological activity
Quantitative descriptors! 
Response in vivo
QSAR Quantitative Structure Activity Relationship.
QSMR Quantitative Structure Metabolism Relationship.
QSPR Quantitative Structure Pharmacokinetic Relationship,
Fig 1.1 Quantitative structure-activity relationships. Descriptors of 
molecular structures, of biological activities and of metabolic properties 
of drugs,
(Reproduced from Faigle, 1987).
41.2 Xenobiotic metabolism.
The living organism is equipped with an efficient chemical defence 
mechanism which deals with many xenobiotics. This mechanism functions 
predominantly by converting xenobiotics into polar metabolites which are 
more water soluble and hence can be more readily excreted from the body. 
Many xenobiotics would otherwise remain in the body for an extended period 
of time, possibly exerting a deleterious effect. The metabolism of 
xenobiotics can be divided into two groups 'Phase I' and 'Phase II' 
reactions. Phase I biotransformations involve primarily three types of 
reactions, oxidation, reduction and hydrolysis. The net result of these 
reactions is the introduction of a polar functional group into the 
compound. During phase II, or conjugation, reactions the polar functional 
group of the xenobiotic is linked to an endogenous molecule such as 
glucuronic acid, sulphate or amino acids which makes the molecule yet 
more polar and hence more readily excretable.
1.3 Xenobiotic metabolism of tertiary amines.
It has been suggested that if an attempt were made to determine the 
average number of nitrogen atoms in all known drug molecules it would 
certainly yield a number larger than 1 (Testa and Jenner 1976). Many of 
these nitrogen-containing drugs are tertiary amines and consequently the 
metabolism and possible deactivation of these drugs is of great 
importance.
The tertiary amine functional group is an important chemical compon­
ent present in many drug molecules including antihistamines, analgesics, 
local anaesthetics and tricyclic antidepressants.
Xenobiotics which contain a tertiary amine functional group may
5undergo both phase I and phase II types of transformation, however the 
tertiary amine function itself can not be conjugated until one or more of 
the groups surrounding the nitrogen have been removed.
The xenobiotic metabolism of tertiary amines has been extensively 
reviewed (Willi and Bickel, 1973; Rose and Castagnoli, 1983 and Testa and 
Jenner, 1976). In general the amine function of a tertiary amine undergoes 
phase I biotransformations which take the form of N-dealkylation, yielding 
a secondary amine and the aldehyde corresponding to the group removed or 
N-oxidation which yields the tertiary amine with an oxygen atom datively 
bound to the nitrogen atom (fig 1.2).
It has been suggested that N-oxidation may lead to N-dealkylation 
(Lotlikar et  a l . ,  1974) via an oxygen insertion reaction into one of the 
N-C bonds (Fish et  a l . ,  1956), however evidence from the relative rates of 
N-demethylation of N,N~dimethylaniline and its N-oxide (Pettit and Zieg­
ler, 1963), the inhibition of N-oxide formation from normethadone by 
dithiothreitol without affecting the rate of N-dealkylation (Beckett et  
a l . ,  1971), and the fact that some compounds that readily undergo N- 
dealklyation such as N-methylcarbazole do not form N-oxides but do form 
stable carbinolamines (Gorrod and Temple, 1976) indicates that N-dealkyl­
ation is a separate process which is not dependent on the compound being 
N-oxidised prior to being N-dealkylated.
6\  +
N-Qxidation,
Fig 1.2 Proposed mechanistic routes for N-dealkylation via N-oxidation or 
alpha carbon atom hydroxylation.
7Theoretical calculations used by Nelson et  a l . (1973) to determine 
the electronic structure of the suspected intermediates involved in the N- 
dealkylation showed that the thermodyamic instability and kinetic 
stability of the N-oxide make this a poor choice of intermediate although 
these workers did not rule it out. They suggested that these compounds are 
subjected to electron loss prior to N-dealkylation.
1,4 N-Dealkylation.
Examination of the literature reveals that many groups attached to 
the nitrogen atom are removed via N-dealkylation provided that the 
functional group has an alpha carbon atom carrying at least one hydrogen 
atom. The following list represents some of the most frequently removed 
substituents:
Methyl -ch3
Ethyl -ch2ch3
n-Propyl -ch2ch2ch3
Isopropyl -CH(CH3)2
n-Butyl -ch2ch2ch2ch:
Propenyl -ch2ch=ch2
Propynyl -ch2c=ch
Hydroxyethyl -ch2ch2oh
Benzyl -ch2c6h5
This list is by no means exhaustive, however a discussion based on leaving 
substituents would not be practical because of the vast number of examples 
in the literature. This review of N-dealkylation will therefore concent­
rate on the classes of leaving substituent using examples from the 
literature to illustrate these various groups.
By far the most frequently- encountered leaving group is the oxidised 
alkyl function. As indicated previously many n-alkyl and branched alkyl 
groups are removed by N-dealkylation but by far the most frequently 
encountered in this class is the methyl group. The i n  v i vo and i n  v i t r o  
metabolism of doxylamine (Fig 1.3 I) in the rat gives a good example of N- 
demethylation, with the parent compound being N-demethylated to the 
secondary amine which is then N-demethylated again to the primary amine 
(Ganes et  a l . ,  1986). Both the secondary and primary amines were identic 
fied in rat urine and rat liver homogenate i n  v i t r o . As a general rule the 
rate of N-dealkylation of a tertiary amine is greater than that of a 
secondary amine.
Another commonly used n-alkyl function is N-ethyl. An example of N- 
de-ethylation is provided by the metabolism of sultopride (fig 1.3 II) 
which is metabolised to its N-de-ethylated metabolite in rat, rabbit and 
dog but not in man (Kobari et  a l . ,  1985). In the rat the N-de-ethylated
metabolite represents only 2.3% of the dose whereas in dog urine it
acounted for 12% of the dose.
The N-dealkylation of longer straight chain hydrocarbon moieties, 
such as n-propyl and n-butyl, also occurs. N-Depropylation was found to be 
a route of metabolism for the dopaminergic agonist DK118 (fig 1.3 III) in 
the rat (Koble et  a l . ,  1985). The N-depropylated metabolite, the major 
metabolite excreted in urine, had also undergone carbon atom oxidation of 
the aromatic methyl group. A example of N-debutylation is provided by the 
i n  v i vo metabolism of bumetamide (fig 1.3 III) which, although a 
secondary amine, is N-debutlyated in the rat and dog. The N-debutylated 
metabolite represented 4.4% of the dose in the rat. This compound also
yielded other metabolites among which were some which had undergone
hydroxylation at the 2 and 3 carbon atoms of the butyl chain.
Attempts to link substituent size with rates of metabolism were
9Fig 1.3 Examples, of N-dealkylation.
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carried out on a series of N-n-alkyl amphetamines by Beckett and Shenoy 
(1973). Using the series N-methyl, N-ethyl, N-n-proyl and N-n-butylamph- 
etamines they were able to assign the order methyl >ethyl >propyl = butyl 
for the total metabolism of these compounds but the effect of the 
different N-alkyl group on the N-dealkylation reaction was not easily 
determined as the contribution from other metabolic routes increased with 
increasing substituent size.
N-Dealkylation is an important metabolic pathway for compounds cont­
aining branched N-alkyl functions. This is illustrated in the i n  v i t r o  
metabolism of the antiarrhythmic agent disopyramide (fig 1.3 V) in rat, 
dog and man (Cook et a l . ,  1982). The compound is metabolised to its des-
isopropyl metabolite in all three species with N-dealkylation being the
only metabolic pathway in dog and man. The des-isopropyl metabolite is
further N-dealkylated in the dog to yield the primary amine which then
cyclises by reaction with the amide group. N-Dealkylation of molecules 
containing tertiary butyl groups is not a usual route of metabolism since 
this group has no hydrogen atoms on the carbon atom alpha to the nitrogen. 
This is exemplified by the i n  v i vo metabolism of the beta-adrenergic 
blocking agent timolol (fig 1.3 VI). This compound yielded no N-dealkyl­
ated metabolite (Tocco et  a l . ,  1980), but metabolism of the tertiary butyl 
group did occur as traces of metabolites were found in which the tertiary 
butyl group had been hydroxylated. However the i n  v i t r o  and i n  v i vo  
metabolism of N-t-butylnorchlorocyclizine (fig 1.3 VII) in the rat yielded 
significant amounts of the N-dealkylated metabolite (Kamm et al., 1972). A 
mechanistic explanation for this may lie in the comparison between the 
metabolism of this compound and that of timolol. Timolol produces a 
metabolite in which one of the beta carbon atoms of the tertiary butyl 
group has been metabolised to a carboxylic acid. It has been postulated 
that a similar metabolite is produced for N-t-butylnorchlorocyclizine
14
which decarboxylates to produce an isopropyl group which is then N- 
dealkylated via alpha carbon atom hydroxylation (Kamm and Szuna, 1973).
Another unsual type of N-dealkylation is N-dephenylation. A number of 
examples of this reaction have been reported, and two notable examples are 
in the metabolism of the neuroleptic agent zetidoline (fig 1.3 VIII) in 
the rat and dog (Assandri et al., 1984) and the metabolism of the anti­
emetic mociprazine (fig 1.3 IX) in the dog (Ponat et al., 1986). Both 
compounds yielded significant amounts of the dephenylated metabolite in 
the urine. The mechanism of this reaction remains a mystery and indeed it 
is not certain that this reaction is oxidative in nature.
The N-debenzylation of drugs is a common metabolic route for com­
pounds containing N-benzyl functions. The metabolism of the anorectic 
agent benzphetamine (fig 1.3 X) was studied both in vivo (Inoue et al., 
1982) and in vitro (Inoue et al., 1983) in the rat. Both of these studies 
yielded methylamphetamine as a metabolite indicating N-debenzylation as 
one of the routes of metabolism. N-Debenzylation of benzphetamine both in 
vivo and in vitro represents a minor route of metabolism with aromatic 
hydroxylation as the major route in vivo and N-demethylation as the major 
metabolic route in vitro. Another example of N-debenzylation is provided 
by the vasodilator nicardipine (fig 1.3 XI). This compound is N-debenzyl- 
ated in dog, man and to a lesser extent in rat and monkey (Higuchi and 
Shiobara, 1980).
The in vivo metabolism of the narcotic analgesic fentanyl (fig 1.3 
XII) in the rat provides an example of N-dephenethylation as the major 
metabolite isolated of this compound isolated from rat urine was the N- 
dephenethylated metabolite (Goromaru et al., 1982).
N-Dealkylation is not only confined to alkyl or aromatic substituent 
groups. Increasing the degree of unsaturation of a substituent group does 
not preclude this group from under going an analogous reaction. The
15
hypotensive drug N,N-diallylmelamine (fig 1.3 XIII) contains two N-propenyl 
groups. This compound is N-dealklyated to the secondary and the primary 
amines in rat, dog and man (Allen et a l . ,  1971). Further unsaturation of 
the substituent group to a triple bond, as in the mitochondrial mono-amine 
oxidase inhibitor deprenyl (fig 1.3 XIV), also does not prevent this 
substituent group from being 'N-dealkylated'. This compound undergoes 
dealkylation of the propynyl function i n  v i vo in the rat (Yohisa et  a l . ,  
1986).
Oxidation of the substituent group as in the anti-inflammatory agent 
tiaramide (fig 1.3 XV) does not prevent the ethylhydroxy group from being 
'N-dealkylated'. Tiaramide is extensivly metabolised i n  v i vo in the rat 
(Noguchi et  a l . ,  1977). One of the metabolites isolated from rat urine was 
the desethylhydroxy metabolite.
The examples presented here by no means represent all the types of N- 
substituents that may be removed from a nitrogen atom by N-dealkylation, 
they do however represent examples of most of the chemical funtional 
groups relevant to the work reported in this thesis.
1.5 Mechanism of N-dealkylation.
The evidence presented above indicates that N-oxidation is not a 
necessary requirement for the N-dealkylation of drugs. The alternative 
mechanism for N-dealkylation, presented in fig 1.2, involves the oxidation 
of one of the carbon atoms alpha to the nitrogen to form a carbinolamine. 
This mechanism has been supported by the isolation of many of these 
carbinolamines directly as in the cases of N-methylcarbazole (Gorrod and 
Temple, 1976), tripelennamine (Yeh, 1987) and clebopride (Segura et  a l . ,
1980) or as trapped adducts as in the cases of propranolol (Shetty et a l . ,  
1985) and phencyclidine (Ward et  a l . ,  1982). In the latter studies the 
carbinolamines have been identified as the cyanide anion addition adduct .
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The isolation of the carbinolamines them, selves -usually requires the 
nitrogen to be in the proximity of a group which will stabilise the 
metabolically formed product.
Both alpha carbon atom oxidation, leading to N-dealkylation, and N- 
oxidation reactions are catalyzed by hepatic mixed function oxidases 
which require both NADPH and dioxygen. Evidence derived from studies on 
substrates such as benzphetamine (Inoue-et a l . ,  1983) show that treatment 
of animals with chemicals such as phenobarbital and 3-methylcholanthrene, 
which induce the cytochrome P-450-dependent mixed function oxidase enzyme 
systems but have little or no effect on the flavin-dependent mixed 
function oxidase enzyme system, increase the rate of the N-dealkylations 
of this compound. The same researchers showed that the i n  v i t r o  rate of N- 
dealkylation could be inhibited by SKF 525A. This compound is a well known 
inhibitor of the cytochrome P-450 enzyme system (Buening and Franklin, 
1976) but has no effect on the flavin-dependent mixed function oxidase 
enzyme system (Beckett, 1971; Bickell, 1971). These same observations have 
been reported for a number of tertiary amines and indicate that the alpha 
carbon atom oxidation is mediated by the cytochrome P-450 enzyme system.
1.6 The cytochrome P-450-dependent mixed function oxidase system.
Cytochrome P-450 is the terminal haemoprotein component of an elec­
tron transport chain ubiquitously distributed throughout living organisms. 
It functions in the aerobic metabolism of a diversity of structurally 
unrelated compounds. The reaction catalysed by this enzyme system involves 
the cleavage of molecular oxygen followed by the insertion of one atom 
into the substrate and the reduction of the second to the level of water, 
according to the following equation:
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NADPH + H+ + SH + 02------ > SOH + H20 + NADP^
where SH represents the compound metabolised. For this reason the above 
reaction has been termed "mixed function oxidation" (Mason 1965). One of 
the best characterised cytochrome P-450 system is that in mammalian liver 
where it is located principally in the smooth endoplasmic reticulum. The 
system comprises two main components (i) NADPH-cytochrome P-450 reductase 
which mediates the transfer of electrons from NADPH to cytochrome P-450 
and (ii) cytochrome P-450, serving as the terminal electron acceptor and 
site of substrate oxidation. Cytochrome b5 and its reductase have also 
been implicated in a number of oxidation reactions (Gibson and Clarke, 
1986; Schenkman et  a l . ,  1976).
1.7 NADPH-Cytochrome P-450 reductase.
The reductase is a flavin-containing oxidoreductase and has been 
purified and characterised from a variety of sources (Blank & Coon, 1982; 
Shively et  a l . , 1984: Yasukochi & Masters, 1976). Typically the detergent- 
solubilised protein has a monomeric molecular weight (Mr) of 74-80Kd. The 
protein on treatment with trypsin yields two fragements, (i) a large 
polypeptide (Mr 70Kd) which contains the flavin prosthetic groups (FAD and 
FMN) along with the ability to mediate NADPH-cytochrome c reduction, and 
(ii) a smaller polypeptide (Mr 6Kd) which contains many hydrophobic amino 
acids and is known as the 'tail peptide' or 'membrane binding peptide'. 
This peptide contains the amino terminus and is considered to be 
important in the anchoring of the protein to the membrane as well as 
forming the binary complex with cytochrome P-450 (Gum & Strobel, 1981). It 
is currently believed that the reductase is anchored to the membrane via 
the 'tail peptide' with its catalytic centre facing the cytosol (Gum & 
Strobel, 1981).
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1.8 Cytochrome P-450.
Cytochrome P-450 is a haemoprotein of the 'b' class of cytochromes. 
In effect the haemoprotein serves as a hydroxylase which requires oxygen 
activation (Coon, 1981). The cytochrome contains a protoporphyrin-IX 
prosthetic group liganded to a cysteine thiol group of the apoprotein at 
the fifth haem coordination site (Gibson & Tamburini, 1984). Cytochrome P- 
450 from a variety of sources has been characterised and has been found to 
be an atypical b-type cytochrome (table 1.1) with a Mr of 46-58Kd.
Cytochrome P-450 is considered an integral membrane protein, with its 
catalytic centre exposed to the cytoplasm (Nebert et  a l . ,  1981; Takemori & 
Kominami, 1984). More recent evidence suggests that the extent of integr­
ity with the membrane is dependent on the isoenzyme and that the haem 
binding pocket is also exposed to the cytoplasm (Hudecek & Anzenbacher, 
1988).
1.9 Phospholipids.
The composition and physical state of the endoplasmic reticulum (ER) 
membrane, to which the mixed function oxidase (MFO) components are bound 
is thought to influence the activity of the system to such an extent that 
the membrane itself is considered a component (Ruckpaul & Bernhardt, 
1984). Phospholipids such as the diacylphosphatidylcholines are known to 
fulfil important roles in organising the structure-activity relationships 
of the MFO system. These phospholipids are thought to have two functions 
(i) phospholipid binding to cytochrome P-450 produces the active conform­
ation of the haemoprotein; (ii) the formation of a fluid environment which 
allows protein to protein coupling to occur aiding electron transport 
(Ruckpaul & Bernhardt, 1984).
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Table 1.1 Unusual properties of the cytochrome P-450 family.
Modified from Gibson & Tamburini (1984).
Characteristic P-450 Other haemoproteins
1. Spectral properties 
a) CO-adduct
bj Ethyl isocyanide adduct 
c) Substrate binding
2. Spin state
3. Ligand and substrate 
binding
Forms split Soret band with Fe2* 
species
Spectral shifts occur on 
substrate binding
a) Fe3" state can exist in both 
low and high spin forms
b) Both Fe3 " low- and high-spin 
states converted to high-spin on 
reduction
Binds usual haemoprotein ligands, 
and also lipophilic substrates, 
of diverse chemical structure both 
to haem and apoprotein.
Approximately 420nm
For e- carrier cytochromes, both 
Fe3-" and Fe2+ states are usually low 
spin
For 02 carriers and peroxidases, 
both Fe3+ and Fe2+ states are 
usually high spin
Bind 02, CO, NO, N3", CN" and F"
4. Mid-point redox potential
5. Concentration
Unusually low, -
Highly inducible by many 
xenobiotics
More positive
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1.10 Topography of the mixed function oxidase components.
The lateral organisation of lipids in microsomal membranes exhibits 
dynamics of a multi-phase system i . e . rigid and fluid areas. These lipid 
states may determine the conformation of the MFO system. There is growing 
evidence for a cluster-like organisation of different cytochrome P-450 
isoenzymes around a limiting number of reductase molecules (Greinert et  
a l . ,  1982). Two models have been proposed for the interactions between the 
various MFO components: (i) the 'rigid' model in which no lateral motion
of the proteins is required for catalysis, (ii) the 'random' model in 
which short range lateral diffusion of cytochrome P-450 and reductase in 
the membrane occurs. Recent evidence supports the second model (Gerinert 
et  a l . ,  1982; Wu & Yang, 1984), although in both cases binary complexes 
between the cytochrome P-450 and the reductase are formed (Paine, 1981).
1.11 Multiplicity of cytochrome P-450,
It is known that cytochrome P-450 exists in many forms or 'isoenz­
ymes' which are often characteristic of an organelle, tissue or animal 
species (Lu & West, 1980; Nebert & Gonzalez, 1987; Nerbert & Negishi, 
1982; Nebert et  a l . ,  1987). The evidence for this multiplicity has been 
obtained from isolation and purification of the isoenzymes to electrophor­
etic homogeneity and their characterisation according to substrate speci­
ficity and homology of primary structures (Guengerich, 1977, 1978, 1979;
Guengerich et  a l . ,  1982; Ryan et  a l . ,  1984).
The adminstration of both endogenous and xenobiotic compounds alters 
the amounts of various of these microsomal cytochrome P-450 isoenzymes. In 
the majority of cases, the mechanism of this induction is not known, but 
its effect can be measured by an increase in certain marker enzymic 
activities. A typical case of this is the administration of phenobarbital, 
a potent inducer (Ioannides and Parke, 1975) which causes an increase in
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the benzphetamine N-demethylase activity in rat hepatic microsomal frac­
tion. This increase in benzphetamine N-demethylase activity was found to 
be due to the induction of two isoforms of cytochrome P-450 termed 
cytochrome P450 IIB1 and IIB2 (Nebert and Gonzalez, 1987 and Nebert et  
a l . ,  1987). Both forms have been purified (Waxman and Walsh, 1982,
Guengerich et  a l . ,  1982 and Ryan et  a l . ,  1979, Ryan et  a l . ,  1980 and Ryan
et  a l . ,  1982). Comparison between the- catalytic activities of these two 
isozymes led to the finding that the majority of the benzphetamine N- 
demethylase activity was attributable to cytochrome P450 IIB1 (Waxman and 
Walsh, 1982; Ryan et  a l . ,  1982;Guengerich et  a l . ,  1982 and Wolf et  a l . ,  
1988 ).
1.12 Cytochrome P-450 catalytic cycle.
The cytochrome P-450 mechanism can be seen in terms of a 'cytochrome 
P-450 cycle' (Gibson & Tamburini, 1984; Schenkman & Gibson, 1983) as
detailed in figure 1.4. A number of steps in this cycle have been examined
and the nature of the processes occurring have been elucidated.
1.12.1 Substrate binding.
This step (a, fig 1.4) is possibly the most studied of the entire 
cycle. The addition of hydrophobic substrates to microsomal or purified 
cytochrome P-450 gives rise to a spectral change (an increase in absor­
bance between 380 and 390 nm and a decrease in absorbance between 417 and 
422 nm) known as the type I spectral change (Schenkman et  a l . ,  1967,
1981). This spectral change has been attributated to an interaction 
between the substrate and the apoprotein which results in changes in the 
electron distribution of the iron atom.
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Key
SH substrate SOH Product
FPT NADPH-cytochrome P-450 reductase b5 Cytochrome b5
FPD NADH-cytochrome b5 reductase
Fig 1.4 Cytochrome P-450 cycle.
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The type II spectral change however, is variable and dependent on the 
identity of the ligand added. It does not represent a substrate inter­
action with the apoprotein, but is probably due to the displacement of the 
endogenous sixth ligand to the haemoprotein by the incoming ligand 
(Schenkman et  a l . ,  1967 and 1981). Recent X-ray crystallographic studies 
using the soluble bacterial isoenzyme cytochrome P-450oam isolated from 
Pseudomonas putida and type II ligands such as metyrapone and some phenyl- 
imidazole isomers have shown that these compounds displace the endogenous 
water ligand and ligand to the iron themselves via one of the lone pairs 
of electrons each possess (Polous and Howard, 1987).
The type I spectral change has been attributed to a change in the 
distribution of the Fe (III) d-electrons from a low spin, s = 1/2, to a 
high spin, s = 5/2, state. These two ferric spin states exhibit different 
Soret absorbances, with the low and high spin states absorbing at 390 and 
412 nm respectively (Schenkman et  a l . , 1981).
The substrate-dependence of the type I spectral change is hyperbolic 
and analysis yields the apparent substrate-dissociation constant (Ka) and 
the maximum spectral change obtainable in the presence of saturating 
substrate concentrations (delta A^x). This latter parameter is a function 
of the ability of the substrate to perturb the cytochrome P-450 spin 
equilibrium.
It has been possible using U.V./visible spectrophotometery to show 
that certain forms of cytochrome P-450 exist in a temperature-dependent 
spin equilibrium in the absence of a substrate. In general these studies 
have made use of the temperature-induced type I spectral change exhibited 
by hepatic microsomal fraction (Cinti et  a l . ,  1979), purified rabbit 
cytochrome P450 IIB4 (Rein et  a l . ,  1977 and Ristau et  a l . ,  1978), 
bacterial cytochrome P-450oam (Sligar et  a l . , 1976) and other purified rat 
liver forms of cytochrome P-450 (Gibson et  a l . , 1980).
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The observation of a spin equilibrium of different magnitudes in the 
presence and absence of substrate lead Sligar (1976), Ristau et  a l ., 
(1978) and Gibson and Tamburini (1984) to propose a thermodynamically 
closed four state model to explain the interaction of a substrate with 
cytochrome P-450 (fig 1.5). These workers were able to quantify the 
equilibrium constants Kx-K4 and showed that tighter binding of a substrate 
to the high spin form than the low spin form produced a greater spin state 
change. Further the large entropy changes, associated with the substrate 
binding reaction, were attributed to a hydrophobic binding mechanism in 
accordance with Sipal et  a l . (1979), who showed that the binding affinity
of type I substrates was a strong function of their octanol/water partition 
coefficients.
The ability of a homologous series of hydrocarbons to alter the spin 
equilibrium of cytochrome P-450 was investigated by Lewis et  a l . (1986). 
These workers related some of the molecular orbital-derived parameters 
of the hydrocarbons to their ability to convert the cytochrome from its 
low spin to its high spin form. They concluded that the ability of a 
compound to alter the spin state of cytochrome P-450 was related to the 
electron donor/acceptor properties of the molecule; molecules that are 
good electron donors and poor electron acceptors convert more of the 
enzyme to high spin.
The kinetics of binding of type I substrates to mammalian cytochrome 
P-450 represents a rapid biphasic process(Blanck et al., 19761; Smettan et  
a l . ,  1978) with fast phase rate constants in the order of 104 M-1 s-1.
The binding of substrates to cytochrome P-450 not only alters the 
spin state of the cytochrome P-450 but also alters its redox potential. 
This effect was demonstrated for the binding of camphor to cytochrome P- 
450cam (Sligar and Gunsalus, 1976) which changed the mid-point redox 
potential of the haemoprotein from -340mV to -170mV, as judged using a dye
25
Fe3"
hs
Fe3"
Is
Fe3""~S
hs
Fe3+-S
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Fe3t
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Fe3+
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Fg -s
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3+
4 /
R2
T
3+
;  Fe -s
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Enzyme in the high spin state with no substrate bound 
Enzyme in the low spin state with no substrate bound 
Enzyme in the high spin state with substrate bound 
Enzyme in the low spin state with substrate bound
This model is thermodynamically closed and hence: 
Kl K3 = K2. K4
Fig 1.5 Spin state model for the interaction between cytochrome P-450 and 
a substrate.
(Reproduced from Gibson and Tamburini 1984).
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photoreduction technique. In the case of mammalian cytochrome P-450, a 
similar correlation is seen between spin state and a more positive redox 
potential (Rein et  a l . r 1979). The unusually low redox potential of 
cytochrome P-450 has been attributed to charge stabilisation of the ferric 
form of the enzyme by the proposed strongly donating thiolate ligand. A 
structural explanation of this was offered by Raag and Poulos (1988) who 
. compared the crystal structures of substrate-bound and substrate-free 
cytochrome P-450cam. They used camphor and norcamphor as substrates and 
suggested that the lower redox potential and higher percentage of low spin 
haemoprotein was due to the presence of a water ligand remaining 
coordinated to the haem.
1.12.2 First electron reduction.
The second step (b, fig 1.4) in the reaction cycle is the one 
electron reduction of the substrate-bound cytochrome P-450. This reducing 
equivalent is derived from NADPH with microsomal and mitochondrial cyto­
chrome P-450 and from NADH with cytochrome P-450cam. The microsomal 
cytochrome P-450 system utilizes a flavoprotein which contains both FMN 
and FAD. It has been speculated by Oprian and Coon (1982) that the FAD 
moiety transfers the electron from NADPH to FMN which reduces the 
cytochrome P-450.
The first electron input to cytochrome P-450 from NADPH has been 
studied by a number groups (Gigon et  a l . ,  1976; Peterson et  a l . ,  1976; 
Taniguchi et a l . ,  1979; Oprian et  a l . ,  1979; Backes et  a l . ,  1980, 1982; 
Blanck ef- ai t f 1983) and has been shown to be biphasic consisting of two 
parallel first order reactions as detected by the formation of carbon 
monoxy-ferrous cytochrome P-450,
A number of hypotheses have been advanced to explain the biphasic 
nature of cytochrome P-450 reduction kinetics. Peterson et  a l . ,  1976
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suggested that cytochrome P-450 exists in the microsomal membrane as a 
cluster surrounding a limiting number of NADPH-cytochrome P-450 reductase 
molecules. Upon addition of NADPH the cytochrome P-450 molecules closest 
to the reductase would be reduced most rapidly whilst those on the 
periphery of the cluster would only be reduced after lateral translation 
to interact with the reductase. Although lateral diffusion is an important 
- factor in cytochrome P-450 kinetics this model fails to explain the 
biphasic reduction rate seen in reconstituted systems containing purified 
NADPH-cytochrome P-450 reductase and cytochrome P-450 where the ratio of 
reductase to cytochrome P-450 is much lower.
A second hypothesis invokes the spin equilibrium of cytochrome P-450. 
A number of workers (Backes et  a l . , 1980, 1982; Tamburini et  a l . , 1984)
have suggested that, on addition of the reducing equivalents the high spin 
cytochrome P-450 is rapidly reduced. This reduction perturbs the spin 
equilibrium and more of the low spin cytochrome is converted to high spin 
from which it is then reduced.
A more recent hypothesis suggests that the addition of a substrate to 
cytochrome P-450 enhances the rate of association between cytochrome P-450 
and NADPH-cytochrome P-450 reductase (Backes and Eyer, 1989). The authors 
suggested that the cytochrome P-450 exists in two forms prior to reduc­
tion; one is a cytochrome P-450/reductase functional complex and the other 
a complex between cytochrome P-450 and the reductase that does not allow 
electron transfer. The biphasic kinetics were attributed to the slow rate 
of formation of cytochrome P-450/reductase functional complex.
1.12.3 Dioxygen Binding.
After the haem has been reduced it is now able to bind one molecule 
of dioxygen (c fig 1.4), which is the first step in oxygen activation. 
Dioxygen coordinates to the iron trans to the thiolate ligand (Dawson and
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Cramer, 1978). This ferrous dioxygen complex is stable enough to be 
observed by ordinary means in the case of cytochrome P-450cam (Peterson et 
al., 1972) but can only be observed at low temperatures and high glycerol 
concentrations in the case of microsomal cytochrome P-450 (Bonfils et  a l . ,  
1980; Maurel et  a l . ,  1980). The binding of the dioxygen molecule to the
haem produces a strong polarization in the oxygen molecule. Theoretical
, calculations considering both thiol and imidazole as the fifth ligand 
(Jang, 1980) indicate that the thiolate ligand induces a stronger pi-back 
donation of electrons from the iron to the oxygen. This back donation 
leads to larger negative charges present on both oxygen atoms with the 
distal oxygen atom being more negative (fig 1.6).
1.12.4 Second electron reduction.
The first reaction steps of the cytochrome P-450 cycle have been 
studied and relatively well clarified whereas the steps that follow are 
still under much debate.
The reduction of the ferrous dioxygen complex (d, fig 1.4) has not 
been measured or even observed in microsomal cytochrome P-450. In cont 
rast, this step has shown to be rate-limiting for the cytochrome P-450cam
system (Tyson et  a l . , 1972).
It has long been known that NADH can weakly support drug oxidation 
reactions (Conney et  a l . ,  1957) and additionally exerts a synergistic 
effect in the presence of NADPH (Hildebrandt and Estabrook, 1971). These 
and other findings have lead to the hypothesis that cytochrome b5 may have 
a role as the second electron donor during the activation of molecular 
oxygen.
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Fig 1.6 Charge distribution between the iron and dioxygen in two 
cytochrome P-450 model systems with A) a thiolate fifth ligand and B) an 
imidazole fifth ligand.
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However the role of cytochrome b5 in drug oxidation is confused by the 
observations that it can be inhibitory (Gibson and Clarke, 1986; Lu et  
a l . ,  1974), stimulatory (Imai and Sato, 1977), obligatory (Sugiyama et  
a l . ,  1979) or has no effect (Imai and Sato, 1977) depending on the 
substrate used in the study. It has been suggested that the concept of a 
universal role for cytochrome b5 modulation of drug oxidations is unten- 
, able (Gibson and Clarke, 1986).
1.12.5 Cleavage of the oxygen-oxygen bond.
It is believed that the oxygen splitting (e, fig 1.4) reaction must
occur after the input of the second electron since the ferrous dioxygen 
complex of cytochrome P-450cam does not insert oxygen into camphor 
(Lipscomb et a l . ,  1976). The 'active oxygen' which is assumed to be 
inserted into the substrate is produced by splitting the oxygen-oxygen 
bond either heterolytically or homolytically (Blanck et  a l . ,  1984). The 
'active oxygen'/cytochrome P-450 complex is generally represented as Fev=0 
although no evidence for this structure exists.
The bound oxygen may at some point pass through most, if not all,
oxidation and protonated states of molecular oxygen (Coon, 1981). Some
evidence suggests the involvment of superoxide anion (02“) as the 'active 
oxygen' species (Coon, 1981; Paine, 1981), although hydroxy radicals have 
been implicated during the oxidation of ethanol (Hagbjork and Ingelman- 
Sundberg, 1982), i . e .  auto-oxidation of the oxy-cytochrome P-450 complex 
liberates superoxide anions which can partially dismutate to hydrogen 
peroxide. Peroxide may react, in an iron-catalysed reaction, to give 
hydroxy radicals which may react with the substrate.
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1.12.6 Oxygen insertion into substrate.
It has been suggested that the hydroxylation of a substrate is a two 
step process (f and g, fig 1.4) involving hydrogen abstraction from the 
substrate and subsequent recombination of the carbon radical and iron- 
bound hydroxyl radical pair (Hori et  a l . ,  1977). This caged radical 
mechanism is supported by evidence from deuterium isotope effects 
(Hjelmeland et a l . ,  1911), the magnitude of which supports this mechanism 
for carbon atom hydroxylation.
1.12.7 Product dissociation.
The dissociation of the oxygenated product from the cytochrome P-450 
active site (h, fig 1.4) completes the cycle. Thermodynamically the polar 
product will probably be bound less strongly than its parent molecule so 
that replacement by a fresh substrate molecule is favoured (White & Coon, 
1980).
1.12.8 The rate-limiting step of the cytochrome P-450 cycle.
Since only a few of the steps have been investigated in the 
cyctochrome P-450 cycle it is not surprising that the nature of the rate- 
limiting step for microsomal cytochrome P-450 remains a mystery. Of the 
steps that have been studied, substrate binding was eliminated as rate- 
limiting because of the high value of the second order rate constant 
found for benzphetamine binding to microsomal cytochrome P-450 (Blanck et 
a l . ,  1976). The first electron reduction is also relatively fast, as is 
the association of dioxygen with the cytochrome, which has an estimated 
rate constant of 7.7 X 105 M_1 s_1 in cytochrome P-450cam (Peterson et  a l  
1972). The hydrogen abstraction step for hydrocarbons has also been ruled 
out since no correlation exists between the rate of their turnover and the
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ease of hydrogen abstraction (Groves et  a l . ,  1978). After these reasonably 
well characterised steps, it becomes a matter of conjecture whether one 
believes that either the transfer of the second electron, the generation 
of active oxygen or the product dissociation steps proceed sufficiently 
slowly for them to become rate-limiting.
1.13 Cytochrome P-450 mediated N-dealklyation.
The majority of N-dealkylation reactions proceed via the oxidation 
of one of the alpha carbon atoms adjacent to the nitrogen atom and are 
catalysed by cytochrome P-450. Examination of the kinetic isotope effects 
of cytochrome P-450 reactions have found that for aliphatic carbon 
oxidation (Groves et  a l . ,  1978), benzylic carbon oxidation (Hjelmeland et  
a l . ,  1977) and O-methyl carbon oxidation (Foster et  a l . ,  1974) the 
effects were large (kH/kD > 10). However studies on the N-demethylation of 
compounds such as N,N-dimethylamphetamine have yielded isotope effects of 
the order of 1-2 (Miwa et  a l . ,  1980).
These low values and the similarity in both regioselectivity and 
isotope effect between enzymic N-dealkylation and the electrochemical 
oxidation of amines (Shono et  a l . ,  1982) has lead to the proposal of a 
mechanism of N-dealklyation which does not resemble that of carbon atom 
hydroxylation (fig 1.7). The main difference is that the N-dealkylation 
mechanism now starts with the one-electron oxidation of the nitrogen atom, 
which allows either a radical or cationic mechanism to ensue, both of 
which result in the formation of a carbinolamine. Support for this 
mechanism comes from the destruction of the haem of cytochrome P-450 by 
cyclopropylamines, so-called suicide inhibitors of cytochrome P-450 
(Hanzlik et  a l . ,  1979). A mechanism by which this inhibition could occur 
was postulated by MacDonald et  a l . (1982) which involved the removal of an
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electron from the nitrogen atom prior to a rearrangement to the species 
which attacks the haem. Further investigation of this phenomenon using a 
series of substituted 1-methylcyclopropanes yielded a correlation between 
the rate of haem destruction and the single-electron oxidation of these 
compounds (Guengerich et  a l . ,  1982).
This evidence strongly implies that the first stage in the cytochrome 
P-450 mediated metabolism of tertiary amines is the single-electron 
oxidation of the tertiary amine.
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Fig 1.7 Proposed mechanism of cytochrome P-450-mediated N-dealkylation.
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Aims of this study.
Many compounds, potentially active as drugs, containing tertiary 
amine functions are deactivated before reaching their target receptors by 
cytochrome P-450-mediated N-dealkylation. Future drug design may be helped 
by a better understanding of the chemical and physico-chemical properties 
of these drugs which pre-dispose them to N-dealkylation.
To gain an appreciation of the features of a molecule which affect 
its rate of N-dealkylation first required the synthesis of a series of 
compounds for which the main route of metabolism was N-dealkylation. 
Having obtained these compounds, their physico-chemical properties such as 
log P and pKa were determined. The investigation of the properties of 
these molecules at an atomic level was carried out using a combination of 
X-ray crystallography and molecular mechanics.
Derived parameters of the interaction of these compounds with both 
hepatic microsomal and purified cytochrome P-450 and their subsequent 
metabolism were determined. The magnitude of these biological parameters 
was compared with the physico-chemical and molecular mechanical properties 
to identify good correlations between the two data sets.
Chapter 2
Synthesis of a series of N-substituted-2-(2,4-dichlorophenoxy)-N-
methylethanamines.
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Before any metabolic studies on N-dealkylation could be carried out 
it was necessary to design and synthesize a series of compounds that would 
not only give a broad range of metabolic rates but also have only one 
major route of metabolism.
The route of metabolism selected in this study was N-demethylation.
, In view of this the tertiary amines were required to have a methyl group 
as one of the nitrogen substitutents. The remainder of the molecule 
consisted of an aromatic system, which it was hoped would bind to the 
enzyme, and the third nitrogen substitutent was varied to give the 
required differences in metabolism.
The aromatic system selected was one based on the ring system of 2,4- 
dichlorophenol which is reasonably lipophilic so that an interaction with 
cytochrome P-450 could be expected and which also has a blocked 4- position such 
that cytochrome P-450-mediated para hydroxylation would be . unlikely . Two 
methylene units were incorporated between the nitrogen atom and the 
aromatic system to reduce the influence that the electronic configuration 
of aromatic system would have on the nitrogen atom.
The changes made to the remaining substituent were designed to change 
the steric and physicochemical properties of the molecule in order to 
explore the effect of such changes on the rate of metabolism.
2.1 Introduction.
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2.2.1 Materials.
Aldrich Chemical Company (Poole, Dorset, UK):
d3-Acetyl chloride, 2-bromoethanol, 1-bromohexane, 1-bromopentane, citric 
acid, deuterochloroform, d6-dimethylsulphoxide, deuterated sulphuric acid, 
deuterated water, 1,2-dibromoethane,- 2,4-dichlorocinnamic acid, 2,4- 
dichlorophenol, 2,4-dichlorophenoxyacetic acid, l-(3-dimethylaminopropyl)- 
3-ethylcarbodiimide hydrochloride, hydrogen peroxide, 1-
hydroxybenzotriazole, lithium aluminium deuteride, lithium aluminium 
hydride, methylamine, N-benzylmethylamine, N-butylmethylamine
dimethylamine hydrochloride, N-ethylmethylamine, N-methylaniline, N- 
methylmorpholine, N-phenethylmethylamine, N-methyl-2-propenamine, N- 
methyl-2-propynamine, N-propylmethylamine, pyridine, sarcosine ethyl 
ester, sodium carbonate, sodium deuteroxide, sodium hydroxide, sodium 
iodide, sodium sulphate.
Fisons (Loughborough, Leicestershire, UK):
Acetonitrile, dichloromethane, diethyl ether, 1,4-dioxane, ethyl acetate, 
hydrochloric acid, sulphuric acid, tetrahdrofuran.
All the compounds used in the chemical synthesis were of at least reagent 
grade.
2.2.2 Methods.
All nuclear magnetic resonance (nmr) studies were carried out on a Nicolet 
Model QE 300 nmr (General Electric, Slough, UK).
All elemental analysis was carried out on a Perkin-Elmer model 240 
analysizer (Beaconsfield, UK).
2.2 Materials and Methods.
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The tertiary amines used in this study were synthesised by reacting a 
secondary amine with an alkyl bromide in the presence of excess sodium 
carbonate to neutralize the hydrogen bromide evolved.
In the cases where the tertiary amine was obtained from the 
corresponding amide, these were synthesised by reacting a secondary amine 
with a carboxylic acid activated by the water soluble carbodiimide l-(3- 
dimethylaminopropyl)-3-ethylcarbodiimide. The tertiary amines were then 
produced by the reduction of the amide with aluminium hydride (generated 
i n  s i t u form lithium aluminium hydride and sulphuric acid. Yoon et al  
1968.).
Synthesis of 2-(2,4-dichlorophenoxy)ethyl bromide.
This compound was synthesised according to the method of Berry et  
a l . (1958).
A solution of sodium hydroxide (llg, 275mmol) in water (32ml) was 
added dropwise to a refluxing mixture of 2,4-dichlorophenol (38.84g 
240mmol) and 1,2-dibromoethane (56g 300mmol) in water (150ml). This 
mixture was refluxed overnight and the organic layer was removed, dried 
over anhydrous sodium sulphate and evaporated. The residue was distilled 
to give the desired compound as a colourless oil, boiling point 118°C at
0.5 mm Hg. Yield 39.69g (61.3%).
Elemental analysis for C8H7Cl2OBr 
Calculated: C 35.59 H 2.61 N 5.19 
Found: C 35.26 H 2.53 N 5.13%
NMR:d(p.p.m.) (CDC13): 3.70(2H -CH2Br), 4.33(2H OCH2-), 6.97(IH aromatic
H), 7.23(1H aromatic H), 7,40(1H aromatic H).
2,3 Synthesis of N-substituted-2-(2,4-dichlorophenoxy)-N-
methylethanamines.
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2-(2,4-Dichlorophenoxy)ethyl bromide (19.17g, 71mmol) was added to 
methylamine (117g, 1131mmol) and the mixture heated at 50°C in a bomb for
'16 hours. The reaction mixture was evaporated and the residue taken up in 
ethyl acetate (100ml) and washed twice with saturated sodium carbonate 
(2x100ml), dried over anhydrous sodium sulphate and evaporated. The 
residue was purifed by chromatography on Si02 (140g) using dicloromethane 
plus 0-5% methanolic ammonia. Appropriate fractions were combined and 
evaporated to give the desired product as a yellow oil. Yield 13.5g 
(86.4%).
Elemental analysis for CgHnClsNO 
Calculated: C 48.81 H 5.03 N 6,25 
Found: C 49.11 H 5.04 N 6.36%
NMR:d(p.p.m.) (CDC13),1.87 (1H, N-H), 2.55(3H N-CH3), 3.06(2H, -CHaN),
4.16 (2H,0CH2-), 6.87(1H aromatic H), 7.19(1H aromatic H) and 7.39(1H
aromatic H).
( On shaking with D20 the signal at 1.87 p.p.m disappeared with a new signal 
appearing at 4.90 p.p.m.)
Synthesis of 2-(2,4-dichlorophenoxy)-N,N-dimethylethanamide.
A mixture of 2,4-dichlorophenoxyacetic acid (4.42g 20mmol), 
dimethylamine hydrochloride (1.62g 20mmol), 1-hydroxybenzotriazole (2.70g 
20mmol), N-methylmorpholine (6.06g 40mmol) and l-(3-dimethylaminopropyl)-
3-ethylcarbodiimide hydrochloride (7.67g 40mmol) in dichloromethane 
(120ml) was stirred overnight at room temperature. The crude reaction 
mixture was washed successively with water (2x150ml), 2M hydrochloric acid 
(2x150ml) and saturated aqueous sodium carbonate (2x150ml), dried over 
anhydrous sodium sulphate and evaporated. The residue was purified by 
chromatography on Si02 (70g) using hexane plus 0-60% ethyl acetate. 
Appropriate fractions were combined and evaporated to give the desired
Synthesis of 2-(2,4-dichlorophenoxy)-N-methylethanamine.
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product as a white solid, melting point 106-108°C. Yield 3.0g (60.3%).
Elemental analysis for CloHxlCl2N02 
Calculated: C 48.41 H 4.47 N 5.65 
Found: C 48.31 H 4.74 N 5.53%
NMR (CDC13) 3.00,3.16 (6H, N(CH3)2), 3.70(2H -CH2N), 4.33(2H OCH2-),
6.97(1H aromatic H), 7.23(1H aromatic Hj, 7.40(1H aromatic H).
(The N-CH3 signal was split due to the anisotropic effect of the carbonyl 
group).
Synthesis of 2~(2,4-dichlorophenoxy)-N,N-dimethylethanamine.
A suspension of lithium aluminium hydride (0,463g 12.2mmol) in
tetrahydrofuran (26ml) was stirred at 0°C and sulphuric acid (0.3ml, 
6.1mmol) was added with stirring over 15 min. The mixture was stirred at 
0°C for 1 hour prior to the dropwise addition of 2-(2,4-dichlorophenoxy)- 
N,N-dimethylethanamide (2.05g 8.3mmol) in tetrahydrofuran (8ml). The 
resulting mixture was stirred for 1 hour and then quenched by the 
cautious addition of a mixture of tetrahydrofuran and water (1/1 v/v) 
(5ml) followed by 0.9M aqueous sodium hydroxide (30ml) and then filtered. 
The filtrate was evaporated and the residue partitioned between ethyl 
acetate and saturated aqueous sodium carbonate solution. The organic layer 
was washed with water, dried over anhydrous sodium sulphate and evapor­
ated. The residue was purified by chromatography on Si02 (70g) using 
dichloromethane plus 0-2.5% methanolic ammonia. Appropriate fractions were 
combined and evporated to give the desired product as a yellow oil. Yield 
1.25g (64.6%).
Elemental analysis of C1oH13C12N0 
Calculated: C 51.30 H 5.60 N 5.98 
Found: C 51.17 H 5.62 N 5.89%
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NMR: d(p.p.m.) (CDC13) 2.39 (6H, N(CH3)2), 2.81 (2H, OCH2-), 4.13 (2H
-CH2N), 6.87 (IH aromatic H), 7.19 (1H, aromatic H) 7.39 (IH aromatic H).
Synthesis 2-(2,4-dichlorophenoxy)-N-ethyl-N-methylethanamide.
A mixture of 2,4-dichlorophenoxyacetic acid (17.68g 80mmol) N-ethyl- 
methylamine (4.72g 80mmol), 1-hydroxybenzotriazole (10.8Ig 80mmol), N- 
methylmorpholine (16.16g 160mmol) and l-(3-dimethylaminopropyl)-3-ethyl- 
carbodiimide hydrochloride (30.67g 160mmol) in dichloromethane (400ml) was 
stirred overnight at room temperature. The crude reaction mixture was 
washed successively with water (2x500ml), 2M hydrochloric acid (2x500ml) 
and saturated aqueous sodium carbonate (2x500ml), dried over anhydrous 
sodium sulphate and evaporated. The residue was purified by chromatography 
on Si02 (7Og) using hexane plus 0-40% ethyl acetate. Appropriate fractions 
were combined and evaporated to give the desired product as a white solid, 
melting point 49-51°C. Yield 9.08g (43.3%).
Elemental analysis of Cx1H13C12N02 
Calculated: C 50.40 H 5.00 N 5.34 
Found: C 50.69 H 5.05 N 5.30%
NMR:d(p.p.m.) (CDC13) 1.16,1.23 (3H, -CH2CH3), 2.97,3.13 (3H, N-CH3), 3.45 
(2H, -CH2CH3), 4.77 (2HOCH2-), 6.97 (IH, aromatic H), 7.19 (IH, aromatic
H) and 7.39 (IH, aromatic H).
(The CH3 signal of the ethyl was split due to the anisotropic effect of 
the carbonyl group).
Synthesis of 2-(2,4-dichlorophenoxy)-N-ethyl-N-methylethanamine.
A suspension of lithium aluminium hydride (1.64g 43mmol) in dry 
tetrahydrofuran (100ml) was stirred at 0°C and concentrated sulphuric acid 
(2.1ml, 42.7mmol) added with stirring over 15 min. The mixture was
stirred at 0°C for 1 hour prior to the dropwise addition of 2-(2,4- 
dichlorophenoxy)-N-ethyl-N-methylethanamide (7.50g 28.6mmol) in tetrahy-
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drofuran (30ml). The resulting mixture was stirred for 1 hour and then 
quenched by the cautious addition of a mixture of tetrahydrofuran and 
water (1/1 v/v) (5ml) followed by 0.9M aqueous sodium hydroxide (30ml) and
then filtered. The filtrate was evaporated and the residue partitioned
between ethyl acetate and saturated aqueous sodium carbonate solution. The 
organic layer was washed with water, dried over anhydrous sodium sulphate 
and evaporated. The residue was purified by chromatography on Si02 (70g) 
using dichloromethane plus 0-5% methanolic ammonia. Appropriate fractions 
were combined and evaporated to give the desired product as an amber oil. 
Yield 4.68g (65.9%).
Elemental analysis of C1;1Hi5C12NO
Calculated: C 53.24 H 6.09 N 5.64
Found: C 53.31 H 6.04 N 5.83%
NMR:d(p.p.m.) (CDC13) 1.13 (3H, -CH2CH3), 2.39 (3H, N-CH3), 2.58 (2H -
CH2CH3), 2.87 (2H, -CH2N), 4.13 (2H, OCH2-), 6.87 (1H aromatic H), 7.19
(1H aromatic H) and 7.35 (1H, aromatic H).
Synthesis of 2-(2,4-dichlorophenoxy)-N-(d5)-ethyl-N-methylethanamine.
d3-Acetyl chloride (1.4g 17.5mmol) was added dropwise to a stirred 
solution of 2-(2,4-dichlorophenoxy)-N-methylethanamine (3.5g 15.9mmol) and 
dry pyridine (1.4g 17.7mmol) in dry dichloromethane (25ml) and the mixture 
stirred at room temperature overnight. The reaction mixture was 
concentrated under reduced pressure and the residue partitioned between 
ethyl acetate (50ml) and aqueous citric acid (50ml lM).The organic layer 
was washed with aqueous sodium carbonate (2x100ml), dried over anhydrous 
sodium sulphate and evaporated. The residue was purified by chromatography 
on Si02 (70g) using hexane plus 0-40% ethyl acetate as the eluent. 
Appropriate fractions were combined and evaporated to give the desired 
product whose nmr (CDC13) was consistent with 2-(2,4-dichlorophenoxy)-N-
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(d3)-ethylamide-N-methylethanamine. Yield 2.7g (64%)-.
A stirred suspension of lithium aluminium deuteride (0.6g 14.7mmol)
in tetrahydrofuran (30ml) was stirred at 0°C and concentrated deuterated 
sulphuric acid was added with stirring over 15 min. The mixture was 
stirred for 1 hour prior to the dropwise addition of 2-(2,4- 
dichlorophenoxy)-N-(d3)-ethylamide~N-methylethanamine (2.7g 10.2mmol) in 
tetrahydrofuran (10ml). The resulting-mixture was stirred for 2.5 hours 
and then quenched by the cautious addition of a mixture of tetrahydrofuran 
and deuterated water (1/1 v/v) (10ml) followed by 0.9M sodium deuteroxide 
in deuterated water (30ml) and then filtered. The filtrate was evaporated 
and the residue partitioned between ethyl acetate and saturated aqueous 
sodium carbonate solution. The organic layer was washed with water, dried 
over anhydrous sodium sulphate and evaporated. The residue was purified by 
chromatography on Si02 using dichloromethane plus 0-5% methanolic ammonia 
as the eluent. Appropriate fractions were combined and evaporated to give 
the desired product as an amber oil. Yield 1.3g (50.4%).
The extent of deuterium incorporation was determined by two methods:
1. NMR (CDC13). A comparison of the nmr spectra of 2-(2,4- 
dichlorophenoxy)-N-ethyl-N-methylethanamine and 2-(2,4-dichlorophenoxy)~N- 
(d5)-ethyl-N-methylethanaraine showed that the signals at 1.13 p.p.m (3H) 
and 2.39 p.p.m (2H) attributed to the methyl and methylene protons from 
the ethyl group were present in the un-deuterated compound but were 
completely absent in the spectrum of the deuterated compound.
2. Mass spectrometry. Mass spectra of 2-(2,4-dichlorophenoxy)-N- 
ethyl-N-methylethanamine and 2-(2,4-dichlorophenoxy)-N-d5-ethyl-N- 
methylethanamine were recorded by passing the compounds directly into the 
mass spectrometer via a thermospray link. The spectrum of the deuterated 
compound showed a protonated molecular ion at m/z 253 with the 
characteristic isotope pattern for a compound of the molecular formula
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CxlHloD5Cl2N0. The spectrum was examined at m/z 248 which is the
protonated molecular ion for 2-(2,4-dichlorophenoxy)-N-ethyl-N- 
methylethanamine but this ion was found to be absent.
These physical techniques together with the elemental analysis 
indicate a deuterium incorporation of greater than 99%.
Elemental analysis for CnHaoDsClsNO 
Calculated: C 52.18 H/D 5.97 N 5.53
Found: C 52.25 H/D 6.12 N 5.48%
NMR:d(p.p.m.) (CDC13) 2.39 (3H, N-CH3), 2.87 (2H, OCH2-), 4.13 (2H, -CH2N)
6.87 (1H aromatic H), 7.19 (1H, aromatic H) and 7.39 (1H aromatic H).
Synthesis of 2-(2,4-dichlorophenoxy)-N-propyl-N-methylethanamine.
A mixture of 2-(2,4-dichlorophenoxy)ethyl bromide (2.0g, 7.4mmol), N- 
propylmethylamine (l.lg, 14.8mmol), sodium carbonate (1.18g, 11.lmmole), 
sodium iodide (0.3g, 2mmole) acetonitrile (50ml) were refluxed overnight. 
The reaction mixture was evaporated and the residue taken up in ethyl 
acetate (100ml) and washed with saturated aqueous sodium carbonate
solution (2X100ml), dried over anhydrous sodium sulphate and evaporated. 
The residue was purified by chromatography on Si02 (70g) using 
dichloromethane plus 0-5% methanolic ammonia as the eluent. Appropriate 
fractions were combined and evaporated to give the desired product as a 
yellow oil. Yield l.Olg (52.1%).
Elemental analysis for C12Hi7C12NO 
Calculated: C 54.97 H 6.54 N 5.34 
Found: C 54.78 H 6.42 N 5.32%
NMR:d(p.p.m.) (CDC13) 0.90 (3H, -CH2CH2CH3), 1.54 (2H, -CH2CH2CH3), 2.48 
(2H, -CH2CH2CH3), 2.39 (3H, N-CH3), 2.87 (2H, -CH2-N), 4.16 (2H, 0-CH2),
6.87 (1H, aromatic H), 7.19 (1H, aromatic H) and 7.71 (1H, aromatic H).
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A mixture of 2,4-dichlorophenoxyacetic acid (4.42g 20mmol), N- 
isopropylmethylamine (1.46g 20mmol), 1-hydroxybenzotriazole (2.70g 
20mmol), l-(3-dimethylaminopropyl)-3-ethyl carbodiimide hydrochloride 
(7.67g 40mmol) and N-methylmorpholine (4.04g 40mmol) in dichloromethane 
(120ml) was stirred overnight at room temperature. The crude reaction 
mixture was washed successively with water (2x150ml), 2M hydrochloric 
acid (2x150ml), saturated aqueous sodium carbonate (2x150ml), dried over 
anhydrous sodium sulphate and evaporated. The residue was purified by 
chromatography using hexane plus 0-50% ethyl acetate as the eluent.
Appropriate fractions were combined and evaporated to give the desired
product as a white solid, melting point 96-97°C. Yield 3.83g (69.4%).
Elemental analysis for C12H15C12N02
Calculated: C 52.19 H 5.47 N 5.07
Found: C 52.19 H 5.53 N 4.99%
NMR:d(p.p.m.) (CDC13) 1.16,1.26 (6H, -CH(CH3)2), 2.84,2.94 (3H, N-CH3),
4.29 (IH -CH(CH3)a), 4.81 (2H, OCH2-), 6.97 (IH, aromatic H), 7.19 (IH,
aromatic H) and 7.39 (IH aromatic H).
(The CH3 signals of the isopropyl group were split due to the anisotropic 
effect of the carbonyl group).
Synthesis 2-(2,4-dichlorophenoxy)-N-isopropyl-N-methylethanamine.
A suspension of lithium aluminium hydride (0.4g 11.36mmol) in tetra- 
hydrofuran (28ml) was stirred at 0°C and concentrated sulphuric acid 
(0.3ml 5.6mmol) added dropwise with stirring over 15 min. The mixture was 
stirred at 0°C for 1 hour prior to the dropwise addition of 2-(2,4- 
dichlorophenoxy)-N-isopropyl-N-methylethanamide (2.0g 7.2mmol) in tetra- 
hydrofuran (8ml). The resulting mixture was stirred for 1 hour and then 
quenched by the cautious addition of a mixture of tetrahydrofuran and
Synthesis of 2-(2,4-dichlorophenoxy)-N-isopropyl-N-methylethanamide.
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water (1/1 v/v) (5ml) followed by 0.9M sodium hydroxide (30ml) and then 
filtered. The filtrate was evaporated and the residue partitioned between 
ethyl acetate and saturated aqueous sodium carbonate solution. The organic 
layer was washed with water, dried over anhydrous sodium sulphate and 
evaporated. The residue was purified by chromatography using dichloro- 
methane plus 0-7.5% methanolic ammonia as the eluent. Appropriate frac­
tions were combined and evaporated to give the desired product as a light 
brown solid, melting point 49-51°C. Yield 1.57g (74.7%).
Elemental analysis for CX2H17C12N0 
Calculated: C 54.97 H 6.54 N 5.34
Found: C 55.02 H 6.57 N 5.21%
NMR:d(p.p.m.) (CDC13) 1.06 (6H, -CH(CH3)2), 2.94 (IH, -CH(CH3)2), 2.39
(3H, N-CH3), 2.87 (2H, -CH2N), 4.13 (2H, OCHa-), 6.87 (IH, aromatic H),
7.19 (IH, aromatic H) and 7.39 (IH, aromatic H).
Synthesis 2-(2,4-dichlorophenoxy)-N-butyl-N-methylethanamine.
A mixture of 2-(2,4-dichlorophenoxy)ethyl bromide (2.0g 7.4mmol), N- 
butylmethylamine (3.2g 32.0mmol), sodium carbonate (3.3g 32.0mmol), sodium 
iodide (0.5g 3.3mmol) in acetonitrile (60ml) was refluxed overnight. The 
reaction mixture was evaporated and the residue taken up in ethyl acetate 
(100ml) and washed with saturated aqueous sodium carbonate solution 
(2x100ml), dried over sodium sulphate and evaporated. The residue was 
purified by chromatography on Si02 using dichloromethane plus 0-7.5% 
methanolic ammonia as the eluent. Appropriate fractions were combined and
evaporated to give the desired product as a yellow oil. Yield 1.73g
(84.6%).
Elemental analysis for CX3HX9C12N0 
Calculated: C 56.53 H 6.93 N 5.07
Found: C 56.71 H 7.06 N 5.36%
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NMR:d(p.p.m.) (CDClg) 0.94 (3H,- -CH2CH2CH2CH3), 1.35 (2H, -CH2CH2CH2CH3), 
1.52 (2H -CH2CH2CH2CH3), 2.48 (2H, -CH2CH2CH2CH3), 2.35 (3H, N-CH3), 2.84
(2H -CH2N), 4.16 (4.16, OCH2-), 6.84 (IH, aromatic H), 7.16 (IH, aromatic
H) and 7.35 (IH aromatic H).
Synthesis of 2-(2,4-dichlorophenoxy)-N-tertiary-butyl-N-methylethanamide.
A mixture of 2,4-dichlorophenoxyacetic acid (4.42g, 20mmol), N- 
tertiary-butylmethylamine (2.09g 24mmol), 1-hydroxybenzotriazole (3.24g 
24mmol), N-methylmorpholine (4.88g 48mmol) and l-(3-dimethylaminopropyl)-
3-ethyl carbodiimide hydrochloride (9.20g 48mmol) in dichlorormethane 
(100ml) was stirred at room temperature over night. The crude reaction 
mixture was washed successively with water (2x100ml), 2M hydrochloric acid 
(2x100ml) and saturated aqueous sodium carbonate (2x100ml), dried over 
anhydrous sodium sulphate and evaporated. The residue was purified by 
chromatography on Si02 (7Og) using hexane plus 0-60% ethyl acetate as the 
eluent. Appropriate fractions were combined and evaporated to give the 
desired product as a white solid. Melting point 102-103°C. Yield 1.77g 
(30.52%).
Elemental analysis for C13H17C12N02 
Calculated: C 53.81 H 5.90 N 4.83
Found: C 53.69 H 5.85 N 4.59%
NMR:d(p.p.m.) (CDC13) 1.39 (6H, -C(CH3)), 3.00 (3H, N-CH3), 4.74 (2H,
OCH2), 6.97 (IH, aromatic H), 7.19 (IH, aromatic H) and 7.39 (IH, aromatic
H).
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A suspension of lithium aluminium hydride (0.34g 9.1mmol) in tetra­
hydrofuran (20ml) was stirred at 0°C and sulphuric acid (0.2ml 4.6mmol) 
was added dropwise over 15 min. The mixture was stirred at 0°C for 1 hour 
prior to the dropwise addition of 2-(2,4-dichlorophenoxy)-N-tertiary- 
butyl-N-methylethanamide (1.77g 6.2mmol) in tetrahyrofuran (6ml). The 
, resulting mixture was stirred for 1 hour and then quenched by the cautious 
addition of a mixture of tetrahydrofuran and water (1/1 v/v) (5ml) 
followed by 0.9M aqueous sodium hydroxide (30ml) and then filtered. The 
filtrate was evaporated and the residue partitioned between ethyl acetate 
(100ml) and saturated aqueous sodium carbonate solution (100ml). The 
organic layer was washed with water, dried over anhydrous sodium sulphate 
and evaporated. The residue was purified by chromatography on Si02 (70g)
using dichloromethane plus 0-7.5% methanolic ammonia as the eluent. 
Appropriate fractions were combined and evaporated to give the desired 
product as a brown solid, melting point 32-34°C. Yield 1.23g (71.2%).
Elemental analysis for C13Hi9Cl2NO 
Calculated: C 56.53 H 6.93 N 5.07
Found: C 56.50 H 7.00 N 5.07%
NMR:d(p.p.m.) (CDC13) 1.16 (6H, -C(CH3)) 2.39 (3H, N-CH3), 2.87 (2H, -
CH2N), 4.18 (2H, OCHa-), 6.84 (IH, aromatic H), 7.16 (IH, aromatic H) and 
7.35 (IH aromatic H).
Synthesis of 2-(2,4-dichlorophenoxy)-N-pentyl-N-methylethanamine.
A mixture of 2-(2,4-dichlorophenoxy)-N-methylethanamine (1.5g 
6.8mmol), 1-bromopentane (1.2g 8.2mmol) sodium carbonate (0.9g 8.2mmol)
and sodium iodide (0.3g 2.0mmol) in acetonitrile (50ml) were refluxed 
overnight. The reaction mixture was evaporated and the residue taken up in 
ethyl acetate (100ml) and washed with saturated aqueous sodium carbonate
Synthesis of 2-(2,4-dichlorophenoxy)-N- tertiary-butyl-N-methylethanamine.
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solution (2x100ml), dried over sodium sulphate and evaporated. The residue 
was purified by chromatography on Si02 (70g) using dichloromethane plus 0- 
10% methanolic ammonia as the eluent. Appropriate fractions were combined 
and evaporated to give the desisred product as a yellow oil. Yield 1.53g 
(77.4%).
Elemental analysis for C14H21Cl2NO 
Calculated: C 57.93 H 7.29 N 4.83
Found: C 57.76 H 7.22 N 4.95%
NMR:d(p.p.m.) (CDC13) 0.90 (3H, -CH2CH2(CH2)2CH3), 1.32 (4H,
-CH2CH2(CH2)2CH3), 1.52 (2H, -CH2CH2(CH2)2CH3), 2.48 (2H,
-CH2CH2(CH2)2CH3), 2.39 (3H, N-CH3), 2.87 (2H, -CH2N), 4.17 (2H, OCH2-),
6.84 (1H, aromatic H), 7.16 (1H, aromatic H) and 7.35 (1H aromatic H).
Synthesis of 2-(2,4-dichlorophenoxy)-N-hexyl-N-methylethanamine.
A mixture of 2-( 2 ,4-dichlorophenoxy)-N-methylethanamine (l.Og 
4.511111101), 1-bromohexane (1.5g 9.1mmol), sodium carbonate (l.Og 7.2mmol) 
and sodium iodide (0.3g 2.0mmol) in acetonitrile (60ml) was refluxed 
overnight. The reaction mixture was evaporated and the residue taken up 
in ethyl acetate (100ml) and washed with saturated aqueous sodium carbon­
ate solution (2x100ml), dried over sodium sulphate and evaporated. The 
residue was purified by chromatography on Si02 (70g) using dichloro­
methane plus 0-10% methanolic ammonia as the eluent. Appropriate fractions 
were combined and evaporated to give the desired product as a yellow oil. 
Yield 0.52g (37.6%).
Elemental analysis for C15H23C12N0 
Calculated: C 59.21 H 7.62 N 4.60
Found: C 59.22 H 7.64 N 4.60%
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NMR: d(p.p.m.) (CDC13) 0.90 (3H, -CH2CH2(CH2)3CH3), 1.32 (6H,
-CH2CH2(CH2)3CH3), 1.52 (2H, -CH2CH2(CH2)3CH3), 2.48 (2H,
-CH2CH2(CH2)3CH3), 2.39 (3H, N-CH3), 2.87 (2H, -CH2N), 4.18 (2H, OCH2-),
6.84 (1H, aromatic H), 7.16 (1H, aromatic H) and 7.35 (IH aromatic H).
Synthesis of 2-[ 2 ,4-dichlorophenoxy)~N~,methyl-2-propenamine.
A mixture of 2-(2,4-dichlorophenoxy)ethyl bromide (2.0g 7.4mmol), N- 
methyl-2-propenamine {2.0g 28.2mmol), sodium carbonate (1.6g 14.8mmol) and 
sodium iodide (0.5g 3.3mmol) in acetonitrile (50ml) was refluxed over­
night. The reaction mixture was evaporated and the residue taken up in
ethyl acetate (100ml) and washed with saturated aqueous sodium carbonate
solution (2x100ml), dried over sodium sulphate and evaporated. The residue 
was purified by chromatography on Si02 (70g) using dichloromethane plus 0- 
10% methanolic ammonia as the eluent. Appropriate fractions were combined 
and evaporated to give the desired product as an amber oil. Yield 1.72g 
(89.3%).
Elemental analysis for C12H15C12N0 
Calculated: C 55.40 H 5.81 N 5.38
Found: C 55.53 H 5.69 N 5.28%
NMR:d(p.p.m.) (CDC13) 5.19 (2H, -CH2CH=CH2), 5.90 (IH, -CH2CH=CH2), 3.19 
(2H, -CH2CH=CH2), 2.39 (3H, N~CH3), 2.87 (2H, -CH2N), 4.16 (2H, OCH2-),
6.87 (IH, aromatic H), 7.19 (IH, aromatic H) and 7.39 (IH aromatic H).
Synthesis 2 - ( 2 ,4-dichlorophenoxy)-N-methyl-2-propynamine.
A mixture of 2-(2,4-dichlorophenoxy)ethyl bromide (2.0g 7.4mmol), N- 
methyl-2-propynamine (2.6g 37.6mmol) sodium carbonate (1.6g 14.8mmol) and 
sodium iodide (0.5g 3.3mmol) in acetonitrile (50ml) was refluxed 
overnight. The reaction mixture was evaporated and the residue taken up in 
ethyl acetate (100ml) and washed with saturated aqueous sodium carbonate 
solution (2x100ml), dried over sodium sulphate and evaporated. The residue
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was purified by chromatography on Si02 (70g) using dichloromethane plus 0- 
10% methanolic ammonia as the eluent. Appropriate fractions were combined 
and evaporated to give the desired product as an amber oil. Yield 1.65g 
(85.0%).
Elemental analysis for CX2HX3C12N0 
Calculated: C 55.83 H 5.08 N 5.43
Found: C 55.63H 5.14 N 5.32%
NMR:d(p.p.m.) (CDC13) 2.29 (1H, -CH2C=CH), 3.48 (2H, -CH2C=CH), 2.48 (3H, 
N-CH3), 2.94 (2H, -CH2N), 4.16 (2H, 0CH2-), 6.87 (1H, aromatic H), 7.19
(1H, aromatic H) and 7.39 (1H aromatic H).
Synthesis of 2- (2,4-dichlorophenoxy)-N-phenyl-N-methylethanamine.
A mixture of 2-(2,4-dichlorophenoxy)ethyl bromide (2.Og 7.4mmol) and 
N-methylaniline (2.4g 22.2mmol) were heated at 100°C for 5 hours. The
reaction mixture was cooled, diluted with ethyl acetate (100ml), washed
with saturated aqueous sodium carbonate solution (2x100ml), dried over 
anhydrous sodium sulphate and evaporated. The residue was purified by 
chromatography on Si02 using dichloromethane plus 0-2% methanolic ammonia 
as the eluent. Appropriate fractions were combined and evaporated to give 
the desired product as a colourless oil. Yield 0.9g (40.1%).
Elemental analysis for CX5HX5C12N0 
Calculated: C 60.83 H 5.10 N 4.73
Found: C 60.96 H 5.20 N 4.70%
NMR:d(p.p.m.) (CDC13) 6.77,7.29 (5H aromatic H), 3.16 (3H, N-CH3), 3.84
(2H, -CH2N), 4.19 (2H, OCH2-), 6.77 (1H, aromatic H), 7.19 (1H, aromatic
H) and 7.29 (1H, aromatic H).
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A mixture of 2-(2,4-dichlorophenoxy)ethyl bromide (2.0g 7.4mmol), N- 
benzylmethylamine (1.8g 14.9mmol) sodium carbonate (1.2g 11.3mmol) and
sodium iodide (0.5g 3.3mmol) in acetonitrile (50ml) was refluxed over­
night. The reaction mixture was evaporated, taken up in ethyl acetate
(100ml) and washed with saturated aqueous sodium carbonate solution 
, (2x100ml), then dried over anhydrous sodium sulphate and evaporated. The 
residue was purified by chromatography on Si02 (70g) using dichloromethane 
plus 0-10% methanolic ammonia as the eluent. Appropriate fractions were 
combined and evaporated to give the desired product as a yellow oil. Yield 
l.OOg (43.5%).
Elemental analysis for C16H1VC12N0 
Calculated: C 61.95 H 5.52 N 4.52
Found: C 61.97 H 5.55 N 4.28%
NMR: d(p.p.m.) (CDC13) 7.35 (5H, -CH2C6H5), 3.68 (2H, -CH2C6H5), 2.42
(3H, N-CH3), 2.90 (2H, -CH2N), 4.16 (2H, OCH2-), 6.81 (IH, aromatic H),
7.19 (IH, aromatic H) and 7.29 (IH, aromatic H).
Synthesis 2-(2,4-dichlorophenoxy)-N-phenethy1-N-methylethanamine♦
A mixture of 2-(2,4-dichlorophenoxy)ethyl bromide (2.0g 7.4mmol), N- 
phenethylmethylamine (2.0g 14.8mmol), sodium carbonate (2.0g 18.5mmol) and 
sodium iodide (0.5g 3.3mmol) in acetonitrile (50ml) was refluxed 
overnight. The reaction mixture was evaporated and the residue taken up in 
ethyl acetate (100ml) and washed with saturated aqueous sodium carbonate 
solution (2x100ml), then dried over anhydrous sodium sulphate and evapor­
ated. The residue was purified by chromatography on Si02 (70g) using 
dichloromethane plus 0-10% methanolic ammonia as the eluent. Appropriate 
fractions were combined and evaporated to give the desired product as a 
yellow oil. Yield 1.86g (77.5%).
Synthesis of 2-(2,4-dichlorophenoxy)-N-benzyl-N-methylethanamine.
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Elemental analysis for C17H19C12N0 
Calculated: C 62.97 H 5.91 N 4.32 
Found: C 62.61 H 5.89 N 4.25%
NMR: d(p.p.m.) (CDC13) 7.26 (5H, -CH2CH2C6H5), 2.84 (4H, -CH2CH2C6H5),
. 2.52 (3H, N-CH3), 2.97 (2H, -CHaN), 4.16 (2H, OCHa-), 6.87 (1H, aromatic
H), 7.19 (1H, aromatic H) and 7.40 (1H, aromatic H).
Synthesis of N,N-Bis-[2-(2,4-dichlorophenoxy)ethyllmethanamine.
A mixture of 2-(2,4-dichlorophenoxy)ethyl bromide (2.45g ll.lmmol),
2-(2,4-dichlorophenoxy)-N-methylethanamine (l.Og 3.7mmol) sodium carbonate 
(0.8g 7.5mmol) and sodium iodide (0.5g 3.3mmol) in acetonitrile (50ml) was 
refluxed overnight. The reaction mixture was evaporated and the residue 
taken up in ethyl acetate (100ml) and washed with saturated aqueous sodium 
carbonate solution (2x100ml), dried over anhydrous sodium sulphate and 
evaporated. The residue was purified by chromatography on Si02 (70g) using 
dichloromethane plus 0-10% methanolic ammonia as the eluent. Appropriate
fractions were combined and evaporated to give the desired product as
a yellow oil. Yield l.OOg (53.8%).
Elemental analysis for C17H17C14N02 
Calculated: C 49.91 H 4.19 N 3.42 
Found: C 50.05 H 4.17 N 3.20%
NMR: d(p.p.m.) (CDC13) 2.39 (3H, N-CH3), 2.87 (4H, -CHaN), 4.16 (4H,
0CH2-), 6.87 (2H, aromatic H), 7.19 (2H, aromatic H) and 7.40 (2H,
aromatic H).
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A mixture of 2-(2,4-dichlorophenoxy)-N-methylethanamine (2.0g 
9.1mmol), 2-bromoethanol (2.0g 16.0mmol), sodium carbonate (1.7g ll.Ommol) 
and sodium iodide (0.3g 2.0mmol) in acetonitrile (60ml) were refluxed for 
72 hours. The reaction mixture was evaporated and the residue taken up in 
ethyl acetate (100ml) and washed with saturated aqueous sodium carbonate 
, solution (2x100ml), dried over sodium sulphate and evaporated. The residue 
was purified by chromatography on Si02 (70g) using dichloromethane plus 0- 
10% methanolic ammonia as the eluent. Appropriate fractions were combined 
and evaporated to give the desired product as a yellow oil. Yield 0.70g 
(29.0%).
Elemental analysis for C1;iH15C12N02 
Calculated: C 50.24 H 5.77 N 5.21 
Found: C 50.02 H 5.72 N 5.30%
NMR:d(p.p.m.) (CDC13) 2.52 (IH, -CH2CH2OH), 3.65 (2H, -CH2CH2OH), 2.94
(2H, -CH2CH2OH), 2.42 (3H, N-CH3), 2.87 (2H, -CH2N), 4.13 (2H, OCH2-),
6.84 (IH, aromatic H), 7.16 (IH, aromatic H) and 7.35 (IH aromatic H).
(On treatment with D20 the signal at 2.52 p.p.m disappeared and a new 
signal appeared at 4.84 p.p.m).
Synthesis of____ N- f 2- (2,4-dichlorophenoxy) ethyl 1 -N-methy lqlycine
hydrochloride.
A mixture of 2-(2,4-dichlorophenoxy)ethyl bromide (4.0g 14.8mmol),
sarcosine ethyl ester (4.6g 29.6mmol), sodium carbonate (3.2g 29.6mmol)
and sodium iodide (0.5g 3.3mmol) in acetonitrile (100ml) was refluxed 
overnight. The reaction mixture was evaporated and the residue taken up 
in ethyl acetate (200ml) and washed with saturated aqueous sodium 
carbonate solution (2x200ml), dried over anhydrous sodium sulphate and 
evaporated. The residue was purified by chromatography on Si02 (70g) using
Synthesis of 2-(2,4-dichlorophenoxy)-N-(2-hydroxyethyl)-N-methylethanamine.
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dichloromethane plus 0-15% methanolic ammonia as the- eluent. Appropriate 
fractions were combined to give the desired product as a white solid. 
Yield 2.88g (63.5%).
Elemental analysis for CX3HX7C12N03 
Calculated: C 50.99 H 5.60 N 4.57
Found: C 50.59 H 5.42 N 4.29%
NMR:d(p.p.m.) (CDC13) 1.29 (3H, -CH2C02CH2CH3), 4.16 (2H, -CH2C02CH2CH3), 
3.45 (2H, -CH2C02CH2CH3), 2.52 (3H, N-CH3), 3.06 (2H, -CH2N), 4.13 (2H,
OCH2-), 6.84 (1H, aromatic H), 7.16 (IH, aromatic H) and 7.35 (IH aromatic 
H).
A solution of N-[2-(2,4-dichlorophenoxy)ethyl]-N-methylglycine ethyl 
ester (2.5g 8.2mmol) and sodium hydroxide (1.6g 40mmol) in a mixture of 
1,4-dioxane (15ml) and H20 (15ml) was stirred at room temperature for 4 
hours and evaporated. The residue was dissolved in water (50ml), washed 
with diethyl ether (2x50ml), acidified with concentrated hydrochloric acid 
and evaporated. The resulting white solid was dissolved in ethanol (50ml) 
and the solution filtered. The filtrate was evaporated and the resulting 
white solid was collected, washed with 1,4-dioxane and dried to give the 
desired compound. Yield 1.34g (52.2% 4.26mmol).
Elemental analysis for C1XH14C12N02.HC1.1/4 H20 
Calculated: C 41.40 H 4.58 N 4.17
Found: C 41.48 H 4.29 N 4.38%
NMR:d(p.p.m.) (ds-DMSO) 2.48 (IH, -CH2COOH), 4.19 (2H, -CHaCOOH), 2.94
(3H, N-CH3), 3.68 (2H, -CH2N), 4.84 (2H, OCH2-), 7.23 (IH, aromatic H),
7.39 (IH, aromatic H) and 7.61 (IH aromatic H).
(On treatment with D20 the signal at 2.48 p.p.m disappeared and a new 
signal appeared at 4.85 p.p.m).
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2-(2,4-Dichlorophenoxy)-N-ethyl-N-methylethanamine (1.7g 6.9mmol) was 
added to hydrogen peroxide (0.9g 26.5mmol) and the mixture stirred until 
the upper organic layer disappeared. The solution was basified with 2M 
sodium hydroxide, washed with diethyl ether (2x5ml), neutralized with 2M 
hydrochloric acid and evaporated. The resulting solid was recrystallised 
from trichloromethane to give the desired compound. Yield 0.7g (38.7%).
Elemental analysis for CXXHX5C12N02.1/2 CHC13 
Calculated: C 42.64 H 4.82 N 4.32 
Found: C 42.42 H 5.12 N 4.27%
NMR:d(p.p.m.) (CDC13) 1.45 (3H, -CH2CH3), 3.29 (3H, N-CH3), 3.55 (2H -
CH2CH3), 3.77 (2H, -CH2N), 4.98 (2H, OCH2-), 6.97 (IH aromatic H), 7.19
(IH aromatic H) and 7.35 (IH, aromatic H).
Synthesis of 3-(2,4-dichlorophenyl)-N-ethyl-N-methylpropanamine,
A mixture of 2,4-dichlorocinnamic acid (6.51g 30mmol), N- 
ethylmethylamine (1.77g 30mmol), 1-hydroxybenzotriazole (4.05g 30mmol), N- 
methylmorpholine (6.06g 60mmol) and l-(3-dimethylaminopropyl)-3-ethyl 
carbodiimide hydrochloride (11.5Og 60mmol) in dichloromethane (200ml) was 
stirred overnight at room temperature. The crude reaction mixture was 
washed successively with water (2x300ml), 2M hydrochloric acid (2x300ml) 
and saturated aqueous sodium carbonate solution (2x300ml), dried over 
anhydrous sodium sulphate and evaporated. The residue was purified by 
chromatography on Si02 (70g) using hexane plus 0-60% ethyl acetate. 
Appropriate fractions were combined and evaporated to give the desired 
product as a white solid. Yield 4.88g (63.05%).
3-(2,4-Dichlorophenyl)-N-ethyl-N-methylpropanamide (2.0g 7.8mmol) was 
dissolved in ethanol (40ml) and hydrogenated overnight in the presence of
Synthesis of 2-(2,4-dichlorophenoxy)-N-ethyl-N-methylethanamine N-oxide.
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a platinum on carbon catalyst. The catalyst was filtered off and the 
reaction mixture concentrated under reduced pressure. The product was not 
isolated at this stage. Crude yield 1.5g.
A stirred suspension of lithium aluminium hydride (0.31g 8.2mmol) in 
dry tetrahydrofuran (40ml) was stirred at 0°C and concentrated sulphuric
acid (0.3ml, 4.1mmol) was added dropwise over 15 min. The mixture was
stirred at 0°C for 1 hour prior to the dropwise addition of 3-(2,4- 
dichlorophenyl)-N-ethyl-N-methylpropanamide (1.50g 5.5mmol) in tetrahydro­
furan (10ml). The resulting mixture was stirred for 1 hour and then
quenched by the cautious addition of a mixture of tetrahydrofuran and 
water (1/1 v/v) (5ml) followed by 0.9M sodium hydroxide (30ml) and then
filtered. The filtrate was evaporated and the residue partitioned between
ethyl acetate (100ml) and saturated aqueous sodium carbonate solution
(100ml). The organic layer was washed with water, dried over anhydrous 
sodium sulphate and evaporated. The residue was purified by chromatography 
on Si02 (70g) using dichloromethane plus 0-10% methanolic ammonia. Appro­
priate fractions were combined and evaporated to give the desired compound 
as a yellow oil. Yield 0.7g (49.3% 2.84mmol).
Elemental analysis for C12H17C12N 
Calculated: C 58.55 H 6.99 N 5.69
Found: C 58.68 H 6.79 N 5.52%
NMR:d(p.p.m.) (CDC13) 1.10 (3H, -CH2CH3), 2.23 (3H, N-CH3), 2.40 (2H -
CH2CH3), 2.40 (2H, -CH2CH2CH2N), 1.78 (2H, -CH2CH2CH2N), 2.73 (2H -
CH2CH2CH2N), 7.18 (2H aromatic H) and 7.38 (1H, aromatic H).
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ditritioethanamine.
A sample of 2-(2,4-dichlorophenoxy)-N-isopropyl-N-methylethanamide 
(lOOmg) was tritiated by Professor J.R.Jones, Department of Chemistry, 
University of Surrey to a specific activity of 667 uCi/mg. The 
radiochemical purity of this compound was assessed as greater than 99% by 
tic using hexane/ethyl acetate (1/1 v/v) as the solvent system.
Unlabelled 2-(2,4-dichlorophenoxy)-N-isopropyl-N-methylethanamide 
(985mg) was added to give a specific activity of 10.01 uCi/mg. A 
suspension of lithium aluminium hydride (0.2g 5.62mmol) in tetrahydrofuran 
(12ml) was stirred at 0°C and concentrated sulphuric acid (0.2ml 3.7mmol) 
was added dropwise over 15 min. The mixture was stirred at 0°C for 1 hour 
prior to the dropwise addition of 2-(2,4-dichlorophenoxy)-N-isopropyl-N- 
methylethanamide (l.Og 7.2mmol) in tetrahydrofuran (4ml). The resulting 
mixture was stirred for 1 hour and then quenched by the cautious addition 
of a mixture of tetrahydrofuran and water (1/1 v/v) (5ml) followed by 
0.9M sodium hydroxide (30ml) and then filtered. The filtrate was evapor­
ated and the residue partitioned between ethyl acetate (100ml) and 
saturated aqueous sodium carbonate solution (100ml), dried over anhydrous 
sodium sulphate and evaporated. The residue was purified by chromatography 
on Si02 (70g) using dichloromethane plus 0-10% methanolic ammonia. Appro­
priate fractions were combined and evaporated to give the desired product 
as a yellow oil. Yield 0.62g (58.9%).
The specific activity of the product was found to be 3.77 uCi/mg and 
the radiochemical purity, determined on tic and hplc, was found to be 
greater than 99%.
Elemental analysis for C^ Hx-zOlaNC)
Calculated: C 54.97 H 6.54 N 5.34 
Found: C 55.15 H 6.43 N 5.36%
Synthesis_______of_______ 2-(2,4-dichlorophenoxy) -N-isopropyl-N-methyl-2,2-
60
NMR:d(p.p.m.) (CDC13) 1.06 (6H, -CH(CH3)2), 2.94 (1H, -CH(CH3)2), 2.39
(3H, N-CH3), 2.87 (2H, -CHaN), 4.13 (2H, -OCHa), 6.87 (1H, aromatic H),
7.19 (1H, aromatic H) and 7.39 (1H, aromatic H).
The structures of all the compounds used in this study and the
abbreviations routinely used are given in figure 2.1.
4
Fig 2.1 2-(2,4-Dichlorophenoxy)-N-methylethanamine.
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2-(2,4-Dichlorphenoxy)-N-ethylhydroxy-N-methylethanamine 
Ethylhydroxy DME
Cl CH^O OH
i2-ch2 - \
c h 3
N-[2-(2,4-Dichlorophenoxy)ethyl]methylglycine 
Carboxymethyl DME
Cl
Cl'
I 0 4 ^ 3  
.O —  CH 2~  CH N.
0H3
2-(2,4-Dichlorophenoxy)-N-ethy!-N-methylethanamine _N_oxide. 
Ethyl DME N-oxide
Cl /CHrpHg 
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3-(2,4-Dichlorophenoxy)-N-ethyl-N-methylpropanamine 
Ethyl DMP
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CHAPTER 3
Determination of the physico-chemical and molecular mechanics properties 
of the 2-(2,4-dichlorophenoxy)-N-methylethanamines.
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To obtain any quantitative structure activity relationships it was 
necessary to determine some of the physico-chemical and molecular mechani­
cal properties of the tertiary amine series of molecules which may
influence the overall rate of metabolism or the binding of the substrate 
to the enzyme. These properties included pKa, log P (octanol / water 
partition coefficient) and log D which is defined as the octanol / water 
partition coefficient at pH 7.4 and hence takes into account not only the 
partition between the two phases but also includes a component from the 
ionisation of the compounds at physiological pH.
The lipophilicity of the compounds was assessed using three different 
methods, one method based on the summation of hydrophobic substituent 
constants (log P), one method using reverse phase thin layer chromato­
graphy (Rm) and one method using reverse phase high pressure liquid 
chromatography (log kQ). Three methods were used since there is no
reliable model for the partition of a compound between a lipid phase and
an aqueous phase, however each of these methods has been used to as a
measure of lipophilicity in quantitative-structure activity relationships 
(Martin et al., 1971; Jack et al., 1988; Minick et al., 1988).
The differing rates of metabolism of these compounds may be governed 
by physico-chemical effects as well as effects which are more subtle such 
as the effect on the electron distribution about the nitrogen atom arising 
from different substituent groups. Investigation of these effects required 
the solution of the crystal structure of one of the molecules and the use 
of the atomic coordinants obtained from this in molecular mechanics 
calculations to yield information about the electronic and energetic 
properties of the molecules.
3.1 Introduction.
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3.2.1 Determination of R™ for selected members of the 2-(2,4-dichloro­
phenoxy ) -N-methy lethanamine series.
The lipophilicity of nine of the 2-(2,4-dichlorophenoxy)-N-methy1- 
. ethanamines and the three 2-(2,4-dichlorophenoxy)-N-methylethanamides was 
estimated using reverse phase thin layer chromatography according to the 
method of Tsantili-Kakoulidou and Antoniadou-Vyza (1988).
All the compounds were dissolved in acetone to give a final 
concentration of ImM and 40 ul of these solutions applied to a reverse 
phase tic plate (Merck 20 X 20 cm). The plate was then developed in a 
solvent system consisting of 6-aminocaproic acid (0.5M) : acetone (60 :
40). The compounds were visualised by examining the plate under ultra­
violet light (254 nm). The Rf value of each compound was used to calculate 
the Rm value according to equation 3.1.
Equation 3.1 Rm ~ log1Q[(1/Rf)-l]
This process was repeated a further three times using tic solvent systems 
containing 50, 60 and 70% acetone respectively.
The Rm values for a given compound were plotted against the acetone 
concentration and the value at 0% acetone determined. This is the true Rm 
value.
3.2 Methods.
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The lipophilicity of the same series of 2-(2,4-dichlorophenoxy)-N- 
methylethanamines and amides as used for 3.2.1 was determined using 
reverse phase high pressure liquid chromatography (hplc) according to the 
methods of Minick et al, (1988) and Pietrogrande (1987).
The compounds were dissolved- in 85% methanol : 0.1M
N'N'N'N'tetramethylethylenediamine (TEMED) phosphate pH 7.4 to give a 
final concentration of ImM. The retention time of each compound was
determined on a 25cm Spherisorb 5 ODS-2 column using 85% methanol : 0.1M
TEMED phosphate pH 7.4 as the mobile phase with uv detection at 280 nm
after injection of 20ul of the stock solution of the compound. The
capacity factor (k') was determined according to equation 3.2.
Equation 3.2 log k' =log [(tR-t0)/tR]
where tR is the retention time of the compound
t0 is the retention time of an unretained compound (in this case the 
dead time of the system was used as the retention time of an unretained 
compound).
This process was repeated with two further mobile phases (90% and 95% 
methanol in 0.1M TEMED phosphate pH 7.4). The values for log k' were 
plotted against methanol concentration and the line extrapolated to give 
log k0 (the capacity factor in 0% methanol).
3.2.2 Determination of log10k0 for some members of the 2-(2,4-
dichlorophenoxy)-N-methylethanamine series.
68
3.2.3 Determination of log D (octanol / water distribution coefficient at 
pH 7.4) for the series of tertiary amines.
Octanol (200ml) and 50mM potassium phosphate buffer (pH 7.4, 200ml)
were mixed together for 1 hour, centrifuged and the octanol and buffer 
phases separated and stored at 4°C until required.
Each of the compounds (1 mg) were dissolved in phosphate buffer- 
saturated octanol (2ml) and the octanol-saturated phosphate buffer (2ml) 
was added. The two phase system was mixed for 1 hour, and then centrifuged 
to clarify the layers. The octanol phase (1ml) was retained, the octanol 
at the interface discarded and the phosphate buffer (1ml) phase was 
collected. Each phase was analysed for the compound using a hplc system 
with the following specifications:
Column: 25 x 0.46 cm Spherisorb ODS-2 5 uM particle size
Flow rate: 1.0 ml/minute
Mobile phase: 90% methanol, 10% 0.1M TEMED phosphate pH 7.4
Injection volume: octanol phase 20ul
phosphate buffer phase 200ul
The partition coefficient was determined from equation 3.3 using the peak 
area of the compound in each phase
Peak area in the octanol phase 
Equation 3.3 log D = log ____________________________
Peak area in the buffer phase.
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3.2.4 Calculation of the intrinsic lipophilicity (log P), molar refract- 
ivity (MR) and Andrews binding energy for the series of 2-(2,4-dichloro­
phenoxy )-N-methylethanamines.
The intrinsic lipophilicity (log P) of all the compounds used in this 
study was determined using the Pomona College MedChem data base. This 
system calculates the lipophilicity of a compound by addition of 
fragmental constants for the different chemical groups present in the 
molecule. This method was also used to calculate the molar refractivity
(MR) and the Andrews binding energy of each molecule. The molar
refractivity of a compound is related to the molecular volume and hence 
the addition of fragments with known refractivities to give the molar 
refractivity also yields a estimate of molecular volume. The Andrews 
binding energy is related to the free energy of the binding reaction
between a substrate and a receptor (Andrews, 1986). This can be calcu­
lated by the addition of fragments that have known free energies of 
binding to give the value for the complete molecule.
3.2.5 Calculation of pKa values for the series of 2-(2.4-
dichlorophenoxy)-N-methylethanamines.
The high lipophilicity of the 2-(2,4-dichlorophenoxy)-N-methylethan­
amines made it very difficult to determine their pKa's in aqueous 
solution. It was necessary to obtain a value for the pKa so that an 
appreciation of the ratio of unionised to ionised compound could be 
attained.
A method for the determination of the pKa of these compounds that 
uses the Taft parameter (sigma*) for the substituent group's inductive 
effects was obtained from (Perrin et al, 1981). The pKa of a tertiary 
amine can be determined using equation 3.4:
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were X = the sum of sigma’" over the molecule 
Therefore the values of sigma* for all the substituents were obtained from 
for each of the molecules and summed to give an estimate of the pKa.
3.2.6 X-ray crystallography.
The atomic coordinates of 2-(2,4-dichlorophenoxy)-N-isopropyl-N- 
methylethanamine and 2-(2,4-dichlorophenoxy)-N-isopropyl-N-methylethan- 
amide were determined from single-crystal X-ray crystallography.
All the data collection for the single-crystal examinations were 
carried out on an Enraf-Nonius CAD4 4-circle diffractometer (Enraf-Nonius 
Delft, The Netherlands) using graphite monochromated molybdenum k alpha 
radiation of wavelength 0.71069 A. The CAD4 diffractometer is based on 4 
circles phi, omega, kappa and chi with the X-ray detector rotating in a 
fifth (2 theta) circle. These circles orientate the crystal such that the 
incident and reflected beams lie in the horizontal (2 theta) plane.
Before the structure of the compounds could be elucidated the unit 
cell dimensions (a, b, c, alpha, beta and gamma) had to be determined. The 
unit cell determination was carried out using the SEARCH option on the CAD 
4 system. This allowed for the random orientation of the crystal and 
involved finding a reflection which was then indexed in terms of the 
Miller indices h,k and 1. These indices were then used to calculate the 
unit cell parameters. A maximum of 25 reflections were used in this 
determination. In order to refine the unit cell the 25 reflections were 
then re-centered using the SETANG option and the unit cell parameters 
redetermined. This was repeated until the standard deviation of the unit
Equation 3.4 pKa = 9.61 - 3.30 X
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cell parameters was minimised. •
During the data collection 4 reflections were monitored as a check on 
the crystal orientation. These were measured every 200 reflections.
The intensity of a chosen reflection was measured every 30 minutes of 
x-ray time as a check of crystal decay.
The data was collected at a speed of 4°/min - 2.8°/min. During the 
data collection the reflections were designated strong or weak based on 
the intensity of the reflection.
Once the data had been collected for both crystals, the structures 
were solved using a PDP11/73 computer in conjunction with the SDP 
(Structure Determination Package, Frenz, 1983) system of programs.
The progess of the structure solution was monitored using the 
correlation coefficient (r) for a plot of calculated intensities of each 
reflection plotted against the experimentally obtained value of the 
intensities.
3.2.7 Molecular analysis of the 2-(2,4-dichlorophenoxy)-N-methylethanamine 
series.
Molecular mechanics has been used in this study to derive parameters 
from the molecular obital energies in an attempt to resolve the observed 
differences in the compounds rate of metabolism with some property of the 
molecule related to atomic charge. These studies were carried out using 
the COSMIC suite of programmes obtained from Smith, Kline and French 
Limited Welywn Garden City U.K. which was run on a Sigmex 6130 molecular 
graphics work-station coupled to a MicroVax II computer.
Obtaining these parameters is essentially a two step process (i) the 
minimum energy conformation of the molecule must be determined (ii) the 
orbital energies calculated using methods that give approximate solutions 
to the Schrodinger wave equation.
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The lipophilicity of a short series of 2-(2,4-dichlorophenoxy)-N~ 
methylethanamines was determined in two different ways based on the 
interaction between the compounds and the lipophilic stationary phases of 
, different chromatographic systems; tic (section 3.2.1) and hplc (section 
3.2.2). The lipophilicity parameter obtained by tic is termed 'Rm' and 
that obtained by hplc is termed 'log k0'. Typical plots for the determin­
ation of Rm and log k0 are given in fig 3.1. The values of Rm, log kD and 
log P for a short series of 2-(2,4-dichlorophenoxy)-N-methylethanamines 
are given in table 3.1. The retention times on hplc were found to be more 
reproducible than Rf values on tic, therefore the log kQ values were 
preferred as an index of the lipophilicity of these compounds.
To enable comparisons to be made between this study and studies 
carried out by other groups, log P was used as a measure of lipophilicity 
since this could be calculated for any molecule as described in section 
3.2.4. To ensure that the value obtained from the data base was in 
accordance the value of log k0, regression analysis was carried out 
between these two parameters for 12 members of the 2-(2,4-dichlorophen­
oxy) -N-methy lethanamines and 2-(2,4-dichlorophenoxy)-N-methylethanamides. 
This analysis yielded a positive correlation (fig 3.2) between the two 
parameters with a correlation coefficient of 0.847. In this study log P as 
a standard method for the assessment of lipophilicity since the ease of 
its calculation allowed comparisons to be made between the 2-(2,4- 
dichlorophenoxy)-N-methylethanamines and other series of tertiary 
amines. The intrinsic lipophilicity (log P) of a tertiary amine is defined 
as the lipophilicity of the compound in the absence of any ionisation of 
the amine function.
3.3 Results.
3.3.1 Lipophilicity of the 2-(2,4-dichlorophenoxy)-N-methylethanamines.
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Correlation coefficient of the regression line in A = 0.991.
Correlation coefficient of the regression line in B = 0.989.
Fig 3.1 Lipophilicity measurement of 2-(2,4-dichlorophenoxy)-N,N-
dimethylethanamine by Rm (A) and log kQ (B).
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Table 3.1 Lipophilicity measurements for 2-(2,4-dichlorophenoxy)-N- 
methylethanamines and 2-(2,4-dichlorophenoxy)-N-methylethanamides.
Substituent Rm Log k0 Log P
Amine series:
Methyl 1.93 1.29 3.34
Ethyl 2.16 1.35 3.79
Isopropyl 1.43 1.37 4.01
t-Butyl 1.38 1.29 4.33
Ethyl hydroxy 1.37 0.71 2.63
Benzyl 3.45 1.55 5.14
Bis 3.40 1.94 6.55
Ethyl DMP 2.12 1.35 4.31
Carboxymethyl 0.60 0.04 3.02
Amide series:
Methyl 1.51 0.46 2.61
Ethyl 1.70 0.59 3.14
Isopropyl 2.06 0.72 3.45
Values for Rm and log kD of the compounds are the average of duplicate 
determinations which varied by less than 5%.
Bis = N,N-Bis-[2-(2,4-dichlorophenoxy)ethyl]methanamine.
Ethyl DMP = 3-(2,4-dichlorophenyl)-N-ethyl-N-methylpropanamine.
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The correlation is described by the equation:
Log P = 1.74(+0.36) log kQ - 2.02(+0.42) 
s = 0.64 r = 0.847 F = 23.44
Fig 3.2 Correlation between experimentally determined log k0 and 
calculated log P for some 2-(2,4-dichlorophenoxy)-N-methylethanamines and 
2-(2,4-dichlorophenoxy)-N-methylethanamides.
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At physiological pH (7.4) most tertiary amines wil-l be ionised to some 
degree. Hence any assessment of the compound's partition between an 
aqueous environment and a lipid environment must take into account the pKa 
of the compound.
, 3.3.2 Distribution coefficient (log D) for the series 2-(2,4- 
dichlorophenoxy)-N-methylethanamines.
The distribution coefficient (log D) of a compound is defined as the 
octanol / water partition coefficient at physiological pH. For many 
compounds this is closely approximated by the intrinsic lipophilicity (log 
P). However, for compounds that contain ionisable groups e.g. carboxylic 
acid or amino, the distribution between the two phases is now dependent 
on the ionisation state of the molecule at the pH of the assay as well as 
its lipophilicity , It has been demonstrated (Manners et al. 1988) that
the distribution coefficient can be an important factor when assessing a 
compound's metabolism. The relationship between log P and the pKa of a 
tertiary amine is illustrated in fig 3.3.
The distribution coefficient for the series of 2-(2,4-dichlorophen­
oxy) -N-methylethanamines were measured by hplc as described in section 
3.2.3. These results are given in table 3.2.
Regresssion analysis carried out on log P and log D indicated that 
log D was not directly dependent on log P ( r = 0.680, p < 0.01 ) although 
the two parameters maybe linked.
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Ka =
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[R3N]:
Distribution coefficient,
[ R3N ] AQUEOUS [R3MH ] AQUEOUS
Combination of these relationships gives equation 3.5:
Equation 3.5 Log [P/D-l] = pKa - pH
Fig 3.3 The dependence of the distribution coefficient (log D) on the 
intrinsic lipophilicity (log P) and the ionisation constant (pKa) for 
tertiary amines.
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Table 3,2 Partition coefficients and calculated pKa values for the 
series of 2-(2,4-dichlorophenoxy)-N-methylethanamines.
Substituent Log D sigma* pKa
Methyl 1.80 0.00 8.25
Ethyl 2.18 -0.10 8.58
n-Propyl 2.84 -0.12 8.65
Isopropyl 2.29 -0.19 8.88
n-Butyl 3.49 -0.25 9.08
t-Butyl 2.33 -0.30 9.24
n-Pentyl 3.41 -0.25 9.08
n-Hexyl 3.48 -0.25 9.08
Phenyl 4.33 0.75 5.78
Benzyl 3.55 0.27 7.36
Phenethyl 3.25 -0.06 8.44
Bis 3.63 0.82 6.89
Propenyl 3.36 0.00 8.25
Propynyl 2.84 0,81 5.58
Ethyl hydroxy 1.94 -0.22 7.54
Ethyl DMP 1.79 -0.10 9.22
Values of log D represent the mean of one determination carried out in 
triplicate.
Bis = N,N-Bis-[2-(2,4-dichlorophenoxy)ethyljmethanamine
Ethyl DMP = 3-(2,4-dichlorophenoxy)-N-ethyl-N-methylpropanamine.
79
The value of pKa for 2-(2,4-dichlorophenoxy)-N-methylethanamine was 
calculated using the experimentally determined values of both log D and 
log P for 2-(2,4-dichlorophenoxy)-N,N-dimethylethanamine.
The value of log P for 2-(2,4-dichlorophenoxy)-N,N-dimethylethanamine 
was experimentally determined as the distribution coefficient at pH 13.5. 
Hence the methodology was the same as for the log D determination in 
section 3.2.3 with the exception that the partition was between 50 mM 
potassium hydroxide and octanol. It was not possible to do this for all 
compounds as it became increasingly more difficult to determine the 
concentration of the compound in the aqueous phase at this high pH.
The pKa of methyl DME was calculated using the following information 
substituted in equation 3.5:
Log D = 1.80 
Log P = 2.65 
pH =7.40 
pKa =8.25
Since sigma* for a methyl group is 0.00 then it was possible to calculate 
sigma* for 2-(2,4-dichlorophenoxy)-N-methylethanamine as 0.412. Using this 
value in conjunction with the values of sigma* for the third nitrogen 
substituent the pKa's for all the 2-(2,4-dichlorophenoxy)-N-methylethan­
amines were calculated. These values are given in table 3.2.
3.3.3 Calculation of pKa- values for the series of 2-(2,4-
dichlorophenoxy)-N-isopropyl-N-methylethanamines.
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methylethanamines.
3.4.1 X-ray crystallography.
Before molecular mechanics calculations could be carried out on the
2-(2,4-dichlorophenoxy)-N-methylethanamines it was necessary to determine 
the atomic coordinates of one of the members of the series by X-ray
crystallography. Two compounds were chosen for single crystal analysis 2- 
(2,4-dichlorophenoxy)-N-isopropyl-N-methylethanamine (isopropyl DME) and
2-(2,4-dichlorophenoxy)-N-isopropyl-N-methylethanamide (isopropyl DMEA).
The data used to determine the structure of both compounds is
summarised in table 3.3.
3.4.2 Structure of Isopropyl DME.
Crystals of isopropyl DME were obtained from the slow evaporation of an 
etheral solution of the compound at 4°C.
A total of 2210 X-ray reflections were collected from this crystal. 
After rejection of reflections based on the unit cell requirements and the 
averaging of symmetry equivalent reflections, 706 reflections were left
with an intensity greater than 3 standard deviations that of the mean of
all the intensities. These reflections were used in the structural
determination.
The space group was determined by examination of the systematic
absence of some reflections. In this case the systematic absences were:
hkO h = 2n
hOl 1 = 2n
Okl k = 2n
These absences indicated the space group to be Pbca.
3.4 X-ray crystallography of the 2-(2,4-dichlorophenoxy)-N-
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Table 3.3 X-ray crystallographic data for 2-(2,4-dichlorophenoxy)-N- 
isopropyl-N-methylethanamine and 2-(2,4-dichlorophenoxy)-N-isopropy1-N-
methylethanamide,
Isopropyl DME Isopropyl DMEA
Formula C12H1VN0C12 c12h 15no2ci2
Mr 2 6 2 . 18 2 7 6 . 1 6
Crystal size (mm) 0 . 3  X 0 . 0 8  X 0 . 1 0 . 6 8  X 0 . 4 8  X 0 . 1
Crystal system Orthorhombic Monoclinic
Space group Pbca P2x/ n
Unit cell parameters: 
a 7 . 1 6 9 9 ( 1 7 )  A 8 . 4 4 8 1 ( 1 7 )  A
b 2 4 . 8 8 2 0 ( 5 0 )  A 2 0 . 5 2 4 9 ( 3 7 )  A
c 1 5 . 2 4 4 6 ( 3 2 )  A 1 6 . 1 6 6 5 ( 2 8 )  A
alpha 9 0 . 0 0 ° 9 0 . 0 0 °
beta 9 0 . 0 0 ° 1 0 4 . 1 2 ( 8 9 ) °
gamma 9 0 . 0 0 ° 9 0 . 0 0 °
Volume 2 7 1 9 . 7  A3 27 1 8 . 5  A3
Z (No of molecules) 8 8
Density (calc) 1. 281  g/cm3 1. 349  g/cm3
Temperature 272 °K 272 ° K
F(000) 1104 1152
Absorption coefficient 4 . 6  cm-1 4 . 7  cm-1
Thetama3C 2 3 . 0 0 2 4 . 0 0
Thetamin 1 . 00 1 . 00
The values in parentheses are the standard deviations of the unit cell 
parameters.
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As the absorption coefficient was low (4.7 cm-1) no correction was applied 
to the data to correct for the absorption of X-rays by the crystal.
The structure was solved by deducing the position of one of the 
chlorine atoms from the Patterson map. The coordinates of this atom were 
then used to generate some phases for a Fourier map which in turn yielded 
the positions of the other chlorine atom and 9 other atoms (r = 0.33).
- These atoms were then used to provide the phase information for a further 
Fourier map which produced the coordinates of remaining 5 atoms (r = 
0.12). All the hydrogen atoms were then added to the structure and the 
whole molecule refined using a least squares routine (r = 0.101). However 
the molecule would refine no further as one of the carbon atoms was in the 
wrong position. The carbon atom was moved using the symmetry operator 1/2— 
x, y, 1/2-z and the structure refined further (r = 0.047).
To minimize random errors in the data a weighting function was 
applied to the data. In this case the normal weighting scheme associated 
with the least squares procedure was sufficient to give a final r value of
0.042 and a weighted r factor of 0.055.
The difference Fourier map calculated using all atoms showed no peaks 
over 1 e k~3 hence the structure was considered solved. The bond lengths 
and angles are given in tables 3.4 and 3.5 with the structure is shown in 
fig 3.5.
3.4.3 Structure of Isopropyl DMEA.
Crystals of isopropyl DMEA were obtained from the evaporation of a 
methanolic solution at room temperature.
A total of 4717 reflections were collected. After data reduction and 
averaging of symmetry equivalent reflections a total of 2952 reflections 
were left with an intensity greater than 3 standard deviations of the mean 
of all the intensities which were used in the structure determination.
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Table 3.4 Bond lengths for 2-(2,4-dichlorophenoxy)-N-isopropyl-N-
methylethanamine determined by X-ray crystallography.
Atom 1 Atom 2 Distance ( A ) .
Cll Cl 1.732(6)
C12 C3 1.737(7)
0 C6 1.362(7)
0 C7 1.435(7)
N C8 1.450(8)
N CIO 1.443(9)
Cl C2 1.378(9)
Cl C6 1.394(8)
C2 C3 1.381(9)
C3 C4 1.390(9)
C4 C5 1.377(9)
C5 C6 1.365(8)
C7 C8 1.510(9)
CIO Cll 1.493(11)
CIO C12 1.524(12)
Numbers in parentheses are the estimated standard deviations in the least 
significant digit.
Hydrogen atoms are not included since their position was derived from 
calculation and not from crystallographic analysis.
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methylethanamine determined by X-ray crystallography.
Table 3.5 Bond angles for 2-(2,4-dichlorophenoxy)-N-isopropyl-N-
Atom 1 Atom 2 Atom 3 Angle (°).
C6 0 C7 117.9(4)
C8 N C9 110.8(5)
C8 N CIO 116.5(5)
C9 N CIO 108.8(5)
Cll Cl C2 119.2(4)
Cll Cl C6 119.6(5)
C2 Cl C6 121.2(6)
Cl C2 C3 118.7(5)
C12 C3 C2 119.5(5)
C12 C3 C4 119.7(5)
C2 C3 C4 120.8(6)
C3 C4 C5 119.1(6)
C4 C5 C6 121.3(6)
0 C6 Cl 116.0(5)
0 C6 C5 125.1(5)
Cl C6 C5 118.9(6)
0 C7 C8 106.4(5)
N C8 C7 110.6(5)
N CIO Cll 115.3(6)
N CIO C12 106.6(6)
Cll CIO C12 111.6(7)
Numbers in parentheses are the estimated standard deviations in the last
significant digits.
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Fig 3.5 Structure of isopropyl DME determined by X-crystallography.
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The space group was determined by examination of the systematically absent 
reflections. In this case the groups of reflections that were 
absent were:
001 1 = 2n+l
OkO k = 2n+l 
hOl h+1 = 2n
These absences are consistent with the space group being P2x/n. As the 
absorption coefficient was low (4.7 cm-1) no correction was applied to the 
data.
The structure was solved by use of the direct methods program 
SHELXS86 (Sheldrick, 1985). This yielded the position of 4 chlorine atoms 
and 28 other atoms (r = 0.457). These coordinates were used to phase a 
Fourier map which yielded the missing 2 atoms (r = 0.151). All the
hydrogen atoms were added and the structure refined using a least squares 
procedure (r = 0.13).
The weighting scheme was adjusted to give a final r value of 0.048 
and a weighted r value of 0.083. The difference Fourier map yielded no 
peaks over 1 e A-3 hence the structure was considered solved. The bond 
lengths and angles are given in tables 3.6 and 3.7. The stucture shown in 
fig 3.6.
3.4.4 Geometry of Isopropyl DME and Isopropyl DMEA.
All the bond lengths in both structures were in the range of expected 
values as determined from other structures (International Tables for X-Ray 
Crystallography, 1974). Isopropyl DMEA was found to be a dimer but the 
geometry of both molecules in the dimer was exactly the same. The 2,4- 
dichlorophenoxy rings in both structures were planar with internal angles 
averaging 120.00° for isopropyl DME and 119.98° for isopropyl DMEA. These 
values were very close to the expected value of 120.0°. In the case of 
isopropyl DME the ethyl chain was in it's extended form
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Table 3,6 Bond lengths for 2-(-2,4-dichlorophenoxy)-N-isopropyl-N-methy1-
ethanamide determined by X-ray crystallography.
Atom 1 Atom 2 Distance ( A ) .
Cll Cl 1.729(4)
C12 C5 1.741(5)
01 C2 1.373(5)
01 C7 1.421(5)
02 C8 1.229(4)
N C8 1.342(5)
N CIO 1.479(5)
N C9 1.457(5)
Cl C2 1.386(5)
Cl C6 1.389(6)
C2 C3 1.390(6)
C3 C4 1.391(6)
C4 C5 1.367(7)
C5 C6 1.371(7)
C7 C8 1.528(5)
CIO Cll 1.523(8)
CIO C12 1.505(8)
Numbers in parentheses are estimated standard deviations in the least 
significant digits.
Hydrogens are not shown here since their positions were not determined 
crystallographically.
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Table 3.7 Bond angles for 2-(2,4-dichlorophenoxy)-N-isopropyl-N-
methylethanamide determined by X-ray crystallography.
Atom 1 Atom 2 Atom 3 Angle (°)
C2 01 C7 118.6(3)
C8 N CIO 123.0(3)
CIO N C9 118.5(3)
Cll Cl C2 119.2(3)
Cll Cl C6 119.7(3)
C2 Cl C6 121.1(4)
01 C2 Cl 116.1(4)
01 C2 C3 124.7(3)
Cl C2 C3 119.1(4)
C2 C3 C4 119.5(4)
C3 C4 C5 120.2(4)
C12 C5 C4 119.6(4)
C12 C5 C6 119.1(3)
C4 C5 C6 121.4(4)
Cl C6 C5 118.6(4)
01 C7 C8 110.8(3)
02 C8 N 122.5(3)
02 C8 C7 120.0(3)
N C8 C7 117.4(3)
N CIO Cll 111.1(4)
N CIO C12 110.5(4)
Cll CIO C12 112.3(4)
Numbers in parentheses are estimated standard deviations in the least
significant digits.
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Fig 3.6 Structure of isopropyl DMEA determined by X-ray crystallography.
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(torsional angle 0, C7, C8, N = 168.1°) with the hydrogens in their trans 
conformation. The nitrogen atom adopted its expected tetrahedral geometry 
with the substituent groups surrounding it at angles averaging 112.3°, 
very close to the expected value of 109.5°. In the case of isopropyl DMEA 
the ethyl chain was in it's extended form (torsional angle 01, C7, C8, N = 
-173.0) with the oxygen of the carbonyl group at an angle of 122.5° to the 
, nitrogen atom. The geometry around the nitrogen atom was planar with the 
substituent group at angles averaging 119.97° very close to the expected 
value of 120°. The torsional angles between the carbonyl group and the 
other two nitrogen substituents were -179.3° for the isopropyl group and - 
2.4° for the methyl group this indicates that 02, C8, N and C9 were lying 
approximately in a plane with the oxygen of the carbonyl group pointing in 
the opposite direction to the methyl group.
3.5 Molecular mechanics calculations on a series of 2-(2,4- 
dichlorophenoxy)-N-methy1 ethanamines.
The determination of the molecular mechanics properties of the 2- 
(2,4-dichlorophenoxy)-N-methylethanamines was carried out according to 
section 3.2.7.
3,5.1 Energetic and geometric optimisations.
Since all of the molecules had a common core in the 2-(2,4- 
dichlorophenoxy)-N-methylethanamine moiety this was used as the basic 
building block for all the molecules in the series. The different 
substituent groups were added using the DRAW option. Once the atoms had 
been added, atom types were assigned i.e. carbon sp3 for carbon atoms in 
an alkyl chain, so that each atom could have predetermined parameters 
assigned to it. The structure was then optimised for both energy and
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geometry using the conjugate gradient minimiser available within COSMIC. 
Minimisation involves the summation of the energy contribution to the
molecule from bond stretching, angle bending, torsion deformation, van der 
Waals interactions and out of plane bending. The programme alters bond
lengths, bond angles and torsional angles until an energy minimum is
reached. As the programme has preset bond length and angle parameters, the 
bond lengths and angles were within the expected range for the various 
atom types i.e. for an sp3 hybridised carbon atom the bond lengths were 
1.52A and the bond angles were approximately 1 0 9 ° .  The minimum energy 
conformation used in further studies was in some cases, not the only one 
since molecules that have long alkyl chains have many conformations with 
approximately the same minimum energy. Generally these conformations can 
be obtained by altering some of the torsional angles along the chain. In 
these cases the first minimum energy conformation obtained was used.
To determine whether this approach could accurately predict the
structure of the 2 - ( 2 , 4-dichlorophenoxy)-N-methylethanamines, the struc­
ture of 2 - ( 2 , 4-dichlorophenoxy)-N-isopropyl-N-methylethanamine was com­
pletely constructed using the DRAW routine and minimised. The resulting 
bond lengths, bond angles and torsional angles were compared with those 
obtained for the same compound using X-crystallograpy in section 3.4. 
Comparison of table 3.8 and table 3.9 with tables 3.4 and 3.5 indicates 
that the DRAW/minimisation routine produces a molecule that accurately 
represents the crystal structure of isopropyl DME.
3.5.2 Molecular mechanics calculations.
Once the minimum energy conformation of the molcules had been 
obtained, molecular mechanics calculations were carried out. These involve 
solving the SchrSdinger wave equation for each molecule. In practise the 
wave equation can only be accurately solved for a hydrogen atom since in
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Table 3.8 Bond lengths for 2-(2,4-dichlorophenoxy)-N-isopropyl-N-methyl-
ethanamine determined by molecular mechanics calculations.
Atom 1 Atom 2 Distance ( A ) .
Cll Cl 1.75
C12 C3 1.75
0 C6 1.31
0 C7 1.47
N C8 1.47
N CIO 1.47
Cl C2 1.40
Cl C6 1.40
C2 C3 1.40
C3 C4 1,40
C4 C5 1.40
C5 C6 1.40
C7 C8 1.52
CIO Cll 1.52
CIO C12 1.52
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Table 3.9 Bond angles for 2-(2,4-dichlorophenoxy)-N-isopropyl-N-
methylethanamine determined by molecular mechanics calculations.
Atom 1 Atom 2 Atom 3 Angle (°).
C6 0 C7 120.7
C8 N C9 110.4
08 N CIO 112.5
09 N CIO 110.7
Cll Cl C2 119.4
Cll Cl C6 120.4
C2 Cl C6 120.4
Cl C2 C3 120.2
C12 C3 C2 120.2
C12 C3 C4 120.4
C2 C3 C4 120.0
C3 C4 C5 120.0
C4 C5 C6 120.3
0 C6 Cl 119.8
0 C6 C5 120.7
Cl C6 C5 119.5
0 C7 C8 108.8
N C8 C7 110.5
N CIO Cll 122.8
N CIO C12 109.7
Cll CIO C12 109.8
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poly-electronic atoms and molecules it is not possible to determine the 
position of the electrons and hence the repulsive energy between them. 
However it is possible to produce approximate solutions of the wave 
equation if certain assumptions are made. One of these assumptions is the 
self consistent field (SCF) method. The SCF method assumes that each 
electron in the molecule moves in the potential field of the nucleus and
. the average potential field of all the other electrons. This allows for an
be.
approximate solution of the Schrodinger equation to/made since it has 
approximated the terms involving the repulsion between pairs of electrons.
To obtain the approximate solution to the wave equation, and hence 
the molecular orbital energies, two approaches can be taken, (i) to
evaluate all of the interactions between all of the orbitals on one atom 
with each of the orbitals on another atom (ab initio) or (ii) to evaluate 
only the interaction between like orbitals on each of the atoms (Complete
Neglect of Differential Overlap, CNDO). The two methods differ in the
amount of computing time and power required to obtain answers. The ab 
initio method requires the use of a Cray computer and hence was not
regarded as a practical method when examining a large number of molecules. 
For the molecular mechanics calculations on the 2-(2,4-dichlorophenoxy)-N- 
methylethanamine series the CNDO/2 programme within COSMIC was used. This 
programme gives the energy, size and shape of the molecular orbitals and 
also yields some parameters derived from these calculations.
3.5.3 Parameters derived from molecular orbital calculations.
The molecular orbital calculations not only gave information 
regarding the energy levels within the molecule but also determined a 
number of derived parameters for each molecule. These derived parameters 
use the molecular orbital information and parameters specific to the atoms 
in the molecule such as atomic number.
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(i) Atomic charge. This parameter is obtained from the square of the
wave function for each of the atoms in the molecule. In this study it was
not necessary to examine the charge on every atom, but particular 
attention was paid to the nitrogen atom and the carbon atoms attached 
directly to it. The atomic charge on the carbon atom in the ethyl chain 
did not change appreciably throughout the series hence it was not used in
. further studies.
(ii) Polarizability. This parameter arises from the effect of an 
electric field on the energy of a molecule . This parameter is determined 
from the orbital coefficients of the occupied and unoccupied orbitals and 
their energies. These calculations give the polarizability of each atom 
which were then summed to give the polarizablity of the molecule.
Since polarizability relates to the effect of an electric field on
the electronic cloud of the molecule a parallel can immediately be drawn
between this effect and the formation of an hydrophobic interaction which 
is thought to depend on the short range interactions between the electron 
clouds of the interacting molecules. The hydrophobic interaction is also 
characterised by the lipophilicity parameter log P. Comparison of the 
polarizabilities and log P values of the 2-(2,4-dichlorophenoxy)-N-methyl­
ethanamines yielded the regression line illustrated in fig 3.7. This 
correlation has been explained by Cammarata and Rodgers (1971) in terms of 
the isotherm that describes the partition of a compound between two 
immiscible solvents:
-delta Epaxrt 
log P = ________  + constant
2.3RT
R = gas constant, T = absolute temperature and delta Epart is the energy 
related to the partitioning. The energy function can be split into the 
solvation energies for the organic and aqueous phases:
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Regression equation:
Log P = -2.60(+0.87) + 0.271(+0.032) polarizability 
s = 0.4736 r = 0.910 F = 67.50
Fig 3.7 Comparison of the lipophilicity parameter log P with the 
molecular mechanics parameter molecular polarizability.
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The solvation energy is made up of many components the most important of 
which are the electrostatic term (Eele) and the polarization term {Epol):
Esolv = E«3le  + Epol
- where the polarization term is related to the molecular polarizablity. 
These calculated polarizablities have been compared with experimental- 
values (Lewis, 1989) and for a series of 50 molecules they were found to 
compare very favourably for all the compounds. The present study used not 
only the polarizability of the whole molecule but also the polarizability 
of individual atoms to attempt to derive a relationship between this and 
enzymatic binding.
(iii) Frontier orbital electron density. This theory was originally 
invented to explain the different reactivity at each position of an 
aromatic hydrocarbon. It is based on the premise that the reaction should
occur at the position of highest electron density in the frontier
orbitals. A more sound theoretical basis for this idea was given by Fukui 
et al. (1952) who introduced the idea of superdelocalizability. They 
proposed three types of superdelocalizability defined according to the
type of reaction j-
a) electrophilic superdelocalizability (Se) which is dependent on the 
energy of the highest occupied molecular orbital (HOMO)
b) nucleophilic superdelocalizability (Sn) which is dependent on the 
energy of the lowest unoccupied molecular orbital (LUMO)
c) radical superdelocalizability (Sr) which is dependent on the 
energies of both the HOMO and the LUMO.
These parameters were calculated for all the atoms in each of the 
molecules used in this study but particular interest was paid to the
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nitrogen atom, the carbon atom of the N-methyl group and the alpha carbon 
atom of the substituent group.
(iv) Dipole moment. This is calculated by drawing vectors from an 
arbitrary point to each of the point charges in the molecule and then 
summing these vectors over the whole molecule. Since dipole moment is a 
vectorial quantity it has both size and direction, however for the 
- purposes of this study the direction of the dipole moment was disregarded 
as it was not certain that each of the molecules occupied the same 
position in space prior to the molecular mechanics calculation.
(v) Ionisation potential. The calculation of the ionisation 
potential of a particular orbital uses Koopermans' theorem which equates 
the ionisation energy of an electron with the energy of the orbital 
associated with that electron. Hence the ionisation potential of the 
molecule can be equated to the negative energy of the HOMO.
In addition to the parameters calculated using molecular mechanics, 
the COSMIC suite was used to determine other features of the molecules. 
These included the length of the molecule measured from the chlorine atom 
in the four position to the last carbon atom in the variable nitrogen 
substituent, Van-der-Waals molecular volume and molecular surface area.
The values for all these molecular mechanics parameters are give in 
the Appendix.
3.6 Photoelectron spectroscopy of a short series of 2-(2,4- 
dichlorophenoxy)-N-methylethanamines.
It was not generally possible to determine the accuracy of the 
parameters obtained from the molecular mechanics calculations since they 
refer to properties such as atomic partial charge which could not be 
directly measured. It was however possible to measure the ionisation 
potential of some of the molecular orbitals in the pure compounds using
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photoelectron spectroscopy. This involves heating a sample until it 
vapourizes and then ionising the gaseous molecules with He I or He II 
radiation. This 'soft' ionisation technique provides enough energy to 
remove electrons from some of the molecular orbitals. The kinetic energy 
of the ejected electron is measured and this energy was used to calculate 
the ionisation potential and hence the energy of the molecular orbital 
from which the electron was derived.
Five of the 2-(2,4-dichlorophenoxy)-N-methylethanamines were subjec­
ted to this technique by Dr K.H. Sze at the University of Oxford. These 
compounds were ethyl DME, t-butyl DME, propenyl DME, phenyl DME and benzyl 
DME. The photoelectron spectra of these compounds were very similar but 
with slight differences occurring in the spectrum of phenyl DME due to the 
pi electron system of the phenyl ring interacting with the nitrogen atom. 
The results confirmed those from the molecular mechanics in that the HOMO 
was found to be situated around the dichlorophenoxy moiety. The energy of 
the HOMO was determined and found to correlate very well (r = 0.999) with 
that of the HOMO obtained from molecular mechanics. Further comparison 
between the energy of the orbitals obtained by photoelectron spectroscopy 
and those obtained by molecular mechanics yielded similar energies in both 
cases which supports the use of molecular mechanics.
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CHAPTER 4.
Preliminary investigations into the metabolic fate of the 2-(2,4- 
dichlorophenoxy)-N-methylethanamine series of compounds in rat 
hepatic microsomal fraction.
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The metabolism of tertiary amines as discussed in section 1.4 tends to 
be centred on the nitrogen atom. However, if the drug molecule contains 
one or more metabolically unstable groups (e.g esters, aromatic rings or 
methyl ethers) then the predicted metabolic profile must take into account 
all these groups. The 2-(2,4-dichlorophenoxy)-N-methylethanamine series of 
. compounds therefore have many sites of potential metabolism:-
1. The 2,4-dichlorophenoxy ring system could be 
hydroxylated,
2. The ether link could be metabolised to give a phenol 
and an aldehyde.
3. The nitrogen atom could undergo N-demethylation and/or 
two other dealkylations.
With these possible metabolic routes in mind it was important to 
determine whether N-demethylation was the primary route of metabolism.
N-Demethylation can be mediated by two different enzyme systems 
(section 1.5). It was therefore important to ascertain if cytochrome P-450 
was the chief enzyme system involved in the metabolism of the 2-(2,4- 
dichlorophenoxy)-N-methylethanamines. To determine this the incubation 
system was inhibited with compounds known to inhibit selectively 
cytochrome P-450.
Various chemicals were used to induce specific cytochrome P-450
isoenzymes. These compounds were then used to determine firstly, if
cytochrome P-450 was responsible for the compounds metabolism and
secondly, which family of cytochrome P-450 isoenzymes was mediating this 
metabolic process. Further evidence on which isoenzyme was responsible for 
the metabolism of the 2-(2,4-dichlorophenoxy)-N-methylethanamines was 
obtained from studies using purified cytochrome P450 IIB4.
4.1 Introduction.
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British Drug Houses Ltd. (Poole, Dorset):
Acetyl acetone, ammonium acetate, diethylamine, dihydrogen potassium 
phosphate, Folin Ciocalteau phenol reagent, magnesium chloride, potassium 
dihydrogen phosphate, sodium chloride, sodium dithionite, sodium hydrogen 
carbonate, sodium potassium tartrate, sucrose, trichloroacetic acid.
Fisons (Loughborough, Leicestershire, UK):
Acetone, ammonia, glacial acetic acid, glycerol, hexane, isopropyl 
alcohol, methanol.
Greyhound Chemical Co. (Berkenhead, Merseyside UK):
Aroclor 1254.
Sigma Chemical Co. Ltd (Poole, Dorset, UK):
Benzphetamine, bovine serum albumin, clofibric acid, clotrimazole, L- 
alpha-dilauroyl phosphatidyl choline, formaldehyde, 3-methylcholanthrene, 
metyrapone, NADPH, sodium phenobarbital, sodium deoxycholate.
Upjohn Co. (Kalamazoo, Michigan, USA):
Pregnenelone-16a-carbonitrile.
9-Hydroxyellipticine was a kind gift from Sapchim, Usine de Sisteron, 
France.
The cytochrome P450 IIB4 was a kind gift from Dr S.E. Clarke (Dept of 
Biochemistry, Unversity of Surrey, Guildford, Surrey, UK).
The NADPH-cytochrome P-450 reductase was a kind gift from Dr R.K. Sharma 
(Dept of Biochemsitry, University of Surrey, Guilford, Surrey, UK).
The SKF 525A was a kind gift from Smith, Kline and French (Welwyn Garden 
City, Hertfordshire, UK).
All chemicals were of at least reagent grade.
4,2 Materials.
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4.3.1 Animals.
Male Wistar Albino rats (approximately 200g),obtained from the Uni­
versity of Surrey Breeding Unit, were housed in cages with sawdust bedding 
and were allowed food and water ad libitum. All animals were starved 
overnight prior to killing.
4.3.2 Animal pretreatment.
Phenobarbital.
Phenobarbital (sodium salt) was administered orally as a 0.1% (w/v)
solution in the drinking water for 6 days. Normal drinking water was 
returned to the cages 24 hours before killing.
Aroclor 1254.
Aroclor 1254 was administered as a single intraperitoneal (i.p.) 
injection at a dose level of 500mg/kg with each animal receiving 
approximately 0.5ml from a 200 mg/ml solution in corn oil. Animals were 
killed 5 days after injection.
3-Methylcholanthrene (3-MC).
3-Methylcholanthrene was administered at a dose level of 25mg/kg as 
an i.p. injection on three consecutive days. Each animal received 
approximately 0.5ml of a lOmg/ml solution in corn oil. Animals were killed 
24 hours after the last injection.
Preqnenelone-16a-carbonitrile (PCN).
Pregnenelone-16a-carbonitrile was administered at a dose level of 
lOOmg/kg as an i.p. injection on three consecutive days. Each animal 
received approximately 0.5ml of a 40mg/ml solution in corn oil. Animals 
were killed 24 hours after the last injection.
4.3 Methods.
104
Clofibric acid.
Clofibric acid (sodium salt) was administered at a dose level of 
400mg/kg as an i.p. injection on three consecutive days. Each animal 
received approximately 0.5ml of 160mg/ml solution in distilled water.
Animals were killed 24 hours after the last injections.
Controls for each treatment group received the appropiate 
volume of solvent only.
4.3.3 Isolation of rat hepatic microsomal fraction.
Rat hepatic microsomal fraction was prepared by ultracentrifugation
essentially by the method of Remmer et al. (1966). Animals were killed by
cervical dislocation. The livers were rapidly excised and perfused with
0.9% (w/v) saline to prevent contamination with haemoglobin , blotted dry
and weighed. All subsequent steps were carried out at 4°C. The livers were
scissor-minced and homogenised in 3 volumes (w/v) of ice cold 0.25 M
sucrose using a motor-driven Potter-Elvehjem glass-teflon homogeniser. The
homogenate was centrifuged at 12,500 g av. for 20 minutes. The supernatant
was decanted and centrifuged at 105,000 g av. for 60 minutes. The
supernatant was discarded and the pellet resuspended in ice-cold 50 mM
potassium phosphate buffer (pH 7.25) containing 20% (v/v) glycerol. The
*' microsomal fractions 
microsomal suspensions were stored at -80°C. The ' 'prepared
and stored as described were stable for several months,
4.3.4 Determination of protein concentration.
The concentration of protein in hepatic microsomal fractions was 
determined by the method of Lowry et al. (1951) with bovine serum albumin 
used to construct the protein standard curve.
Compensation for any interfering substances such as glycerol 
(Peterson, 1979) was made by adding the interfering substance to the 
standard curve at the same concentration present in the samples.
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4.3.5 Determination of cytochrome P-450.
Total cytochrome P-450 was routinely determined as the concentration 
of the reduced carbon monoxide adduct (Omura and Sato, 1964). Microsomes 
were diluted in 50 mM potassium phosphate buffer pH 7.25 containing 20% 
(v/v) glycerol to a concentration of 2-3 mg/ml. Reduction of the ferric to 
ferrous form of the haemoprotein was achieved by the addition of a few 
- grains of sodium dithionite. The sample was then split between two 
cuvettes and the baseline recorded between 400-500 nm on a Uvikon 860 
spectrophotometer. Carbon monoxide was passed through the sample cuvette 
(approximately 1 bubble/second) for about one minute. The spectrum was 
repeatedly scanned until no further absorbance increase at 450 nm was 
observed. The concentration of cytochrome P-450 was calculated using the 
difference extinction coefficient (450-490 nm) of 91 mM-1 cm"1.
4.3.6 Incubation for cytochrome P-450-dependent mixed function oxidase 
activity (in vitro) using hepatic rat microsomal fraction.
Reagents:
Stock Concentration. Component. Final Concentration.
150 mM Magnesium chloride. 15 mM
400 mM Potassium phosphate buffer pH 7.4 50 mM
Hepatic microsomal fraction. luM cytochrome P-450 
40 mM NADPH in 1% NaHC03 1 mM
Stock solution of substrate.
Distilled water was added to give a final assay volume of 1.0 ml.
All the components of the incubation with the exception of the NADPH 
were pre-incubated at 37°C for 5 min before the reaction was initiated by 
the addition of the NADPH. Reactions were terminated after 10 min using 
the appropriate reagent as specified.
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4.3.7 Assay of cytochrome P-450-dependent mixed function oxidase activity 
{in vitro) using purified reconstituted protein components.
Reagents: '
Stock Concentration. Component Final Concentration.
300 ug/ml L-alpha-dilauroyl phosphatidyl choline (DLPC). 30 ug/ml
4 uM Purified cytochrome P450 IIB4. 0.1 uM
55 U/ml NADPH-cytochrome P-450 reductase (FPT). 0.9 U/ml
500 ug/ml Sodium deoxycholate (DOC). 50 ug/ml
400 mM Potassium phosphate buffer pH 7.25. 50 mM
150 mM Magnesium chloride. 15 mM
40 mM NADPH in 1% NaHC03
Stock solution of substrate.
1 mM
The components were added in the order given above at 4°C and made up 
to a final volume of 1 ml with distilled water.
All the components of the incubation with the exception of the NADPH 
were pre-incubated at 37°C for 5 min before the reaction was initiated by 
the addition of the NADPH. Reactions were terminated after 10 min using 
the appropriate reagent as specified.
4.3.8 N-Demethylation of selected substrates,
N-Demethylase activity was measured by the formation of formaldehyde, 
which was quantitated by the method of Nash (1953).
The standard assay systems described in section 4.35 and 4.3.6 were 
employed. The concentrations of the substrates used were: Benzphetamine
(1.5 mM) in distilled water, 2-(2,4-dichlorophenoxy)-N-isopropyl-N- 
methylethamine (2 mM), 2-(2,4-dichlorophenoxy)-N-benzyl-N-methylethamine 
(2mM), 2-(2,4-dichlorophenoxy)-N-ethylhydroxy-N-methylethanamine (2 mM)
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in acetone. Reactions were terminated by addition of ice cold 12.5% (w/v) 
trichloroacetic acid (0.5 mM), and allowed to stand on ice for 5 minutes, 
followed by centrifugation at 3,500 rpm for 10 minutes for the hepatic 
microsomal fraction and 10,000 rpm for 10 minutes for the reconstituted 
assay system. The supernatant (1 ml) was removed for the determination of 
formaldehyde, using the Nash assay. Enzyme blank and substrate blank 
experiments were carried out with the omission of NADPH and substrate 
respectively.
Nash Assay.
Reagent:
Ammonium acetate (150 g) was dissolved in 900 ml of distilled water. 
Acetylacetone (2 ml) was added and completely dissolved. The pH was 
adjusted to 6.0 with glacial acetic acid and volume adjusted to 1 litre. 
The reagent was stored at 4°C for a maximum of 7 days.
Method:
The supernatant from the trichloroacetic acid (TCA) precipitation (1 
ml) was added to the Nash reagent (1 ml), mixed, and heated in the dark at 
60°C for 10 minutes. After cooling, the absorbance at 412 nm was recorded. 
A standard curve was constructed using 1 ml volumes and containing 
formaldehyde from 0 to 140 uM. The standard curve was treated the same as 
the assay system. Standard curves were accepted only if r2 > 99.8%.
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The standard assay system described in section 4.3.5 was used in 
conjunction with a radiometric assay. The 1 ml incubation contained [3H]- 
2-(2,4-dichlorophenoxy)-N-isopropyl-N-methylethanamine (2 mM final
concentration) added as a solution in acetone to give 2.5 uCi per 
incubation. The pre-incubation time was 5 minutes and the incubation time 
was 10 minutes unless stated otherwise. The reaction was terminated by 
addition of 1M NaOH (1 ml).
Extraction and analysis of 2-(2,4-dichlorophenoxy)-N-isopropyl-N- 
methylethanamine and its metabolites.
The incubation mixtures were transferred to 15 ml screw cap Soveril 
tubes and extracted with diethyl ether (4 ml), and shaken for 10 minutes. 
After centrifugation at 2,000 rpm for 10 minutes to clarify the phases, 
the upper ether layer was removed and the process repeated a further two 
times. The efficiency of extraction was monitored by taking 2 x 100 ul 
aliquots from the residual aqueous phases and 2 x 20 ul from the organic 
phases, adding 5 ml of Unisolve E scintillation fluid and counting for 4 
minutes in an LKB 1216 Rackbeta liquid scintillation counter. All the 
ether extracts were combined and evaporated to dryness under a stream of 
nitrogen.
4.3.9 Hepatic microsomal metabolism of 2-(2,4-dichlorophenoxy)-N-iso-
propyl-N-methyl-2,2-ditritioethanamine ([3H]-isopropyl DME).
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Thin layer chromatography (tic).
The dried ether extracts were reconstituted in lOOul of ethyl acetate 
and 60ul was spotted on to silica gel GF plates (Merck 20 X 20 cm). The
plates were developed in 3 different solvent systems :
Solvent system 1) hexane : ethyl acetate : diethylamine (80 : 20 : 10 v/v)
Solvent system 2) dichloromethane : methanol : ammonia (96 : 4 : 0.4 v/v)
Solvent system 3) hexane : isopropanol : ammonia (90 : 10 : 5 v/v).
The radioactive areas corresponding to the parent compound and its
metabolites were localised using a Berthold LB 2723 tic scanner with data 
processing on Apple II computer. The unlabelled standards were visualised 
under uv light at 254nm.
4.3.10 Identification of metabolites of selected 2-(2,4- 
dichlorophenoxy)-N-methylethanamines using high performance liquid 
chromatography-mass spectrometry (LC-MS).
The standard hepatic microsomal assay system as described in 4.3.6 
was employed with each of the substrates present at a concentration of
2mM. The assay was allowed to proceed for 10 minutes and then terminated
by removal of the microsomal protein by centrifugation (3,500 rpm for 15 
minutes). An aliquot of the supernatant (1ml) was loaded onto an hplc 
system of the following specifications:
Chromatographic analysis of- 2-(2,4-dichlorophenoxy)-N-isopropyl-N-
methylethanamine and its metabolites.
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Column: 25 x 0.46 cm Spherisorb ODS-2 5 uM particle size.
Flow rate: 0.7 ml/minute.
Mobile phase: A = 0.1 M ammonium acetate, B= methanol
Gradient: 0% B (100% A) for 15 minutes * then a linear gradient
from 0-100%B over 30 minutes, holding at 100% B for 15 
minutes.
*During this 15 minutes the column eluent was sent to 
waste to remove salts, proteins etc. not 
compatible with the thermospray interface.
Post column flow: 0.3ml/min 0.1M ammonium acetate (minimum amount of
aqueous buffer for thermospray function).
This hplc system was linked directly to a VG 12-250 quadropole mass 
spectrometer via a VG thermospray interface to allow the hplc eluate to 
be passed directly into the mass spectrometer.
As 2-(2,4-dichlorophenoxy)-N-methylethanamines contained two chlor­
ine atoms the molecular ion (M") was influenced by both the isotopes and 
their relative abundances (35C1:37C1 75.8:24.2) and hence had the follow­
ing relative abundances:
Ion Number of chlorine atoms Relative abundance
M+ 35C1+35C1 100
M^+2 35C1+37C1' 31.9
M++2 37C1+35C1 31.9
M++4 37C1+37C1 10.2
Hence when examining the mass spectral data it was possible to reject 
all spectra that did not have M'~, M^+2 and M",'+4 in the ratio of 100 : 63.8 
: 10.2 which allowed the identification of the 2-(2,4-dichlorophenoxy)-N-
methylethanamines and their metabolites although there may have been many 
other compounds eluting from the hplc with similar retention times.
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4.4.1 Metabolism of 2-(2,4-dichlorophenoxy)-N-isopropyl-N-methyl-2,2- 
ditritioethanamine ([3H]-isopropyl DME) by rat hepatic microsomal 
fraction.
The hepatic microsomal metabolism of 2-(2,4-dichlorophenoxy)-N-iso- 
propyl-N-methyl-2,2-ditritioethanamine ([3H]-isopropyl DME) was studied in 
the hepatic microsomal fraction of rats that had been pretreated with 
phenobarbital. The specific content of cytochrome P-450 in this fraction 
was 1.91 nmol cytochrome P-450/mg protein. Using the assay system des­
cribed in 4.3.6 the metabolism of [3H]-isopropyl DME was allowed to 
proceed for 10 minutes. The ether extracts were analysed on tic together 
with authentic standards of isopropyl DME and its desisopropyl metabolite 
(desisopropyl DME) (table 4.1).
From examination of the three chromatograms it was apparent that 
solvent system 1 gave the best separation of the parent compound and its 
metabolites (fig 4.1) and therefore this tic solvent system was selected 
for use in further experiments.
In all three chromatograghic systems two radioactive peaks were 
seen, one major peak (metabolite A) and one minor, more polar, peak 
(metabolite B).
Comparison of the Rf values of the authentic standards with those of 
metabolites A and B led to the tentative identification of metabolite A as 
isopropyl DME since in all the chromatographic systems this metabolite had 
the same Rf values as the authentic material. Metabolite B did not co­
chromatograph with the standards of either isopropyl DME or desisopropyl 
DME. It had an Rf value between the two standards indicating that although 
it was not positively identified it may have been desmethyl DME.
4.4 Results and conclusions.
112
Table 4,1 Comparison between metabolites A and B and authentic isopropyl 
DME and desisopropyl DME.
Compound Rf value
Solvent system 1 Solvent system 2 Solvent system 3
Isopropyl DME 0.72+0.04 0.52+0.03 0.63+0.03
Desisopropyl DME 0.22+0.03 0.21+0.01 0.07+0.03
Metabolite A 0.71+0.03 0.53+0.01 0.62+0.04
Metabolite B 0.42+0.01 0.43+0.01 0.28+0.02
The results presented here represent the mean + standard deviation of 
six determinations.
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Fig 4.1 Chromatographic separation of [3H]-isopropyl DME (metabolite A) 
from its major metabolite (B) using solvent system 1 (hexane: ethyl
acetate: diethylamine 80:20:10 v/v).
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Incubations using rat hepatic microsomal fraction and unlabelled 
isopropyl DME were carried out for 10 minutes as described in section 
4.3.6. However on this occasion the microsomal protein was removed by 
centrifugation and the supernatant injected directly on to an hplc system 
linked to a mass spectrometer via a thermospray interface (section 4.3.8). 
The mass spectrometer recorded many mass spectra per minute which were 
then interrogated for spectra that contained only the characteristic 
isotope pattern of two chlorine atoms (section 4.3.10) (table 4.2).
The assignment of tentative structures implies that isopropyl DME 
undergoes not only N-demethylation (m/z 248) but also N-dealkylation to 
give both desisopropyl DME (m/z 220) and desisopropyl-desmethyl DME (m/z 
206). Since this technique is not quantitative it was not possible to 
assess the amounts of each of these metabolites present in the incub­
ation. However it was possible to obtain approximate amounts by examining 
the relative ion currents. These indicated that the desmethyl metabolite 
was present in greater amounts than either the desisopropyl or the 
desisopropyl-desmethyl metabolite, suggesting that metabolite B from the 
tic experiments may be desmethyl DME.
These ions were all present in a sample that was incubated for an 
hour, but in addition there was an ion of m/z 278, 16 mass units above
that of isopropyl DME (m/z 262) suggesting the incorporation of an oxygen 
atom into the parent molecule. This metabolite could either be a N-oxide 
or a hydroxylated form of isopropyl DME. The mass spectrum of this 
metabolite was compared with that of a related authentic N-oxide.
The mass spectrum of authentic 2-(2,4-dichlorophenoxy)-N-ethyl,N- 
methylethanamine N-oxide (fig 4.2) showed not only the molecular ion (m/z 
264) but also a fragment ion at m/z 248 (M-16). This fragmentation is 
indicative of the loss of oxygen from the molecular ion.
4.4,2 Mass spectral analysis of isopropyl DME and its metabolites.
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Table 4.2 Mass spectral data for isopropyl DME and its metabolites.
Molecular ion Relationship of molecular ion Tentative identification
to isopropyl DME (M+) .
262 0 Mass spectrum identical to that of authentic
isopropyl DME
248 [M-14]+ Desmethyl DME. Difference of 14 mass units is
indicative of the loss of a methyl group 
from isopropyl DME.
220 [M-42]+ Desisopropyl DME. Difference of 42 mass units
is indicative of the loss of a isopropyl group 
from isopropyl DME.
206 [M-66]+ Desisopropyl-desmethyl DME. Difference of 66 mass
units is indicative of the loss of both a 
isopropyl and a methyl group from isopropyl
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Fig 4.2 Positive ion mass spectrum of authentic 2-(2,4-dichlorophenoxy-N- 
ethyl-N-methylethanamine N-oxide.
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Oxygen loss is not unexpected since the oxygen is only held to the 
compound by a dative bond and therefore the thermal energy provided by the 
ion source is sufficient to cleave it. No ion is seen at m/z 262 ([M-16]) 
in the spectrum of the oxygenated metabolite and hence this metabolite is 
possibly an hydroxylated metabolite.
* 4.4.3 Metabolism of 2 - ( 2 , 4-dichlorophenoxy)-N,N-dimethylethanamine, 2 -  
(dichlorophenoxy)-N-ethy1-N-methylethanamine and 2-(2,4-dichlorophenoxy) -  
N-tertiary-butyl-N-methylethanamine.
Hepatic microsomal incubations were performed as described in section
4.3.6 using 2-(2,4-dichlorophenoxy)-N,N-dimethylethanamine (methyl DME), 
2-(2,4-dichlorophenoxy)-N-ethy1-N-methylethanamine (ethyl-DME) and 2-(2,4- 
dichlorophenoxy)-N-tertiary-buty1-N-methylethanamine (t-butyl DME) as sub­
strates. The incubations were allowed to proceed for 1 hour before being
processed for thermospray mass spectral analysis.
The mass spectra were collected and analysed using the dichloro 
substitution pattern described in section 4.3.10. The metabolites found 
for each of these compounds are summarised in table 4.3.
All the compounds (including isopropyl DME) are N-demethylated to 
some degree. The compounds that contained alpha hydrogens (methyl DME, 
ethyl DME and isopropyl DME) underwent demethylation and dealkylation. 
However when there were no alpha hydrogen atoms (t-butyl DME) demethyl­
ation appeared to be the only metabolic route. The possible hydroxylated 
metabolite was also absent from the metabolite profile of t-butyl DME
indicating a possible link between the hydroxylated and dealkylated
metabolites. From these results it is possible to speculate that the 
hydroxylated metabolite formed from isopropyl DME may be a » carbinolamine 
formed prior to the N-dealkylation.
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Table 4.3 Summary of the metabolites found for methyl DME, ethyl DME and 
t-butyl DME in rat hepatic microsomal fraction incubated for 1 hour.
Metabolic route Methyl DME •Ethyl DME t-Butyl DME
N-demethylation / / /
N-dealkylation - /a X
di-N-dealkylation13 / / X
Mono-oxygenation / / X
a N-de-ethylation
b N-demethylation and N-dealkylation.
/ = metabolite observed 
X = metabolite not observed
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4.4.4 Rate of metabolism of isopropyl DME as measured by the formation of 
its demethylated metabolite and the formation of formaldehyde.
The rate of metabolism of isopropyl DME was assessed by two methods, 
firstly by the rate of formation of its metabolite measured using [3H]- 
isopropyl DME and secondly by the formation of formaldehyde in the 
, incubation mixture. Duplicate rat hepatic microsomal fraction incubations 
were performed as described in section 4.3.5, and one incubation was 
assayed for the metabolite of isopropyl DME (section 4.3.9) and the other 
for formaldehyde (section 4.3.7) at various time points.
Table 4.4 shows the rate of formaldehyde production at each time 
point corrected for the endogenous formaldehyde produced by the incubation 
mixture in the absence of the substrate. The rate of desmethyl DME 
formation was corrected for the production of any of this metabolite 
produced in the absence of NADPH. It is clear from the time course data 
that the rates of formation of desmethyl DME and formaldehyde in this 
system are linked. When the two rates of formation are plotted against one 
another this yields a straight line (fig 4.3) with a regression co­
efficient of 0.999 (equation 4.1).
Eq 4.1 Rate(desmethyl DME) = 26.13(+7.03) + 1.78(+0.05) Rate(formaldehyde)
s = 3.110 r = 0.999 F = 259.6
The absolute values for the N-demethylation of isopropyl DME as 
measured by desmethyl DME production and formaldehyde production were 
different. The values for the formaldehyde production were less than the 
value for the N-demethylated metabolite production. This implies that the 
values for the production of formaldehyde have been underestimated. This 
may be due to a number of factors, among which is the inclusion of
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Table 4.4 Time course for the formation of desmethyl DME and 
formaldehyde from rat hepatic microsomal fraction with isopropyl DME as 
the substrate.
Time (minutes) Metabolite formed (nmol/nmol cytochrome P-450)
Desmethyl DME Formaldehyde
10 175+52 84.4+1.8
20 234+47 114.9+5.5
30 276+63 138.9+6.1
40 287+93 148.1+7.9
60 305+75 156.3+11.6
Each value represents the mean' + standard deviation of five separate 
determinations.
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Fig 4.3 Comparison between the rate of formaldehyde production and the 
rate of desmethyl DME formation in hepatic microsomes using isopropyl DME 
as the substrate.
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experimental blanks. The blanks used in this experiment were:
1). No substrate
2). No NADPH
3). No hepatic microsomal fraction.
Blanks 2 and 3 were included to assess any chemical and non-NADPH 
- dependent breakdown of isopropyl DME to formaldehyde. Both these blanks 
showed negligible formaldehyde formation. Blank 1 was used to take into 
account the endogenous production of formaldehyde by the microsomal system 
in the absence of substrate. This blank may have led to an overestimation 
in the amount of formaldehyde produced since in the absence of a preferred 
substrate cytochrome P-450 will metabolise compounds such as glycerol, and 
it has been shown that cytochrome P-450 will metabolise glycerol to 
formaldehyde (Winters et al., 1988).
In view of this the time course data for the rate of formaldehyde 
production was not corrected for blank 1 and the regression equation for 
the rate of desmethyl DME formation against the rate of formaldehyde 
production redetermined (equation 4.2). This produced a regression line 
with the same gradient that intercepted the axes at the origin.
Eq 4.2 Rate(desmethyl DME) = 0.64(+7.75) + 1.78(+0,05) Rate(formaldehyde)
s = 3.110 r = 0.999 F = 259.6
However inclusion of the blank did not fully account for the discrepancy
since after correction the rate of formaldehyde production at 60 minutes 
was 170.6+11.6 (nmol HCHO/nmol cytochrome P-450) as compared with the 
rate of desmethyl DME formation which was 305+75 (nmol product/nmol 
cytochrome P-450). The loss of formaldehyde was not fully explained but 
was attributed to other factors such as binding to microsomal proteins.
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Addition of semicarbazide to the incubation did not alter the recovery of 
formaldehyde (data not shown).
Since the rates of formaldehyde and desmethyl DME production are 
linked, the rate of formaldehyde production was used as the index of 
metabolism for all the remaining compounds as their radiolabels were not 
available. Both the rate of formation of desmethyl DME and the rate of 
formaldehyde production were found to be linear over the first 10 minutes 
of the incubation hence this time point was used in all subsequent assays.
4.4.5 Induction of the rate of N-demethylation of selected 2-(2,4- 
dichlorophenoxy)-N-methylethanamines in the hepatic microsomal fraction 
from animals pretreated with different chemical inducers of cytochrome P- 
450.
Animals were pretreated with different chemicals known to induce the 
levels of hepatic cytochrome P-450 (section 4.3.3). These chemicals were 
chosen such that they induced members of different families of cytochrome 
P-450. Specific hepatic cytochrome P-450 contents for each group are given 
in table 4.5. The rates of N-demethylation for isopropyl DME, benzyl DME, 
ethylhydroxy DME and benzphetamine (table 4.6) were determined in the 
hepatic microsomal fraction from the pretreated animals.
The rates of N-demethylation of these compounds in hepatic microsomal 
fraction from animals pretreated with 3-MC, PCN and clofibrate were 
similar to the rates seen in control hepatic microsomal fraction. The rate 
of N-demethylation in hepatic microsomal fraction from animals pretreated 
with Aroclor 1254 and phenobarbital was found to be significantly greater 
than the rate in control microsomes for all the compounds tested.
PCN and 3-MC induce the families of isoenzymes which appear not to 
be involved in the N-demethylation of either benzphetamine or the 2-(2,4- 
dichlorophenoxy)-N-methylethanamines. Aroclor 1254 is a mixed inducer
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Table 4.5 Cytochrome P-450 specific contents in the hepatic microsomal 
fraction from rats pretreated with chemical inducers.
Inducer Specific content
(nmol cytochrome P-450/mg protein).
Control 0.58
Aroclor 1254 2.58
3-MC 1.82
PCN 1.29
Clofibrate 0.78
Phenobarbital 1.78
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Table 4.6 Comparison between the rates of N-demethylation for a series of 
2-(2,4-dichlorophenoxy)-N-methylethanamines in hepatic microsomal fraction 
from animals pretreated with different enzyme inducers.
Rate of N-demethylation 
(nmol formaldehyde / min / nmol cytochrome P-450)
Inducer Isopropyl DME Benzyl DME Ethyl hydroxy DME Benzphetamine
Control 2.47+0.07 3.43+0.10 2.72+0.13 3.35+0.37
Aroclor 1254 3.15+0.19*** 3.95+0.32*** 3.83+0.39*** 6.42+0.41**
3-MC 2.68+0.11* 2.98+0.48 2.57+0.11 3.84+0.49
PCN 2.54+0.09 3.74+0.12 3.03+0.18 4.41+0.45*
Clofibrate 2.37+0.13 3.42+0.15 2.78+0.20 3.44+0.42
Phenobarbital 6.65+0.14*** 6.16+0.24*** 3.52+0.31*** 11.72+0.32***
Each result is the mean + standard deviation from three animals per 
inducer. Statistical comparison is' between each induced and the control 
situations using the Students t test.
* p < 0.05, ** p < 0.01, *** p < 0.001.
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increasing levels of cytochrome P450 IIB1 which • is reflected in an 
increase in the N-demethylase activity of both benzphetamine and the 2- 
(2,4-dichlorophenoxy)-N-methylethanamines.
Induction of cytochrome P-450 mediated activity by clofibrate is 
attributable to an increase in a single isoenzyme, cytochrome P450 IVA1 
(Sharma et  a l . ,  1988). It has previously been found that induction of 
cytochrome P450 IVA1 is accompanied by a decrease in the rate of N- 
demethylation of benzphetamine.
However this effect was only seen after long term dosing, whereas 
after a single dose of clofibrate the benzphetamine N-demethylase activity 
was comparable to that of the control. The N-demethylase activity of 2-(2,4- 
dichlorophenoxy)-N-methylethanamines mirrored that of benzphetamine.
Pretreatment of rats with phenobarbital causes an elevation in 
cytochrome P-450 levels. This increase is associated with an induction of 
cytochrome P450 IIB1 and cytochrome P450 IIB2. These isoenzymes 
preferentially N-demethylate benzphetamine (Mizukami et  a l . ,  1983) and the 
series of 2-(2,4-dichlorophenoxy)-N-methylethanamines.
The metabolism of [3H]-isopropyl DME in the various induced hepatic 
microsomal samples yielded different amounts of desmethyl isopropyl DME 
(table 4.7). No other metabolites were detected in any of the hepatic 
microsomal fractions produced from the pretreated rats. Comparison with 
the rate of formaldehyde production from this substrate (fig 4.4) gave 
few differences in the overall profile confirming that induction with 
phenobarbital increases an isoenzyme of cytochrome P-450 which specifical­
ly metabolises this substrates.
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Table 4.7 Rate of formation of [3H]-desmethyl isopropyl DME in hepatic 
microsomal fraction from animals pretreated with chemical inducers.
Inducer Rate of product formation.
(nmol / min / nmol cytochrome P-450).
Control 4.30+0.70
Aroclor 1254 5.08+0.22
3-MC 4.62+0.52
PCN 4.86+0.30
Clofibrate 4.84+0.92
Phenobarbital 11.58+0.18
*** p < 0.001
Each result represents the mean + standard deviation of three 
animals per inducer. Statistical comparison made between the control 
group and the the test groups using the Students t test.
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Fig 4.4 Comparison between the rates of product formation in hepatic 
microsomal fractions from rats pretreated with different chemical 
inducers.
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methylethanamine and benzphetamine N-demethylase activity by chemical 
inhibitors of cytochrome P-450.
The N-demethylase activities, using isopropyl DME and benzphetamine 
as substrates of the hepatic microsomal fraction from rats pretreated with 
phenobarbital were inhibited by a variety of chemicals known to inhibit 
cytochrome P-450.
The decrease in N-demethylase activity seen when benzphetamine 
metabolism was inhibited with metyrapone, 9-hydroxyellipticine, 
clotrimazole and SKF 525A was paralleled by a decrease in the N- 
demethylation activity of isopropyl DME under the same conditions (figure 
4.5).
Metyrapone, SKF 525A and clotrimazole have previously been reported 
as specific inhibitors of cytochrome P-450 IIB1 (Ullrich and Kremers 1977, 
Franklin 1977 and Rodriques et  a l 1988). At the higher concentrations 
these compounds decreased the rate of N-demethylation of isopropyl DME by 
amounts comparable with the decrease in N-demethylation of benzphetamine.
9-Hydroxyellipticine, a member of the ellipticine family of potent 
cytochrome P-450 inhibitors (Lesca et  a l . ,  1979), inhibited the N- 
demethylation of both compounds. However this compound inhibits not only 
the isozymes induced by phenobarbital but also those induced by Aroclor 
1254 and benzo[a]pyrene and hence is regarded as a more general inhibitor 
of cytochrome P-450's. Therefore any effect seen is not specific to 
cytochrome P450 IIB1.
4.4.6 Inhibition of 2-(2,4-dichlorophenoxy)-N-isopropyl-N-
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The control value for benzphetamine was 13.30+1.40 nmol 
formaldehyde produced / min / nmol cytochrome P-450.
The control value for isopropyl DME was 4.42+0.74 nmol 
formaldehyde produced / min / nmol cytochrome P-450.
Each value is the mean + standard deviation of three determinations.
Fig 4,5 The effect of chemical inhibitors of cytochrome P-450 on the rate 
of the N-demethylation of benzphetamine and isopropyl DME.
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methylethanamines by purified rabbit cytochrome P450 IIB4 in a 
reconstituted system.
The metabolism of isopropyl DME, benzyl DME, ethylhydroxy DME and 
benzphetamine was studied using purified rabbit cytochrome P450 IIB4 in a 
reconstituted system (section 4.3.6).
The rate of metabolism of these compounds as measured by the rate of 
formaldehyde production was significantly increased over the rate in 
hepatic microsomal fraction from rats pretreated with phenobarbital (table 
4.8) as well as from rabbits also pretreated with phenobarbital (data not 
shown).
This significant increase indicates that this particular isoenzyme 
metabolises these compounds preferentially as seen with benzphetamine. The 
rates of metabolism of the 2-(2,4-dichlorophenoxy)-N-methylethanamines 
were lower than the rate of metabolism for benzphetamine indicating that 
although they undergo the same metabolic transformation there are funda­
mental differences between the compounds affecting the rate of this 
transformation.
The rate of metabolism of [3H]-isopropyl DME in the reconstituted 
system was 23.39+1.12 nmol desmethyl isopropyl DME / min / nmol 
cytochrome P-450. This value was in good agreement with the value for the 
amount of formaldehyde formed (26.52+1.74 nmol formaldehyde formed / min 
/ nmol cytochrome P-450) under the same conditions. This indicates that 
under these conditions the amount of formaldehyde formed in the absence of 
the substrate was negligible compared with that formed in the presence of 
the substrate and therefore the endogenous metabolism of glycerol is 
negligible.
4.4.6 Metabolism of a series of 2-(2,4-dichlorophenoxy)-N-
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Table 4.8 Rates of N-demethylation for a short series of 2-(2,4- 
dichlorophenoxy)-N-methylethanamines by purified rabbit cytochrome P450 
IIB4.
Compound Rate of N-demethylation 
(nmol formaldehyde / min / nmol cytochrome P-450)
Isopropyl DME 26.52+1.74
Benzyl DME 24.87+0.51
Ethylhydroxy DME 7.42+0.28
Benzphetamine 48.36+0.87
Results expressed as the mean + standard deviation of three separate 
determinations.
Assay carried out at a fixed substrate concentration of 2mM.
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The hepatic microsomal fraction from rats has been found to meta­
bolise a short series of 2-(2,4-dichlorophenoxy)-N-methylethanamines. This 
metabolism has been determined to be predominantly N-demethylation. How­
ever compounds that contain a nitrogen substitutent with one or more 
alpha hydrogen atoms also underwent N-dealkylation and mono oxidation. The 
. quantitative studies indicated that although these metabolites were 
detectable by mass spectrometry, they were present in negligible amounts 
and therefore these routes of metabolism can be considered insignificant. 
This indicated that in subsequent studies the rate of N-demethylation 
could be used as an index of metabolism for this series of compounds.
Comparison between the i n  v i t r o  metabolism of the 2-(2,4-dichloro­
phenoxy) -N-methylethanamines and that of benzphetamine (Inoue et  a l . ,  
1982) shows many similarities. Benzphetamine undergoes the same metabolic 
transformations as the 2-(2,4-dichlorophenoxy)-N-methylethanamines. The 
major route of metabolism for benzphetamine is N-demethylation with N- 
debenzylation and aromatic hydroxylation as minor routes. Aromatic hyd- 
roxylation is not a route of metabolism for the 2-(2,4-dichlorophenoxy)-N- 
methyl ethanamines because the two chlorine atoms on the aromatic ring 
block this route. As there are a number of similarities between the 
metabolism of the 2-(2,4-dichlorophenoxy)-N-methylethanamines and benz­
phetamine, benzphetamine could be used as a positive control.
The N-demethylation of 2-(2,4-dichlorophenoxy)-N-methylethanamines 
was increased in the hepatic microsomal fraction isolated from rats 
pretreated with Aroclor 1254 and phenobarbital. Both these compounds are 
effective inducers of cytochrome P450 IIB1 amongst other isoenzymes. This 
isoenzyme has been identified as the cytochrome P-450 responsible for the 
majority of benzphetamine N-demethylase activity (Mizukami et  a l . ,  1983). 
This is reflected by an increase in the benzphetamine N-demethylase
4.5 Discussion.
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activity in the hepatic microsomal fractions from rats pretreated with 
both Aroclor 1254 and phenobarbital.
The rate of N-demethylation of the 2-(2,4-dichlorophenoxy)-N-methyl­
ethanamines and benzphetamine was inhibited by chemicals known to inhibit 
cytochrome P-450. Some of the inhibitors (metyrapone, SKF 525A and 
clotrimazole) used were specific for cytochrome P450 IIB1 and the effect 
, that these compounds had on the rate of N-demethylation of the 2-(2,4- 
dichlorophenoxy)-N-methylethanamines and benzphetamine reflected the role 
that cytochrome P450 IIB1 plays in the metabolism of these compounds.
N-Demethylation appeared to be the major route of metabolism for the 
2-( 2 ,4-dichlorophenoxy)-N-methylethanamines. This metabolic route appears 
to mediated by one of the cytochrome P-450 family of isoenzymes. The 
isoenzyme that is responsible for majority of the N-demethylase activity 
appears to be the major phenobarbital inducible form cytochrome P450 IIB1 
in the rat and its equivalent isoform (cytochrome P450 IIB4) in the 
rabbit. Experiments using the rabbit isoenzyme in a reconstituted system 
indicated that the 2-(2,4-dichlorophenoxy)-N-methylethanamines were 
metabolised by this isoenzyme at higher rates than were found when the 
hepatic microsomal fraction from phenobarbital-induced rats or rabbits was 
used. This supports the conclusion that this isoenzyme is major one 
responsible for these compounds metabolism.
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Chapter 5
Evaluation of the structure-metabolism relationships for a series of 
2-(2,4-dichlorophenoxy)-N~methylethanamines in the hepatic microsomal 
fraction isolated from rats pretreated with phenobarbital.
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Although the catalytic cycle of cytochrome P-450 is very complex the
metabolism of a substrate by this enzyme can be split into two basic parts
(i) the binding to the enzyme and (ii) the metabolic reaction. Both of 
these can be described in terms of the Michaelis-Menten constants, Km for 
. binding and Vma3C for metabolism. Because of the unusual spectral proper­
ties of cytochrome P-450, there is an alternative means by which the 
binding of a substrate may be determined. When a substrate is added to 
cytochrome P-450 it may exhibit a characteristic 'binding spectrum' 
(Schenkman e t . a l . 1967). This spectral change produced by increasing 
substrate concentration can be analysed in the same way that the Michae­
lis-Menten plot may be analysed to yield the dissociation constant for the 
enzyme-substrate complex and indirectly the amount of the cytochrome P-450 
haem-iron converted from its low spin to high spin form.
In order to develop a structure-activity relationship for the 2- 
(2,4-dichlorophenoxy)-N-methylethanamine series, parameters describing the 
N-demethylation of the substrate and the binding of the substrate to the 
enzyme were determined for each member of the series.
To gain more insight into the interaction of substrates with 
cytochrome P-450, a further shorter series of compounds were also examined 
in the same way. This series of compounds was based on the phenoxy-N,N-
dimethylethanamine moiety with different substituents in the phenoxy
aromatic system. The structures of these compounds are given in fig 5.1.
5.1 Introduction.
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Fig 5.1 Substituted phenoxy-N,N-dimethlyethanamine series.
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2-(2,3-Dichlorophenoxy)-N,N,-dimethylethanamine.
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2-(2,3-Dimethylphenoxy)-N,N-dimethylethanamine
O— CHo— CH2 ~   2“  N \
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2-(2-methylphenoxy)-N,N-dimethylethanamine
CH^H^Hg
0-CH2~CH2“!^
OH.
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138
CHo— CHp- N\
,ch3
CH.
2-(2-Benzylphenoxy)-N,N-dimethylethanamine
p — ch2- c h 2- n^
z CH3
CH*
Diphenhydramine.
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5.2.1 Quantification of the spin equilibrium of hepatic microsomal
cytochrome P-450.
The spin equilibrium of hepatic microsomal cytochrome P-450 was 
determined by the method of Cinti et  a l . (1979) using temperature to 
perturb the position of the spin equilibrium.
Hepatic microsomal cytochrome P-450 was diluted to a concentration of 
2nmol cytochrome P-450/ml with 50mM potassium phosphate buffer, pH 7.4, 
containing 20% glycerol. The solution was transferred to a 1ml masked 
cuvette and placed in the thermostated cuvette housing of an Aminco DW2 
spectrophotometer operating in dual wavelength mode. A calibrated 
thermistor probe (model C, Edale Instrument Ltd., U.K.) was directly 
inserted into the cuvette and the temperature decreased to 4°C by addition 
of ice to the external water bath. After thermal equilibrium at 4°C was 
attained the cuvette temperature was gradually raised to 40°C over one 
hour. The increase in absorbance difference between 390 and 420nm was 
recorded in parallel with the cuvette temperature.
The absorbance versus temperature data was analysed using a double 
parameter computer fit analysis wherein the correlation coefficient served 
as a convergence criterion for the least squares fit of:
In (Ax - At) = delta S - delta H
In Keq[ — _______  ______  ______
(At - Ah) R RT
where Ah and K± are the maximal and minimal absorbance differences (390- 
420nm) occurring with 100% high spin and 100% low spin cytochrome P-450 
respectively, characterised by a difference absorbance coefficient of 126 
mM_1cm~1 (Gibson et  a l . 1980), At is the absorbance difference (390-420nm)
5.2 Methods.
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of the cytochrome P-450 Soret region at temperature t, corresponding to an 
equilibrium mixture of high and low spin cytochrome P-450, Keq is the 
equilibrium constant = Feha3"*V Fe1s3*' (where hs and Is refer to the high 
and low spin forms respectively), and delta S and delta H are the 
thermodynamic parameters (entropy and enthalpy changes respectively) 
characterising the spin equilibrium process. R is the gas constant (8.314 
J K“1mol"1).
5.2.2 Measurement of substrate-induced binding spectra.
The substrate-induced binding studies were routinely performed by the 
method of Schenkman et  a l . (1967).
The hepatic microsomal fraction from rats pretreated with phenobarbi­
tal was diluted with 50mM phosphate buffer, pH 7.4, containing 20% 
glycerol to give a final concentration of lnmol cytochrome P-450 / ml.
This solution was divided between two 1ml masked cuvettes and placed in 
the thermostated cuvette housing of a Uvikon 860 spectophotometer. After 
recording a baseline of equal absorbance between 500 and 350nm, substrate 
dissolved in dimethylsulphoxide (DMSO) was added in microlitre amounts to 
the sample cuvette. To reduce any effects due to the solvent, an equal 
volume was added to the reference cuvette. The contents of the cuvettes 
were mixed and the spectrum repetitively scanned between 500 and 350 nm 
until there was no further development in the difference spectrum. This 
procedure was repeated until the addition of substrate failed to produce 
any further spectral change.
The resultant peak to trough absorbance values were measured and the 
data analysed by the Hanes-Woolf method to determine the spectral binding 
parameters.
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The rate of N-demethylation was determined at various substrate 
concentrations for each of the 2-(2,4-dichlorophenoxy)-N-methylethanamine 
series of compounds as in section 4.3.8. The concentration of substrate 
used ranged between 10 and 1500 uM. The rate of N-demethylation was 
evaluated in samples from the same batch of hepatic microsomal fraction 
used to determine spectral binding constants in section 5.3.2.
The values of Km and Vma3C for the N-demethylation of each substrate 
were determined from the rate of N-demethylation at the various substrate 
concentration using the Hanes-Woolf plot.
5.2.3 Determination of Km and for the N-demethylation of the 2-(2,4-
dichlorophenoxy)-N-methylethanamines.
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5.3.1 Determination of the cytochrome P-450 high spin content of hepatic 
microsomal fraction isolated from rats pretreated with phenobarbital.
When a substrate interacts with cytochrome P-450 it alters the spin 
state of the iron atom. This alteration of the spin state can be described 
by the four component model (fig 5.2). The micro-equilibrium constants Kx, 
K2 f K3 and K4 describe the spin state change and the binding of the 
substrate to the protein. The equilibrium constant Kx represents the spin 
state equilibrium of the haemoprotein in the absence of any substrate. The 
other constants represent the dissociation constants of the substrate- 
protein complex in its high (I<4) and low (K3) spin state forms, and the 
spin state change from low spin to high spin induced by the substrate 
(K2). Before the equilibrium constants K2, K3 and K4 could be evaluated 
for any of the substrates the value for Kx for the microsomal system used 
was first determined to allow the calculation of the other constants from 
the spectral binding constant (Ks) and the maximum spectral change.
Using temperature-induced spin state analysis as described in section
5.3.1 the temperature induced spectral change for cytochrome P-450 in the 
hepatic microsomal fraction isolated from rats pretreated with phenobarbi­
tal was determined in the absence of a substrate. The plot of spectral 
change (390-420 nm) is shown in fig 5.3. The inflexion apparent at about 
20°C may be due to the change in state of the lipid membrane from a more 
solid phase to a more liquid phase. Using the equation detailed in section
5.3.1 the data obtained for the absorbance change with respect to 
temperature was used to determine the thermodynamic parameters for this 
equilibrium. This process was repeated until the correlation coefficient 
for the plot of InK against 1/RT was at a maximum (r = 0.999).
5.3 Results.
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Fig 5.2 Spin state model for the interaction between cytochrome P-450 and 
a substrate.
Reproduced from Gibson and Tamburini, 1984.
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SO
Each point represents the average of two determinations which did not vary 
by more than 4%.
Fig 5.3 Induction of a type I spectral change by increasing temperature 
in the hepatic microsomal fraction isolated from rats pretreated with 
phenobarbital.
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This yielded the following regression equation:
InK = -14.54/RT + 24.79 
s = 0.0332 r = 0.999 F = 9613.49
From this equation the enthalpy change = -121 KJ mole-1
and the entropy change = 206 KJ mole-1
This equation was also used to determine the equilibrium constant for this
change at 20°C. In the absence of a substrate this equilibrium constant is 
the fraction of the haemoprotein in the high spin form (Fhs) and by use of 
the following equation the equilibrium constant (Kx) can be determined at 
this temperature:
Fhs = Ki/(1+Kx)
For this sample of hepatic microsomes Fhs at 20°C was 0.48, which is 
equivalent to 48% of the cytochrome P-450 being in its high spin form, and 
hence Kx was 0.923.
5.3.2 Spectral interaction between the series of 2-(2,4-dichlorophenoxy)- 
N-methylethanamines and rat hepatic microsomal cytochrome P-450.
The substrate-induced spectral interaction produced by each of the 2- 
(2,4-dichlorophenoxy)-N-methylethanamines was studied in the hepatic mic­
rosomal fraction isolated from rats pretreated with phenobarbital. The 
cytochrome P-450 specific content of this hepatic microsomal preparation 
was 1.76 nmol cytochrome P-450 / mg microsomal protein.
Each of the substrates studied exhibited a 'type I' binding spectrum 
characterised by a peak at 390nm and a trough at 420nm. The absorbance 
difference was plotted against concentration for each compound to ensure 
that saturation had been reached before the data was analysed using the 
Hanes-Woolf plot to obtain the spectral binding constant (Ks) and the
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maximum spectral change (delta Ama3<). An example of the Hanes-Woolf 
transformation used to calculate the spectral binding constants is given 
for 2-(2,4-dichlorophenoxy)-N-phenyl-N-methylethanamine in figure 5.4. 
Using the maximum spectral change (delta Am£OC) obtained from the Hanes- 
Woolf plot it was possible to determine the percentage of cytochrome P-450
converted to its high spin form by the compound. This is calculated using
. the maximum spectral change and the extinction coefficient for the type I 
spectral change (126 mM-1 cm'1, Gibson et a l . 1980). The values for % high 
spin conversion (%HS) and Ks are given in table 5.1.
All the compounds expressed type I binding spectra with the exception r 
of ethyl DME N-oxide and carboxymethyl DME which showed no binding spectra 
over the stated concentration range.
The affinity of binding increased as the n-alkyl chain was increased 
from Cx-C5. This trend was reversed when the chain was increased to C6. 
Increasing the number of branches in the alkyl chain from none (methyl
DME) to four (t-butyl DME) also increased the strength of binding.
The inclusion of an aromatic system in the tail group increased the 
strength of binding relative to methyl DME. Increasing the degree of 
unsaturation in the side chain from none (propyl DME) to a double bond 
(propenyl DME) to a triple bond (propynyl DME) also had the effect of 
increasing the strength of binding.
Oxidation of the side chain from ethyl DME to ethylhydroxy DME 
increased the strength of binding between this substrate and the enzyme. 
Changing the oxygen atom in the phenoxy link in ethyl DME for a methylene 
group (ethyl DMP) resulted in tighter binding.
The percentage high spin conversion showed similar trends to the Ks 
values. The percentage high spin increased with increasing n-alkyl chain 
length from Ci-Cs, with this trend reversing at C6. The inclusion of an 
aromatic nucleus in the tail group increased the percentage high spin with
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Each point is the mean of three determinations.
Fig 5,4 Hanes-Woolf plot for the type I spectral interaction 
dichlorophenoxy)-N-phenyl-N-methylethanamine with hepatic 
cytochrome P-450.
of 2-(2,4- 
microsomal
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Table 5.1 Spectral binding parameters for the 2-(2,4-dichlorophenoxy)-N~
methylethanamine series.
Substituent KS (UM) % HS
Methyl 77.5+15.4 ■ 6.1+0.5
Ethyl 64.7+12.2 9.5+0.7
n-Propyl 50.0+9.1 19.1+1.0
Isopropyl 60.7+5.3 20.5+0.7
n-Butyl 44.0+5.3 30.2+1.1
t-Butyl 47.1+5.2 26.1+1.1
n-Pentyl 38.0+4.8 39.6+1.6
n-Hexyl 23.1+2.1 28.4+0.9
Phenyl 6.4+1.7 28.3+1.1
Benzyl 8.7+0.7 26.3+0.5
Phenethyl 16.8+1.9 27.1+1.0
Bis 11.0+1.2 15.5+0.5
Propenyl 12.0+1.7 20.8+0.7
Propynyl 9.1+1.5 16.6+0.6
Ethylhydroxy 21.5+4.5 5.7+0.4
Ethyl DMP 31.5+5.0 7.2+0.6
Each result is expressed as the mean and standard deviation of three
separate determinations.
Bis = N,N-bis[2-(2,4-dichlorophenoxy)ethyljmethylamine.
Ethyl DMP = 3-(2,4-dichlorophenyl)-N-ethyl-N-methylpropanamine.
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respect to methyl DME. There was, however, little difference between the 
aromatic containing molecules, with the exception of bis DME which had a 
lower value of %HS.
Increasing the degree of unsaturation had little effect on the 
percentage high spin conversion with propyl, propenyl and propynyl DME all 
having very similar values of % HS. However oxidation of ethyl DME to 
, yield ethylhydroxy DME produced a decrease in the percentage high spin 
conversion.
5.3.3 Estimation of the micro-equilibrium constants K2, K3 and K4 for the 
series of 2-(2,4-dichlorophenoxy)-N-methylethanamines.
Using the model detailed in fig 5.2, Gibson and Tamburini (1984) were 
able to derive the following expression which defines the spectral binding 
constant Ks in terms of the micro-equilibrium constants Kx, K2, K3 and K4.
Ks = K3 (l+Ka)/(1+Kx)
Since this is a thermodynamically closed model then:
Kx.K3 = K2 .K4
Using these equations it possible to formulate a series of
expressions that for a given compound (using its Ks and percentage high
spin conversion (% HS) and the value of the percentage high spin fraction
present in the absence of a substrate (Fhs) j
/
give values for the following equilibrium constants
K2 = (Fhs + % HS)/[1 - (Fhs + % HS)]
K3 = Ks (1+Kx)/(1+Ka)
K4 = Ks (K2/1+K2)/(Kx/1+Kx)
For the sample of hepatic microsomal fraction utilised in the present
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study it was possible to determine each of the remaining equilibrium 
constants (table 5.2).
The structurally related trends in K3 and K4 closely mirrored those 
of Ks. Despite the difference in values, both K3 and K4 decreased with 
increasing alkyl chain length up to pentyl DME after which the trend 
reversed.
The inclusion of an aromatic system in the tail group produced much 
tighter binding to both low and high spin forms of the enzyme. Inclusion- 
of an unsaturated system in the substituent group increases the strength 
of binding relative to the fully saturated analogue (propyl DME). The 
degree of unsaturation appears not to affect the strength of binding since 
both propenyl and propynyl DME have similar values of K3 and K4.
Oxidation of the ethyl side chain of ethyl DME to give ethylhydroxy 
DME produced an increase in the strength of binding. Changing the oxygen 
in the phenoxy link of ethyl DME for a methylene unit (ethyl DMP) also 
produced tighter binding.
The structurally related trends in K2 closely mirrored those observed 
for % HS (section 5.3.2). The n-alkyl substituents caused increasing 
values of K2 from Cx-C5 with the trend reversing at C6. Increasing the 
number of chain branches from none (methyl DME) to four (t-butyl DME) also 
increased K2.
A general increase in K2 was noted on the inclusion of an aromatic 
system in the substituent group, although the position of this aromatic 
system with respect to the nitrogen atom made little difference to K2. 
This was with the exception of bis DME which produced a lower value of K2 
than the other molecules containing a second aromatic group.
Increasing the degree of unsaturation from fully saturated (propyl 
DME) to fully unsaturated (propynyl DME) had little effect on the value of 
K2 as did oxidation of ethyl DME to ethylhydroxy DME.
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Table 5.2 Micro-equilibrium constants for the binding of the 2-(2,4-
dichlorophenoxy)-N-methylethanamine series to cytochrome P-450.
Substituent k2 K3(uM) K4(uM)
Methyl 1.18 68.40 53.50
Ethyl 1.36 52.74 35.80
n-Propyl 2.04 31.65 14.32
Isopropyl 2.18 36.81 15.66
n-Butyl 3.59 18.41 4.73
t-Butyl 2.85 23.53 7.62
n-Pentyl 7.06 9.54 1.25
n-Hexyl 3.24 10.47 2.98
Phenyl 3.21 2.98 0.84
Benzyl 2.89 4.30 1.37
Phenethyl 3.02 7.96 2.39
Bis 1.74 7.68 4.08
Propenyl 2.20 7.22 3.03
Propynyl 1.83 6.19 3.12
Ethylhydroxy 1.16 19.12 15.22
Ethyl DMP 1.23 27.14 20.36
Bis = N,N-Bis[2-(2,4-dichlorophenoxy)ethyl]methylamine.
Ethyl DMP = 3-(2,4-dichlorophenyl)-N-ethyl-N-methylpropanamine.
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The rate of N-demethylation was determined for each substrate at at 
least four substrate concentrations.
The rate of N-demethylation was plotted against substrate concen- 
* tration for each compound to ensure that saturation had been achieved 
prior to the calculation of the kinetic parameters Km and VmeL3C from the 
Hanes-Woolf plot. The Hanes-Woolf plot for 2-(2,4-dichlorophenoxy)-N- 
isopropyl-N-methylethanamine is given in figure 5.5. The values for Km, 
Vmax and the ratio Vma3C/Km are given for each compound in table 5.3.
No detectable N-demethylation was found for ethyl DME N-oxide and 
carboxymethyl DME over the concentration range 10-10,000uM.
In general the values of Km for the n-alkyl series increased from Cx- 
C6. Increasing the number of branches in the alkyl group from none (methyl 
DME) to four (t-butyl DME) also resulted in increasing values of Km. 
Inclusion of a further aromatic system in the substituent group decreased 
the Km relative to methyl DME the further this group was from the nitrogen 
atom. Increasing the degree of unsaturation from fully saturated (propyl 
DME) to fully unsaturated (propynyl DME) resulted in decreasing Km values. 
Oxidation of ethyl DME to ethylhydroxy DME resulted in an increase in Km. 
Changing the oxygen atom in the phenoxy link in ethyl DME to a methylene 
unit (ethyl DMP) resulted in a decrease in Km.
The values of Vma3C for this series of compounds did not vary a great
deal. However some trends were observed. The value of decreased from
Cx to C3 but then increased to Cs after which it decreased slightly. 
Branching the alkyl with methyl groups chain showed a decrease in Vma5c
from no branches (methyl DME) to one branch (ethyl DME) and then an
increase to four branches (t-butyl DME).
5.3.4 Determination of Km and Vmasc for the N-demethylation of the 2-(2,4-
dichlorophenoxy)-N-methylethanamine series.
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Fig 5.5 Hanes-Woolf plot for the determination of Vma5C and Km for the N- 
demethylation of 2-(2,4-dichlorophenoxy)-N-isopropyl-N-methylethanamine.
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Table 5.3 Kinetic parameters for the N-demethylation of the 2-(2,4-
dichlorophenoxy)-N-methylethanamine series.
Substituent Vmax Km Vm a x /Km(X103)
Methyl 12.0+0.2 134+12 89.7
Ethyl 5.1+0.1 • 141+24 36.2
d5-Ethyl 5.7+0.2 168+23 34.0
n-Propyl 5.0+0.1 150+12 33.1
Isopropyl 8.4+0.1 224+17 37.7
n-Butyl 9.7+0.4 179+17 54.2
t-Butyl 17.5+0.2 299+15 58.3
n-Pentyl 14.1+0.5 180+23 78.3
n-Hexyl 12.2+0.3 225+28 53.9
Phenyl 11.4+0.3 163+29 69.8
Benzyl 9.9+0.1 96+13 103.9
Phenethyl 8.4+0.3 86+14 96.8
Bis 3.9+0.1 51+9 76.8
Propenyl 8.7+0.2 118+12 73.4
Propynyl 10.3+0.1 35+3 295.7
Ethylhydroxy 3.0+0.1 178+21 16.5
Ethyl DMP 8.8+0.1 119+8 74.1
Each value is the mean + S.D of three separate determinations.
Km has units of uM
Vmax has units of nmol HCHO produced / min / nmol cytochrome P-450
Bis = N,N-bis[2-{2,4-dichlorophenoxy)ethyl]methylamine.
Ethyl DMP = 3-(2,4-dichlorophenyl)-N-ethyl-N-methylpropanamine.
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The inclusion of a further aromatic system in the substituent group caused 
a slight decrease in Vma3C relative to methyl DME. This decrease continued 
the further the aromatic system was from the nitrogen atom.
Increasing the degree of unsaturation in the series propyl to 
propynyl DME resulted in increasing Vma3C. Oxidation of ethyl DME to 
ethylhydroxy DME produced a lower value of Vma3C. Changing the oxygen atom 
in the phenoxy link of ethyl DME to a methylene unit (ethyl DMP) increased 
the value of Vma3C.
The Vma3C/Km ratio also showed little variation although again some 
trends were noticed. The Vma>c/Km ratio for the n-alkyl group and the 
branched alkyl group follow the trends already stated for these compounds' 
Vma3C values. The inclusion of aromatic containing moieties as substituent 
group had little effect on the Vma3C/Km ratio with the exception of benzyl 
DME which exhibited a large increase in this ratio relative to methyl DME.
Increasing the degree of unsaturation from propyl DME to propynyl DME 
resulted in a large increase in the Vma2C/Km ratio.
Oxidation of ethyl DME to ethylhydroxy DME resulted in a decrease in 
the Vma3i;/Km ratio. Changing the phenoxy link in ethyl DME to a methylene 
group produced an increase in VmaiC/Km.
5.3.5 Determination of the substrate binding constants for the 
substituted phenoxy-N,N-dimethylethanamines.
The substrate-induced spectral binding constants for the substituted 
phenoxy-N,N-dimethylethanamines were determined as detailed in section 
5.3.2, The same batch of hepatic microsomal fraction was used to allow 
comparisons between this series of compounds and the 2-(2 ,4- 
dichlorophenoxy)-N-methylethanamine series. The substrates were titrated 
with the hepatic microsomal fraction over a concentration range of 10-
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The substrate-induced spectral binding constants for N,N-dimethyl- 
aniline, N,N-dimethylbenzylamine, (R) -(+)-N,N-dimethyl-1-phenethylamine
and (S)-(-)-N,N-dimethyl-l-phenethylamine were also determined in this 
same batch of hepatic microsomal fraction. The values for the spectral 
binding constant Ks and the percentage of the cytochrome P-450 converted 
to its high spin form (% HS) for each of these compounds were determined 
from the Hanes-Woolf plot after the plot of spectral change (390-420nm) 
against substrate concentration indicated that saturation had been 
reached. These values are given in table 5.4.
Since this sample of hepatic microsomal fraction had been charact­
erised for the amount of cytochrome P-450 in the high spin form in the 
absence of substrate (section 5.3.4) it was possible to calculate the 
micro-equilibrium constants K2, K3/ and K4 for all of this series of
compounds. These values are given in table 5.5.
Changing the substitution on the phenoxy nucleus of this series of 
compounds resulted elicited changes in the strength of binding reflected 
by changes in Ks, K3 and K4. All these values decreased when the chlorine 
substitution was changed from 2,3- to 2,4-. However changing from 2,3- 
dichloro substituted to 2,4-dimethyl substituted resulted in an increase 
in Ka, K3 and K4.
The inclusion of a further aromatic group as a phenoxy substituent 
decreased the strength of binding when the aromatic systems were fused (1- 
napthyl analogue) together but increased when both aromatic systems were 
not rigidly linked to one another (benzyl analogue and diphenhydramine).
In general increasing the length of the alkyl chain in the 2-position 
resulted in a decrease in strength of binding with increasing chain length 
from Cx-C4 although K4 shows a decrease from C3 to C4.
200uM.
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Table 5.4 Spectral binding constants for the substituted phenoxy-N,N-
dimethylethanamine series.
Substituent Kg % HS
2,4-Dichloro 77.5+15.4 6.1+0.5
2,3-Dichloro 28.9+3.9 19.8+0.6
2,3-Dimethyl 40.8+1.7 19.2+0.3
1-Naphthyl 43.5+3.1 9.6+0.2
2-Methyl 51.7+6.3 13.9+0.6
2-n-Propyl 69.9+8.4 13.5+0.7
2-n-Butyl 93.8+13.4 19.1+1.5
2-Benzyl 4.0+0.5 6.6+0.2
DPH 9.4+1.1 7.3+0.2
DMA 16.6+3.7 11.1+0.4
DMB 2210+325 12.5+0.9
(R)-(+) DM-l-P 1168+84 24.7+0.5
(S)-(-) DM-l-P 1466+152 30.8+1.1
Each result is the mean and standard deviation of the mean from three
separate determinations.
DPH = Diphenhydramine.
DMA = N,N-Dimethylaniline.
DMB = N,N-Dimethylbenzylamine.
(R)-(+) DM-l-P = (R)-(+)-N,N~Dimethyl-l-phenethylamine. 
(S)-(-) DM-l-P = (S)-(-)-N,N-Dimethyl-l-phenethylamine.
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Table 5.5 Micro-equilibrium constants for the binding and spin state 
change observed when the phenyl-substituted phenoxy-N,N-dimethylethanamine 
series were titrated with hepatic microsomal cytochrome P-450.
Substituent K2 K3(uM) K4(uM)
2,4-Dichloro 1.18 68.40 53.50
2,3-Dichloro 2.11 12.96 5.70
2 ,3-Dimethyl 2.05 25.69 11.57
1- Naphthyl . 1.36 35.42 24.04
2-Methyl 1.63 37.77 21.39
2-n-Propyl 1.60 51.68 29.81
2-n-Butyl 2.04 59.34 26.85
2-Benzyl 1.20 1.05 0.81
DPH 1.24 8.07 6.01
DMA 1.44 13.04 8.36
DMB 1.53 1679 1013
(R)-(+) DM-l-P 2.66 2223 771
(S)-(-) DM-l-P 3.72 3599 893
DPH = Diphenhydramine.
DMA = N,N-Dimethylaniline.
DMB = N,N-Dimethylbenzylamine.
(R)-(+) DM-l-P = (R)-(+)-N,N-Dimethyl-l-phenethylamine. 
(S)-(-) DM-l-P = (S)-(-)-N,N-Dimethyl-l-phenethylamine,
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The binding affinity of N,N-dimethylbenzylamine and (R)- and (S)- 
N,N-dimethyl~l-phenethylamines resulted in large decreases in the binding 
affinity, however N,N-dimethylaniline was a very strong binder relative to 
these compounds.
Changing the position of the chlorine substitution from 2,3- to 2,4- 
, resulted in an increase in the high spin fraction of the enzyme as 
described by both % HS and K2. The inclusion of an further aromatic system 
as a substituent in the phenoxy nucleus resulted in decreases % HS but had 
little effect on I(2 relative to the 2,3-dichloro substituted molecule. 
Changing the length of the n-alkyl chain in the 2- position made little 
difference to either % HS or K2.
Investigation of N,N-dimethylaniline, N,N-dimethylbenzylamine and 
(R)- and (S)-N,N-dimethyl-l-phenethylamines indicated that as the distance 
between the nitrogen atom and the aromatic system was increased the values 
of % HS and K2 both increased with the (R)- and (S)-N,N-dimethyl-l- 
phenethylamines having the highest values.
5.3.6 Kinetic constants for the N-demethylation of the substituted 
phenoxy-N,N-dimethylethanamines.
The kinetic constants Km and Vma3C for the N-demethylation of the 
substituted phenoxy-N,N-dimethylethanamine series were determined in the 
same manner as those for the 2(2,4-dichlorophenoxy)-N-methylethanamine 
series detailed in section 5.3.4. The same microsomal fraction was used to 
allow comparisons to be made. The substrate concentrations ranged between 
20 and 2000 uM.
The kinetic constants were determined in each case from the Hanes- 
Woolf plot after the plot of rate of N-demethylation against substrate 
concentration indicated that saturation had been reached.
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The values of Vmax, Km and the ratio Vma3c/Km for each compound are 
given in table 5.6.
Changing the chlorine substitution from 2,4-dichloro to 2,3-dichloro 
resulted in a no statistical change in Km. However changing 2,3-dichloro 
for 2,3-dimethyl resulted in only a slight increase in Km. Inclusion of a 
further aromatic system resulted in no consistent change in Km relative to 
, the 2,4-dichloro substituted molecule. In the aromatic substituted molec­
ules the 1-napthyl analogue had the highest Km value. Increasing the 
length of the side chain in the 2- position resulted in no consistent 
trend.
The series containing N,N-dimethylaniline, N,N-dimethylbenzylamine 
and (R)- and (S)-N,N-dimethyl-l-phenethylamines showed no consistent trend 
although a clear increase in the value of Km was noted for the latter 
three molecules.
As with the 2-(2,4-dichlorophenoxy)-N-methylethanamine series the 
Vma3C values of this series of molecules did not show a great deal of 
variation. A slight decrease in Vma3C was found on changing the chlorine 
substitution from 2,4- to 2,3-, which was followed by another slight 
decrease on changing from 2,3-dichloro to 2,3-dimethyl substitution.
In general the inclusion of a further aromatic system produced a 
decrease in Vma3C relative to the 2,4-dichloro substituted molecule. No 
consistent trend existed within the group of aromatic substituted mole­
cules.
Increasing the length of the n-alkyl side chain in the 2- position 
resulted in no consistent trend in the VmaiC values from Cx substituted to 
C4 substituted.
The short series of molecules containing N,N-dimethylaniline, N,N- 
dimethylbenzylamine and (R)- and (S)-N,N-dimethyl-l-phenethylamine showed 
no consistent trend although all these molecules had much higher Vmasc
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Table 5.6 Kinetic constants Vma5C and Km for the N-demethylation of the
substituted phenoxy-N,N-dimethylethanamine series.
Substituent vv  m a x Km Vm^/Km(X 103)
2,4-Dichloro 12.0+0.2 134+12 89.7
2,3-Dichloro 10.0+0.1 131+8 76.3
2 ,3-Dimethyl 
1-Nagfthyl
9.8+0.2 171+10 57.5
6.7+0.2 206+18 32.2
2-Methyl 8.8+0.2 230+19 38.4
2-n-Propyl 12.7+0.1 190+8 66.8
2-n-Butyl 10.6+0.4 114+20 93.1
2-Benzyl 5.8+0.4 128+31 44.8
DPH 7.5+0.2 44+18 168.3
DMA 24.0+0.5 169+14 142.0
DMB 17.5+0.6 4830+338 3.6
(R)-(+) DM-l-P 20.8+0.2 1840+112 11.3
(S)-(-) DM-l-P 21.9+0.2 1726+80 12.7
Each value represents the mean and standard deviation of three separate 
determinations.
Km has units of uM
Vmax has units of nmol HCHO produced / min / nmol cytochrome P-450.
DPH = Diphenhydramine.
DMA = N,N-Dimethylaniline.
DMB = N,N-Dimethylbenzylamine.
(R)-(+) DM-l-P = (R)-(+)-N,N-Dimethyl-l-phenethylamine.
(S)-(-) DM-l-P = (S)-(-)-N,N-Dimethyl-l-phenethylamine.
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values than the rest of the series. The Vmax/Km ratio for this series of 
molecules did not vary much. However for diphenhydramine and N,N-dimethyl- 
aniline the values of this ratio were much higher than for the other 
members of the series.
5.3.7 Correlation matrices between the binding and spin state parameters 
and the kinetic parameters for both series of compounds.
In order to determine if any of the spectrally determined binding and 
spin state parameters were inter-related to any of the kinetic parameters 
correlation matrices were calculated for both series of compounds. These 
matrices are given in table 5.7 and 5.8. In the case of the substituted 
phenoxy-N,N-dimethylethanamine series it was necessary to exclude N,N- 
dimethylbenzylamine, (R)-(+)-N,N-dimethyl-l-phenethylamine and (S)-(-)- 
N,N-dimethyl-l-phenethylamine since the large numerical values for Ka (and 
hence K3 and K4) and Km led to these compounds exerting large influences 
on any correlation in which these parameters were involved.
For the correlations to be statistically significant only correlation 
coefficients above a certain level were accepted. Since the numbers in 
each of the groups were different, the correlation coefficient required to 
give maximum statistical significance also varies. For the 2-(2,4-di­
chlorophenoxy) -N-methylethanamine series only correlation coefficients 
above 0.742 (pjO.OOl) were accepted and for the substituted phenoxy-N,N- 
dimethylethanamine series only values above 0.872 (pjO.OOl). The signifi­
cance level p < 0.001 was selected because at this level any correlation 
involving the 2-(2,4-dichlorophenoxy)-N-methylethanamines would explain at 
least 55% of the variation and any correlation involving the substituted 
phenoxy-N,N-dimethylethanamines would explain at least 76% of the varia­
tion.
Using these criteria revealed a number of significant correlations. 
Both series of compounds yielded correlations between K3 and K4, Kz and %
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Table 5.7 Correlation matrix for the binding, spin state change and
metabolism parameters of the 2-(2,4-dichlorophenoxy)-N-methylethanamine
series.
^maK Km Ymsiic / Km Kg % HS k2 k3 k4
Vtna.3c 0.597 0.024 0.020 0.504 0.522 -0.159 -0.192
Km -0.643 0.334 • 0.242 0.259 0.156 0.037
Vtnajc/Km -0.408 -0.040 -0.088 -0.321 -0.236
Ks -0.252 -0.102 0.912 0.775
% HS 0.897 -0.584 -0.771
k2 -0.437 -0.524
k3 0.958
Correlations with r > 0.742 are significant at p <_ 0.001 (greater than 55% 
of the variation explained).
Table 5.8 Correlation matrix for the binding, spin state and kinetic 
parameters of the substituted phenoxy-N,N-dimethylethanamine series.
Vmaac Km Vma3c / Km Kg % HS k2 k3 k4
7max 0.162 0.478 -0.006 0.125 0.076 0.008 0.005
Km -0.703 0.319 0.164 0.098 0.406 0.507
Vmasc / Km -0.291 -0.185 --0.176 -0.301 -0.332
Kg 0.601 0.563 0.979 0.895
% HS 0.996 0.467 0.286
k2 0.418 0.228
k3 0.964
Correlations with r > 0.872 are significant at p 1 0.00! (greater than 76%
of the variation explained).
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HS, K3 and Ks and K4 and Ks. The 2-(2,4-dichlorophenoxy)-N-methylethan­
amine series also yielded a correlation between K4 and % HS.
The variation in K2 in both series was not very great which results 
in the expressions given above for K3 and K4 simplifying to a direct 
correlation between Ka and K3 and K4 since Kx is constant and K2 is 
essentially constant. This also yields a correlation between K3 and K4.
- The correlation between K2 and % HS also arises from the lack of large 
variations in the values K2 which results in an almost linear relationship 
between these two quantities.
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To obtain a complete structure-activity relationship (SAR) for these 
compounds both the metabolism and the spin state change produced by 
substrate binding were examined and separate SAR's developed for each of 
these. For the purposes of this discussion the 2-(2,4-dichlorophenoxy)-N- 
methylethanamine series of compounds are referred to as the 'tail' group 
, series and the substituted phenoxy-N,N-dimethylethanamine series are re­
ferred to as the 'head' group series.
In order to elucidate an SAR for the binding of the compounds to 
cytochrome P-450 the spectral binding constant K3 and the micro-equili­
brium constants K3 and K4 were examined. Changes in the tail group had 
large influences on Ks and both K3 and K4 (table 5.2). The increase in 
binding affinity demonstrated in sections 5,3.2 and 5.3.3 for the n-alkyl, 
branched alkyl and aromatic~containing molecules in general parallels the 
increase in lipophilicity of these molecules (appendix). There are however 
a number of exceptions to this. Both bis and hexyl DME exhibit lower 
binding affinities than would be expected of molecules with log P values 
of 6.83 and 5.74 respectively. These molecules are also the largest in the 
tail group series. This suggests that although hydrophobic interactions 
are important in the binding of these molecules to the enzymejthe active
site of the enzyme, although large, is not large enough to accommodate
particular 
these molecules.
Both the unsaturated analogues of propyl DME and ethylhydroxy DME 
exhibit binding which is much stronger than would be expected from the 
relatively low log P values of these molecules. This implies that these 
molecules are binding to the protein by some interaction other than a 
hydrophobic one. In the case of ethylhydroxy DME the possibility exists 
for the compound to bind to the haem via the oxygen of the hydroxyl group. 
This would produce a so-called 'reverse type I' binding spectrum. No
5.4 Discussion,
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evidence of such a spectrum was detected.
The unusually strong binding of propenyl and propynyl DME is diffi­
cult to explain although both these molecules belong to functional groups 
which are known to alkylate the D ring of cytochrome P-450 porphyrin 
(Ortiz de Montellano et  a l . 1985) in the case of double bond containing 
molecules and the A ring in the case of triple bonded molecules (Kunze et  
a l . 1983). The inactivation of cytochrome P-450 by both these functional 
groups requires the presence of oxy-cytochrome P-450 which in turn-
requires the presence of NADPH for its production. The unusually strong
binding of these compounds may represent an interaction with porphyrin as 
well as an interaction with the apoprotein.
Changes in the substitution on the phenoxy nucleus of the head group 
series also elicited changes in the values of Ks, K3 and K4 (tables 5.1 
and 5.2). The trends highlighted in sections 5.3.5 also represent a 
compromise between the lipophilicity of the compound and its size. The 
values of log P for this series are given in the appendix. The very high 
values of Ks/ K3 and K4 for N,N-dimethylbenzylamine and both (R)- and (S)- 
N,N-dimethyl-l-phenethylamines illustrate this since these are small mole­
cules with low values of log P (1.96 and 2.19 respectively). N,N- 
Dimethylaniline is unusual for this series since it is the smallest in 
terms of molecular size and also has a low log P (2.34) yet binds very 
tightly to the enzyme.
In general the remaining members of this series show increased 
binding with increasing lipophilicity with the exception of diphenhydr­
amine and 2-(2,3-dichlorophenoxy)-N,N-dimethylethanamine. Both these com­
pounds exhibit stronger binding than would be expected from their values 
of log P. In the case of 2-(2,3-dichlorophenoxy)-N,N-dimethylethanamine 
this appears to be as a direct result of changing the chlorine substit­
ution pattern since the 2,4-dichloro analogue exhibits much weaker bindi-
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ng. This again suggests the possibility that the binding site for the head 
group series of molecules is a certain size.
In the case of diphenhydramine an explanation of its tight binding is 
not clear although it may be related to the fact the two aromatic systems 
in this molecule are free to rotate and which may enable them to interact 
more strongly with the active site than more hindered molecules such as 2- 
(2-benzyl)-N,N-dimethylethanamine.
Since K2 was highly correlated with the high spin conversion (table 
5.7) this parameter will be used to discuss the effect of structure on the 
conversion of cytochrome P-450 from its low spin to its high spin state.
On the whole the trends observed for Ks, K3 and K4 were mirrored by
trends in K2 (table 5.2). Notable exceptions to this were propenyl,
propynyl and ethylhydroxy DME. Despite the strong binding of these
compounds they failed to convert as much of the enzyme to its high spin
form as compounds with similar values of Ks, K3 and K4. This enforces the 
suggestion made above that these compounds interacting with the enzyme in 
a different way to the rest of the series.
On the whole values of K2 in the head group series did not vary very
much (tables 5.4 and 5.5), although it is apparent that both the (R)- and 
(S)-N,N-dimethyl-l-phenethylamines do induce the largest amounts of the 
high spin form of the enzyme. This appears to be a function of the
chirality of the molecule with the (S)-f0rm having a higher value of K2 
than the (R)- form . This gives an indication that the presence of the 
methyl group and its three dimensional position affect the conversion of 
low spin cytochrome P-450 to its high spin form.
In the Michaelis-Menten description of enzyme kinetics Km is genera­
lly regarded as a measure of the affinity of the enzyme for a given 
substrate. In the model of cytochrome P-450 spin state proposed by Gibson 
and Tamburini, (1984) (fig 5.2) it is assumed that only the high spin form
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of the enzyme can be readily reduced, therefore bind oxygen and hence 
support metabolism. Studies to attempt to relate the spectral binding 
parameters K3 and K4 to Km were carried out using a variety of model 
systems based on the above assumption. In all cases Km was found to be a 
complex mixture of many rate and equilibrium constants with no direct 
dependence on either K3 or K4. This is supported by the lack of
, correlation between either K3 and K4 and Km (tables 5.7 and 5.8). It
should be remembered however that in the Michaelis-Menten treatment of
enzyme kinetics that Km is related to the rates of formation and breakdown 
of an enzyme-substrate complex which reaches steady state. If in the case 
of cytochrome P-450 this steady state complex is not the initial one
formed as defined by K3 and K4 then no direct relationship between these
constants and Km may be expected. Previous studies carried out under
similar conditions by Blanck et a l . (1983) and White and McCarthy (1986)
also showed a lack of correlation between spectral binding parameters and
kinetically determined binding parameters.
The trends observed for Km in the tail group series are not related 
to the lipophilicity of the molecules. There appears to be no restriction 
imposed on the Km values by the size of the molecules since the values of 
Km for the n-alkyl group increase from Cx to C6. The inclusion of
unsaturated moieties in the tail group resulted in no change in Km from 
that of the fully saturated molecule. It is clear however that a further 
aromatic system in the molecules does result in lower Km values. It is 
also clear that the greater the distance this aromatic group is from the 
nitrogen atom the lower the value of Km.
The value of Km for ethylhydroxy DME was higher than that of ethyl
DME which suggests that this compound may have been too polar to form the
particular enzyme/substrate complex on which Km depends. However changing 
the phenoxy link in ethyl DME to a methylene unit so decreasing the
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polarity of the molecule resulted in little change to . the Km value.
Trends in the values of Km for the head group series of molecules 
were highlighted in section 5.3.6. In the case of the head group there is 
an apparent link between the lipophilicity and the size of the molecule 
since in the series of molecules with n-alkyl substituents in the 2- 
position the Km values decrease with increasing n-alkyl chain length.
The importance of an aromatic group in obtaining low Km values is 
again exemplified by this group of molecules with the exception of the 1- 
napthyl analogue. This may be related to the ability of the aromatic
CL.
functions to rotate since the 1-napthyl analogue is rigid 1 structure. The
L -
implication of this is that for low Km values the molecules must have one 
or more aromatic groups which are able to rotate in order for the compound 
to form this particular enzyme/substrate complex.
The series of molecules containing N,N-dimethylaniline, N,N-dimethyl- 
benzylamine and both (R)~ and (S)-N,N-dimethyl~l-phenethylamines again 
highlighted N,N-dimethylaniline as unusual. This compound yielded a much 
lower value of Km than the other members in this series. It is known that 
N,N~dimethylaniline undergoes both N-dealkylation and N-oxidation. In the 
case of this molecule it has been shown that the N-oxidation leads to N- 
dealkylation (Pettit and Ziegler, 1963). It is possible that in this case 
the Km value represents a composite of the Km value for N-dealkylation and 
the Km value for N-oxidation. This may also explain why the Vmax of this 
molecule is greater than those of N,N-dimethylbenzylamine and both (R)- 
and (S)-N,N-dimethyl-l-phenethylamines.
The high Km values of N,N-dimethylbenzylamine and the N,N-dimethyl- 
phenethylamines may be related to either lipophilicity or size since as 
stated above these are the smallest and least lipophilic of the molecules 
studied. The interaction between the optical isomers (R)- and (S)-N,N- 
dimethyl-l-phenethylamine and the enzyme appears to be non-specific since
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the Km values were not statistically different.
The same kinetic analysis that yielded Km also provided values for 
the maximum rate of substrate metabolism Vma3C. In a previous study carried 
out by Blanck et a l . (1983) it was reported that the Vma3C of a compound 
was linearly related to the amount of cytochrome P-450 converted into its 
high spin form by that compound. The data presented in this chapter and 
the data presented by White and McCarthy (1986) failed to produce the same 
correlation. This is possibly due to the differences in the compounds used 
since the compounds used by Blanck et a l . were a closely related series of 
benzphetamine analogues whereas in this study and the study of White and 
McCarthy more diverse series of compounds were used.
On the whole the Vma3C values for the tail group series did not vary a 
great deal (table 5.3). However some trends were noticed and highlighted 
in section 5.3.4. It is difficult to ascribe any structure-activity 
relationship to the n-alkyl or branched alkyl chain series since there 
appears to be no consistent trend, although t-butyl and n-pentyl DME have 
the highest Vmax values .
The inclusion of aromatic substituent groups in the tail groups 
resulted in a decrease in Vma3C values relative to methyl DME. This finding 
is in opposition to the trend found with Km.
It appears that the polarity of molecules is an important determinant
of Vma3C. Ethylhydroxy DME has a low value of Vmax relative to ethyl DME
indicating that increasing the polarity of the tail group decreases Vma3C.
Ethyl DMP has a larger value of Vma3C relative to ethyl DME indicating that
decreasing the polarity of aromatic function ;increasesj the rate of
\\
metabolism.
Increasing the degree of unsaturation from n-propyl DME through 
propenyl DME to propynyl DME had the effect of increasing Vma3C.
The lack of consistent trends amongst the Vma3C values of the tail
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group series implies that the rate of metabolism is not dependent on 
physico-chemical or molecular mechanical parameters but on a factor such 
as the position of the nitrogen atom relative to the 'active oxygen'.
This observation is supported by the lack of consistant trends in the 
Vam3C values of the head group series. Molecules that contain a second 
aromatic system in the head group exhibited lower values of Vma3C than the 
, other molecules in this series.
The ratio of Vma3C to Km was also investigated here since this value 
represents the clearance of the compound in this hepatic microsomal system 
and may be considered as a measure of efficiency with which cytochrome P- 
450 handles these substrates. The values of Vmax/Km are all similar for 
the tail group series with the exception of the values for benzyl and 
propynyl DME. These molecules have much higher values of Vma3c/Km and hence 
are more rapidly cleared from the microsomal system. In terms of a 
structure-activity relationship these molecules indicate that an aro­
matic/unsaturated system one carbon atom from the nitrogen atom is 
required for both high affinity and high metabolic rate.
Changes in the head group resulted in changes in the Vma3C/Km ratio 
(table 5.5). This group of compounds also produced values of Vma5<:/Km that 
were similar. Diphenhydramine exhibited the highest value Vmasc/Km in this 
series suggesting that two unhindered aromatic groups were required for 
high affinity and high metabolic rate in this series of compounds.
N,N~Dimethylaniline also exhibits a large Vma3C/Km ratio however as 
stated above this ratio may represent a composite of Vma3C/Km ratios for N- 
dealkylation and N-oxidation leading to N-dealkylation.
Examination of all the binding, spin state change and kinetic 
parameters yielded a few correlations. Both series of compounds investi­
gated produced correlations between K3 and Ks, K4 and Km, K3 and K4 and K2 
and % HS. The inter-relation between K3, K4 and Ks arises from the
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Equation 1. Ks = K3(l+K2)/(1+K1)
Equation 2. KX.K3 = K2.K4
Since Kj. is a constant, Ka is dependent on K2 and K3, and as K2 is small with 
respect to Ks and K3, then the inter-relation of these two parameters is 
not surprising. Rearranging equation 2 and substituting in equation 1 
produces the following relationship:
Equation 3. Ks = K4 (1+K2)/K2.Kx(1+KX)
which again, given the conditions above, produces a relationship between 
Ks and K4.
The percentage increase in the high spin fraction (% HS) is related 
to K2 according to equation 4.
Equation 4. % HS = K2/(l+K2)
Although this expression is not a linear one % HS can only have values 
between 0 and 0.52 over which range K2/(l+K2) approximates to a linear 
expression.
following two equations:
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Chapter 6.
Evaluation of structure-activity relationships for the 2-(2,4-dichloro­
phenoxy) -N-methylethanamine series with a reconstituted system containing
purified cytochrome P450 IIB4.
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In order to understand how the 2-(2,4-dichlorophenoxy)-N-methylethan­
amines interact with, and are metabolised by, cytochrome P-450, similar 
investigations were carried out to those detailed in chapter 5 using a 
purified form of cytochrome P-450 in a reconstituted system.
The choice of which isoenzyme of cytochrome P-450 to purify was made
based on the information set out in chapter 4 which indicated that the
rate of the metabolism of these compounds could be significantly increased 
if the rats from which the hepatic microsomal fraction was obtained were 
pretreated with phenobarbital. Therefore the cytochrome P-450 used in 
these studies was one of those induced by phenobarbital. Since these 
experiments would require a large amount of the purified enzyme the 
particular cytochrome P-450 chosen was rabbit cytochrome P450 IIB4 as it 
can be obtained in good yield at a high purity.
Once the pure enzyme was obtained the spectral binding constants Ks 
and delta Ama3C were determined along with the kinetic constants Km and 
Vma3C* These values were then used to develop structure-activity relation­
ships for these various biological parameters in conjunction with compar­
ison with the values obtained from the hepatic microsomal fraction from 
rats pretreated with phenobarbital in chapter 5.
6.1 Introduction.
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These were described in sections 2.2 and 4.2 for substances such as 
NADPH-cytochrome P-450 reductase. Additional chemicals and suppliers not 
previously mentioned are given below:
British Drug Houses Ltd (Poole, Dorset, U.K.):
Ammonium persulphate, glycine, propan-2-ol, sodium dodecyl sulphate 
and sodium cholate.
National Diagnostics (Alyesbury, U.K.):
Acrylagel and bisacrylagel.
Pharmacia Fine Chemicals Ltd (Milton Keynes, U.K.):
CM-Sepharose and hydroxylapatite.
Sigma Chemical Co. Ltd (Poole, Dorset, U.K.):
Agar, bromophenol blue, Coomassie brilliant blue R-250, polyethylene 
glycol 6,000-8,000, Tergitol NP-10 and Tris (Trizma base).
Whatmann Ltd (Maidstone, Kent, U.K.):
DEAE-cellulose (DE-52).
6.2 Materials and suppliers.
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6.3.1 Purification of rabbit cytochrome P450 IIB4.
Rabbit cytochrome P450 IIB4 was purified essentially according to the 
method of Coon e t . a l . (1979) with the exception that Tergitol was used as 
the detergent to keep the cytochrome P-450 in solution.
Eight male New Zealand white rabbits (University of Surrey Breeding 
Unit, approximately 2 kg) were allowed to drink 0.1% aqueous phenobarbital 
for 1 week prior to sacrifice. The hepatic microsomal fraction was 
prepared from the combined livers as indicated in the above method and 
stored in 50mM tris buffer (pH 7.5) containing ImM EDTA and 20% glycerol. 
Solubilisation of this hepatic microsomal fraction was achieved with 
sodium cholate under nitrogen. The solubilised microsomes were then 
subjected to polyethylene glycol (PEG) precipitation. The majority of the 
cytochrome P-450 was found in the fraction precipitated by 8-10% PEG. This 
fraction was resuspended and dialysed against lOmM tris buffer, pH 7.5, 
containing ImM EDTA, 20% glycerol and 0.5% Tergitol before being applied 
to a Whatmann DE-52 column. The cytochrome P-450 was eluted, from this 
column by washing the column with buffer of the same composition as the 
dialysis buffer. The fractions containing cytochrome P-450 were identified 
by monitoring the eluent at 415 nm for cytochrome P-450 and at 280 nm for 
total protein. The overall purity was increased by selecting those samples 
that contained the largest amounts of cytochrome P450 IIB4 as assessed by 
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE). 
Further chromatography was carried out using an hydroxylapatite column 
increasing the concentration of tris buffer using a linear gradient from
10-lOOmM to elute the cytochrome. The fractions containing cytochrome P450 
IIB4 were identified by SDS PAGE gels and pooled. The cytochrome P-450 was 
dialysed against lOmM sodium phosphate buffer, pH 7.5, containing ImM 
EDTA, 20% glycerol and 0.15% Tergitol. The final step in the purification
6.3 Methods.
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was to remove the Tergitol from the enzyme. This was achieved by applying 
the enzyme to a CM-Sepharose column and washing it with the above 
phosphate buffer until the absorbance at 280nm reached that of the eluting 
buffer indicating that all the Tergitol had been removed. The cytochrome 
P-450 was then eluted by increasing the salt concentration of the buffer 
to 400 mM potassium phosphate. The final purified protein was stored under 
nitrogen at -80°C for not longer than 8 months, Under these conditions the 
protein was found to retain its catalytic activity,
6.3.2 Sodium dodecyl sulphate polyacrylamide gel electrophoresis
Reagents
Acrylagel (30% w/v acrylamide).
Bisacrylagel (2% w/v N,N-methylene-bis-acrylamide).
Separating gel buffer: 1.5M Tris-HCl (pH 8.8) containing 0.4% (w/v)
sodium dodecyl sulphate (SDS).
Stacking gel buffer: 0.5M Tris-HCl (pH 6.8) containing 0.4% (w/v)
SDS.
Electrode buffer: 2.5mM Tris-HCl (pH 8.3) containing 192mM glycine
and 1% (w/v) SDS.
Sample solubilisation buffer: 62.5mM Tris-HCl (pH 6.8) containing
2.3% (w/v) SDS, 15% (v/v) glycerol, 5% (v/v) 2-mercaptoethanol and 
0.001% (w/v) bromophenol blue.
Ammonium persulphate 10% (w/v).
N,N-tetramethylethylethylenediamine (TEMED).
Prestained molecular weight markers (MW-SDS-blue) consisting of:
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Protein Approximate Mr 
(daltons)
180,000
116,000
Macroglobulin
B-Galactosidase
Fructose-6-phosphate kinase
Pyruvate kinase
Fumarase
84,000
58,000
48,500
Lactate dehydrogenase 
Triose phosphate isomerase 26,600
36,500
The proteins were first rendered monomeric by boiling in sample 
solubilisation buffer for 1.5-3 minutes. Electrophoresis was performed 
at room temperature using a vertical slab gel assembly, in which the gel 
was contained in a glass and perspex cassette of internal dimensions 
120mm x 130mm x 1.5mm. The glass plates were washed in tap water, dis­
tilled water and then acetone prior to use.
The cassettes were clamped in a vertical position and sealed with 2% 
(w/v) agar. The lower (separating) gel was prepared by mixing acrylagel, 
bisacrylagel, separating gel buffer and distilled water to give a 10% 
(w/v) acrylamide/0.27% (w/v) bis-acrylamide gel containing 0.1% (w/v) SDS. 
The polymerisation process was initiated by the addition of TEMED and 
freshly prepared ammonium persulphate. This solution was then poured into 
the cassette to a height of approximately 80mm. Distilled water was gently 
layered above the gel mixture to ensure a smooth interface.
On completion of polymerisation the water layer was removed and the 
stacking gel applied. The stacking (upper) gel was prepared by mixing 
acrylagel, bisacrylagel, stacking gel buffer and distilled water to give a 
3% (w/v) acrylamide/0.08% (w/v) bis-acrylamide gel containing 0.1% (w/v)
SDS. Polymerisation was initiated as before and the wells were formed by
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After polymerisation the bottom edge spacer and sample comb were 
removed and the gel slab was placed in the electrophoresis tank. Electro­
phoresis buffer was poured into the anode and cathode reservoirs and any 
air bubbles trapped in the sample wells or underneath the gel were removed 
with a syringe and fine tubing.
The samples were loaded based on the amount of cytochrome P-450 
present in the sample using a Hamilton syringe. Samples were run under a 
20mA constant current until the bromophenol indicator entered the sepa­
rating gel whereupon the current was increased to 40mA.
The lower running gel was cut out and stained overnight in propan-2- 
ol/acetic acid/ water (25:10:65 by volume) containing 0.05% (w/v) coo-
massie brilliant blue R-250. Background destaining was achieved by succe­
ssive washes with destaining solution (propan-2-ol/acetic acid/water - 
1:1:8 by volume)
6.3.3 Determination of the kinetic constants Km and Vmax for the 2— (2,4— 
dichlorophenoxy)-N-methylethanamine series in purified cytochrome P450 
IIB4,
The rates of N-demethylation for the 2-(2,4-dichlorophenoxy)-N- 
methylethanamine series were determined using essentially the same method 
detailed in section 4.3.7.
The differences between the two methods can be ascribed to differen­
ces in the preparation of the cytochrome P-450. The N-demethylation of 
these compounds was determined in purified cytochrome P450 IIB4 using the 
following incubation mixture:
the introduction of a perspex comb.
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Stock Concentration. Component Final Concentration.
300 ug/ml L-alpha-dilauroylphosphatidylcholine (DLPC). 30 ug/ml
5 uM Purified cytochrome P450 IIB4. 0.1 uM
55 U/ml NADPH-cytochrome P-450 reductase (FPT). 0.9 U/ml
500 ug/ml Sodium deoxycholate (DOC). 50 ug/ml
400 mM Potassium phosphate buffer pH 7.25. 50 mM
150 mM Magnesium chloride. 15 mM
40 mM NADPH in 1% NaHC03 1 mM
Stock solution of substrate.
The reagents were added at 4 °C in the order stated above with the 
exception of the NADPH. The mixture was allowed to pre-incubate at 37 °C 
for five minutes prior to the reaction being initiated by the addition of 
the NADPH. The reaction was terminated after 10 minutes by the addition of 
lml of 12.5% trichloroacetic acid. The rates of N-demethylation and hence 
the Km and Vma3C values were determined as in section 5.2.3.
6.3.3 Quantitation of the spin state equilibrium in the absence of 
substrate (Kx) for purified rabbit cytochrome P450 IIB4.
The method used to determine the spin equilibrium for the purified 
cytochrome P450 IIB4 was the same as that used by Guengerich (1983),
The purified cytochrome P-450 (2nmol) and NADPH-cytochrome P-450 
reductase (18 units) were reconstituted in 300ul DLPC (90ug) and 300ul DOC 
(150ug) and then diluted with 50mM potassium phosphate buffer, pH 7.4 
containing 20% glycerol to give a final volume of 2.0 ml. This mixture, 
contained in a 3.0ml quartz cuvette was placed in the sample holder of the 
thermostated cuvette housing in a Uvikon 860 split beam spectrophotometer 
set at 25 °C. The reference quartz cuvette contained 300ul DLPC, 300ul
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DOC, NADPH-cytochrome P-450 reductase (18 units)- and 50mM potassium 
phosphate buffer to a final volume of 2.0ml. The spectrum of the sample 
was then recorded between 700 and 300nm. To calculate the fraction of the 
haemoprotein in the high spin form, the second derivative of this absolute 
spectrum was calculated using software available on the spectrophotometer. 
The peak to trough differences for the second derivatives of the two Soret 
bands at 412nm and 392nm were then used to calculate the fraction of the 
enzyme in the high spin form (Fhs) using the following equation developed 
by Guengerich (1983) from O'Haver and Green (1976).
Fhs = 2 X PT392/[(2 X PT392) + PT412J
where PT392 is the peak to trough difference for the high spin Soret band 
and PT412 is the peak to trough difference for the low spin Soret band.
6.3.5 Measurement of substrate-induced binding spectra.
The spectral changes resulting from the addition of increasing 
concentration of ligand on purified cytochrome P450 IIB4 were determined 
in essentially the same way as for the hepatic microsomal fraction in 
section 5.2.2. Cytochrome P450 IIB4 (luM) and NADPH-cytochrome P-450 
reductase were reconstituted in DLPC (90ug) and DOC (150ug) and diluted 
with 50mM potassium phosphate buffer, pH 7.4 containing 20% glycerol. This 
solution was split into two masked cuvettes and placed in the thermostated 
housing of a Uvikon 860 split beam spectrophotometer set at a temperature 
of 25°C. The binding spectra of the compounds were then recorded and 
processed as in section 5.2.2.
The determination of the micro-equilibrium constants K2, K3 and K4 
was carried out in the same manner as detailed in section 5.3.3.
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6.4.1 Purification of rabbit cytochrome P450 IIB4.
Cytochrome P450 IIB4 was purified from rabbits pretreated with 
phenobarbital as described in section 6.3.1. This gave a final yield of 
cytochrome P-450 of 453 nmol which was determined as being electroph- 
etically pure by examination of an SDS PAGE gel which had different 
amounts of this final preparation loaded on it. The specific content of 
this final preparation was 17.7 nmol cytochrome P-450 / mg protein. The 
absorbance spectrum of this preparation showed the expected bands at 419 
and 392 nm, corresponding to the Soret bands of the high and low spin 
forms of the enzyme, the alpha and beta bands of the porphyrin system and 
a band at 280 nm attributable to the absorbance of the apoprotein.
The details of the purification are given in table 6.1 and an SDS 
PAGE gel showing different loadings of the purified enzyme is shown in 
figure 6.1.
6.4.2 Determination of the kinetic constants Km and Vmax of the 2-(2,4- 
dichlorophenoxy)-N-methylethanamine series mediated by cytochrome P450 
IIB4.
The kinetic constants for the 2-(2,4-dichlorophenoxy)-N-methylethan­
amines were determined in a reconstituted system containing purified 
cytochrome P450 IIB4 as indicated in section 6.3.3.
The rates of N-demethylation for the 2-{2,4-dichlorophenoxy)-N- 
methylethanamine series were determined over the concentration range 10- 
2000 uM. The results were analysed in the same manner as those from 
hepatic microsomal fraction detailed in section 5.3.4.
6.4 Results.
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Table 6.1 Purification of cytochrome P450 IIB4 from the hepatic 
microsomal fraction of rabbits pretreated with phenobarbital.
Purification Volume Protein Total P-450 Total Purity Yield
Stage Protein P-450
(ml) (mg ml"1) (mg) (uM) (nmoles) (nmol mg-1) w
Microsomes 600 24.3 14580 47.6 28459 1.96 100
Solubilisation 1050 3.9 8157 78.5 16478 2.02 58
PEG Precipitation 215 23.3 5020 59.3 12757 2.54 45
DE-52 342 2.2 737 14.9 5082 6.90 18
Hydroxyl apatite 1930 * * 0.5 985 * 3.5
CM-Sepharose 86 0.3 26 5.3 457 17.7 1.6
* Samples too dilute to assess protein concentration.
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1 2  3  4 ®
Track N°
1 Molecular weight markers.
2 2pmol cytochrome P450 IIB4
3 4pmol cytochrome P450 IIB4
4 8pmol cytochrome P450 IIB4
5 lOpmol cytochrome P450 IIB4
Fig 6.1 SDS PAGE showing increasing amounts of the purified rabbit 
cytochrome P450 IIB4.
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All the compounds were N-demethylated with the exception of ethyl DME 
N-oxide and carboxymethyl DME which showed no evidence of N-demethylation 
over a 1000 fold concentration range. No values of and Km were
determined for hexyl DME as this compound was not available. The kinetic 
constants VOTajc and Km for the other members of the series and the ratio 
Vma5c/Km are given in table 6.2.
The VmaJC values for these compounds showed no consistent trend with 
all the values being similar with the exception of bis, ethylhydroxy and 
propynyl DME. These compounds all exhibited lower Vmase values than the 
other members of the 2-(2,4-dichlorophenoxy)-N-methylethanamines.
The values of Km for the n-alkyl series show a drop in Km from methyl 
to ethyl and then an increase to pentyl DME. The branched chain analogues
also show a drop in Km values but this drop continues from methyl DME to
the fully branched analogue (t-butyl DME).
In general the inclusion of an aromatic system results in a drop in 
the value of Km relative to methyl DME with the exception of benzyl DME 
which has a larger Km.
Increasing the degree of unsaturation from propyl to propenyl to
propynyl DME also results in a decrease in the value of Km.
Oxidation of ethyl DME to ethylhydroxy DME produces a large increase
in the value of Km whereas changing the phenoxy link in ethyl DME to a
methylene link produces a lower value of Km.
The Vma3c/Km ratio for the n-alkyl shows an increase from methyl to
propyl DME and then a decrease to pentyl DME. The branched chain series 
show no consistent trend.
The molecules containing aromatic/unsaturated side chains all have
high Vma3C/Km ratios with the exception of benzyl and bis DME.
Oxidation of ethyl DME to yield ethylhydroxy DME results in a large 
decrease in Vma3C/Km ratio, whereas changing the phenoxy link in ethyl DME
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Table 6.2 Kinetic constants Vma3C and Km for the 2-(2,4-dichlorophenoxy)-
N-methylethanamine series in a reconstituted system containing purified
cytochrome P450 IIB4.
Substituent Vmax Km Vma3C/Km(X103)
Methyl 40.2+0.8 554+29 72.5
Ethyl 26.2+0.8 221+33 118.7
ds-Ethyl 26.4+0.5 232+24 113.9
n-Propyl 32.8+0.7 208+16 157.6
Isopropyl 25.0+0.9 307+31 81.6
n-Butyl 25.4+0.6 264+17 96.0
t-Butyl 21.3+0.5 180+18 118.3
n-Pentyl 25.5+1.0 308+31 82.6
n-Hexyl N.D. N.D. -
Phenyl 24.3+0.4 99+1 i 246.7
Benzyl 26.5+0.3 251+17 105.4
Phenethyl 20.3+0.3 72+11 282.6
Bis 3.7+0.2 125+24 29.2
Propenyl 33.9+1.0 145+21 233.9
Propynyl 16.0+0.2 71+8 225.9
Ethylhydroxy 9.5+0.3 449+38 21.2
Ethyl DMP 21.7+0.8 182+33 119.2
Each value represents mean + s.d of the three determinations.
N.D. Not determined.
Km has units of uM
Vma3C has units of nmol HCHO produced / min / nmol cytochrome P-450 
Bis = N,N-Bis[2-(2,4-dichlorophenoxy)ethyl]methanamine.
Ethyl DMP = 3-(2,4-dichlorophenyl)-N-ethyl-N-methylpropanamine.
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6.4.3 Determination of the spin equilibrium in the absence of substrate 
(Kx) for the purified cytochrome P450 IIB4 in a reconstituted system.
The absolute spectrum and the second derivative spectrum of the 
cytochrome is given in fig 3.3a and 3.3b respectively. The peak to trough 
distances were determined for the two Soret bands and using the equation 
detailed in section 6.3.2 the high spin fraction of this haemoprotein 
incorporated in lipid was found to be 30.87+0.58% at 25 °C after three 
separate determinations. This value was then used to calculate the value 
of Kx using the equation detailed below:
Kx = Fhs/ (1 - Fhs)
This gave a value of Kx = 0.447.
The value of the high spin fraction detailed here is considerably 
higher than the value obtained by Petzold et a l . (1985) of 9%. This 
difference may be due in part to the different methods of reconstitution 
of the cytochrome P-450 in the lipid and also to the presence in the 
system of the NADPH-cytochrome P-450 reductase which is known to increase 
the high spin fraction of cytochrome P-450.
6.4.4 Determination of the substrate-induced binding spectra of the 2- 
(2,4-dichlorophenoxy)-N-methylethanamines in purified cytochrome P450 
IIB4.
The binding spectra of the 2-(2,4-dichlorophenoxy)-N-methylethan­
amines were determined in a reconstituted system of purified cytochrome 
P450 IIB4 in lipid. Preliminary studies to assess the importance of the 
lipid in this system were carried out with isopropyl DME. This substrate
for a methylene unit produces little change in the Vma3C/Km ratio.
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Fig 6.2 The absolute spectrum (a) and second derivative spectrum (b) of 
purified cytochrome P450 IIB4.
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was titrated with the purified cytochrome P-450 both in the presence and 
absence of lipid. The Hanes-Woolf plots of both these states are shown in 
fig 6.3, from which the spectral binding constant Ks and the percentage of 
the haemoprotein converted to its high spin form (% HS) were determined as 
in section 5.3.2:
Ks (uM)
% HS (%)
- lipid 
456 
32
+ lipid 
226 
44
These results showed that in the presence of lipid when this substrate had 
a higher binding affinity and converted more of the enzyme to its high
spin form. This seems to indicate that the lipid is holding the cytochrome 
P-450 in a conformation which allows both tighter binding of substrates 
and increased substrate-induced spin state conversion.
The binding spectra of the other members of the series were determin­
ed in the presence of lipid over a substrate concentration range of 50 to
1000 uM. Unlike the results found with the hepatic microsomal fraction,
with purified cytochrome P-450 not all the substrates gave 'type I' 
binding spectra. Both methyl DME and ethyl DME exhibited 'type II' binding 
spectra with maxima at 432 nm and minima at 416 nm. It is not clear what 
is meant by the Ks value for a type II spectral change and since no
extinction coefficient exists for this spectral change, no further 
analysis of these spectra were carried out. Ethylhydroxy DME also gave a 
spectrum which was not a type I, however in this case the spectrum was a 
so-called 'reverse type I' characterised by a peak at 420 nm and a trough 
at 390 nm. This type of spectrum is generally associated with molecules 
that contain an alcohol function such as methanol and ethanol.
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Fig 6.3 Hanes-Woolf plots for the determination of Ks and % HS for
isopropyl DME with purified cytochrome P450 IIB4 in the presence and 
absence of lipid.
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The remainder of the molecules exhibited type I binding spectra and hence 
the values of Ks and % HS were determined for each compound with the 
exception of carboxymethyl DME and ethyl DME N-oxide which failed to 
produce any spectral change over the concentration range 10-20,000 uM. 
These values are presented in table 6.3 with the exception of the results 
of hexyl DME and ethyl DMP which were not determined as none of these 
compounds remained.
The binding spectrum of benzphetamine was also recorded under these 
conditions. This compound had a value of Ka of 48 uM and a percentage high 
spin conversion (% HS) of 28.2%. Although the value of Kx was considerably 
different from that obtained by Petzold (1985) these values for benzphet­
amine are in good agreement when the value of the high spin fraction 
present in the absence of substrate (Fha) is added to the percentage high 
spin conversion of the compound.
No consistent trend was observed in the Ka values for the remaining 
members of the n-alkyl and branched alkyl series of molecules.
The inclusion of an aromatic system caused an increase in the binding 
affinity with phenethyl DME exhibiting the strongest binding. The 
inclusion of an unsaturated system also resulted in an increase in binding 
affinity although very little difference existed between the values for 
propenyl and propynyl DME.
No consistent trend in the percentage high spin conversion (% HS) was 
observed for the n-alkyl or branched alkyl groups. It was clear however 
that the remaining members of the branched alkyl group (isopropyl and t- 
butyl DME) produced the largest high spin conversion.
The inclusion of an aromatic nucleus increased the high spin conver­
sion (relative to propyl DME) but no consistent trend was observed within 
the series of aromatic substituted molecules.
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Table 6.3 Spectral binding constant Ka and percentage of the enzyme 
converted to its high spin form (% HS) for the 2-(2,4-dichlorophenoxy)-N- 
methylethanamines in reconstituted system containing purified cytochrome 
P450 IIB4.
Substituent Ka (UM) % HS
Methyl Type II
Ethyl Type II
n-Propyl 1111 20.1
Isopropyl 235 47.0
n-Butyl 123 18.1 .
t-Butyl 665 45.7
n-Pentyl 132 24.4
n-Hexyl N.D. N.D.
Phenyl 81 29.6
Benzyl 46 26.6
Phenethyl 18 38.2
Bis 77 39.6
Propenyl 20 14.6
Propynyl 37 11.6
Ethylhydroxy Reverse type I
Ethyl DMP N.D. N.D.
Each result is expressed as the average of two separate
determinations which did not vary by more than 5.2%.
N.D. Not determined.
Bis = N,N-Bis-[2-(2,4-dichlorophenoxy)ethyl]methanamine.
Ethyl DMP = 3-(2/4-dichlorophenyl)-N-ethyl-N-methylpropanamine.
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The inclusion of unsaturated systems in the substituent group prod­
uced a drop in high spin conversion when the double (propenyl DME) and the 
triple (propynyl DME) bond containing molecules are compared with the 
fully unsaturated molecule (propyl DME).
6.4.5 Evaluation of the micro-equilibrium constants K2, K3 and K4 for the 
members of the 2-(2,4-dichlorophenoxy)-N-methylethanamines which yielded 
type I binding spectra in purified cytochrome P450 IIB4,
The micro-equilibrium constants K2, K3 and K4 which describe the 
conversion of the haemoprotein from low to high spin by a substrate and 
the binding of the same substrate to both the low and high spin form of 
the haemoprotein were evaluated for the members of the 2-(2 ,4-dichloro­
phenoxy) -N-methy lethanamines which on spectral titration described above 
gave type I binding spectra. The calculations were carried out as detailed 
in section 5.4.3 using the value of Kx obtained in section 6.4.3. The 
values of each of these constants for each of the compounds eligible for 
this analysis are given in table 6,4.
The values of K3 and K4 closely mirrored those of Ks. No consistent 
trend was observed in the alkyl substituted group although both n-propyl 
and t-butyl DME exhibited very weak binding.
As with the values for Kg the aromatic and unsaturated substituent 
groups exhibited the strongest binding, with phenethyl DME binding to the 
enzyme most tightly.
The values of K2 followed those of the high spin conversion (% HS). 
No consistent trend was observed for the alkyl substituted (n-alkyl or 
branched alkyl) series although isopropyl and t-butyl DME did produce the 
largest values of K2.
The inclusion of an aromatic group in the substituent group increased 
K2 relative to propyl DME with Bis DME exhibiting the largest value of K2
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Table 6.4 Micro-equilibrium constants for the binding and spin state 
change observed upon the interaction between 2-(2,4-dichlorophenoxy)-N- 
methylethanamines and purified cytochrome P450 IIB4 in a reconstituted 
system.
Substituent k2 k3
(uM)
k4
(UM)
n-Propyl 1.04 1567 673
Isopropyl 3.04 632 93
n-Butyl 0.96 167 78
t-Butyl 3.27 1963 268
n-Pentyl 1.23 203 74
Phenyl 1.53 141 41
Benzyl 1.35 74 25
Phenethyl 2.23 40 8
Bis 2.39 180 34
Propenyl 0.84 26 14
Propynyl 0.74 45 27
Bis = N,N-bis-[2-(2 ,4-dichlorophenoxy)ethyl]methanamine.
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As with the values for the high spin conversion (% HS) the values of 
K2 for the double (propenyl DME) and triple bonded (propynyl DME) 
substituent groups were lower than the fully saturated molecule (propyl 
DME).
6.4.6 Correlation matrix to assess any- link between the spectral binding 
and spin state parameters and the kinetic constants for the 2-(2 ,4- 
dichlorophenoxy)-N-methylethanamine series in purified cytochrome P450 
IIB4.
To determine if a link exists between the micro-equilibrium constants 
K2, K3 and K4, the kinetically determined constants Vma3C, Km and the ratio 
Vmax/Km, a correlation matrix was constructed (table 6.5). It was not 
possible to use the data from methyl DME, ethyl DME, hexyl DME, ethyl­
hydroxy DME and ethyl DMP since for reasons stated in sections 6.4.2 and
6.4.3 these compounds did not have complete data sets. This gave eleven 
compounds in the correlation and hence for the correlation to be statisti­
cally significant (p < 0.001) the correlation coefficient r must be 
greater than 0.861. This level of significance was chosen since it
indicated that over 74% of the observed variation between two groups was 
explained by a linear relationship.
The correlation matrix produced correlations between high spin con­
version and K2 and Ka and K3. These correlations were similar to those
obtained from the data determined in the phenobarbital-induced hepatic 
microsomal fraction (section 5.4.6).
The correlation between K3 and Ks arises as a result of the small
variation seen in the values of K2. This small variation in conjunction 
with the constant value of Kx means that Ka in the following equation
in this short series.
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Table 6.5 Correlation matrix for the binding, spin state change and 
metabolism parameters of the 2-(2,4-dichlorophenoxy)-N-methylethanamine 
series in purified cytochrome P450 IIB4.
7max Km Ynaac/Km Ks % HS k2 k3 k4
Vtnax 0.377 0.186 0.322 -0.398 -0.383 0.185 0.365
Km -0.742 0.334 0.213 0.047 0.207 0.201
-0.202 -0.131 -0.176 -0.254 -0.165
K„ 0.098 0.148 0.912 0.775
% HS 0.973 -0.584 -0.771
Ka 0.454 -0.004
k3 0.809
Correlations statistically significant at p < 0.001 when r > 0.861.
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becomes dependent solely on K3.
6.4.7 Correlation matrix to assess any link with the micro-equilibrium 
constants and kinetic constants from the interaction between the 2-(2,4- 
dichlorophenoxy)-N-methylethanamines and purified cytochrome P450 IIB4 and 
those produced on the interaction between the 2 - ( 2 , 4-dichlorophenoxy)-N- 
methylethanamines and hepatic microsomal cytochrome P-450.
This correlation matrix was constructed in the same manner as the 
correlation matrix in section 6.4.6. The data on the same compounds was 
selected from sections 5.3.4 and 5.3.5. This correlation matrix is shown 
in table 6.6. Since the same number of compounds were involved as in 
section 6.4.6 the correlation coefficient required to give the statistical 
significance of p > 0.001 is 0.861. This level of significance was chosen 
since it indicated over 74% of the observed variation between two groups 
was explained by a linear relationship.
This matrix highlights two correlations, one between the values of K2 
obtained from the reconstituted system containing purified cytochrome P450 
IIB4 and the values of % HS obtained from phenobarbital-induced hepatic 
microsomal fraction and the other was between K3 from the reconstituted 
system and Ks from the hepatic microsomal system.
These correlations indicate that although there are differences in 
the primary structure between rat cytochrome P450 IIB1 and rabbit cyto­
chrome P450 IIB4, they bind the same substrates. The lack of any other 
correlations between the hepatic microsomal and reconstituted systems 
suggests that the purification of the protein has changed its conformation 
such that it still has catalytic activity towards these substrates but not 
to the same degree as it had in the membrane.
Ks = K3 (1+KX)/(1+K2)
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Table 6.6 Correlation matrix for all the binding, spin state and kinetic 
parameters for the 2 -*(2,4-dichlorophenoxy)-N-methylethanamines derived 
from both purified cytochrome P450 XIB4 and hepatic microsomes.
7max Km K. % HS k2 k3 k4
t^nax 0.168 0.159 0.029 0.169 0.599 0.200 0.269 -0.146
Km 0.380 0.513 -0.248 0.756 0.390 0.502 0.676 0.337
Vmaic/Knn -0.351 -0,462 0.239 -0.529 -0.298 -0.373 -0.376 -0.349
k b -0.018 0.463 -0.378 0.611 -0.223 0.211 0.918 0.786
% HS 0.140 0.439 -0.447 0.259 -0.106 0.909 -0.236 -0.451
k2 0.215 0.466 -0.123 -0.138 -0.035 -0.127 -0.131 -0.138
k3 0.285 0.534 -0.387 0.700 0.321 0.419 0.705 0.655
k4 0.227 0.401 -0.335 0.700 0.288 0.383 0.658 0.676
Correlations statistically significant at p > 0.001 when r > 0,861.
Data for the purified cytochrome P450 IIB4 is expressed horizontally and 
the data from the hepatic microsomal fraction is expressed vertically.
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Examination of the binding, spin state and kinetic data obtained for 
the 2-(2,4-dichlorophenoxy)-N-methylethanamines in the reconstituted sys­
tem with cytochrome P450 IIB4 may indicate which structural features have 
an influence on these biological parameters and hence allow for an SAR to 
be developed for each of these biological parameters.
Comparison between the binding, spin state and kinetic data for the 
2-(2,4-dichlorophenoxy)-N-methylethanamines determined in the hepatic mic­
rosomal fraction from rats pretreated with phenobarbital (chapter 5) and 
that determined in cytochrome P450 IIB4 purified from rabbits pretreated 
with phenobarbital yields many differences in these parameters. The 
differences observed between the systems may be due to either differences 
in the primary structure of the isozyme in rats and rabbits or changes in 
the tertiary structure of the isozyme brought about as a result of the 
purification process.
In the case of the purified cytochrome P-450 it was not possible to 
obtain full data sets for the spectrally determined constants Ks and % HS, 
and hence the micro-equilibrium constants K2, K3 and K4, as not all the 
compounds produced type I binding spectra. Methyl DME and ethyl DME both 
yielded type II binding spectra. This is unusual for tertiary amines since 
a type II binding spectra is normally associated with the formation of a 
substrate-cytochrome P-450 complex via displacement of the sixth ligand of 
the cytochrome and its replacement by the compound (Schenkman et  a l .  
1967). Recent X-crystallographic studies on the complex formed between a 
selection of type II ligands and cytochrome P-450cam (Poulos and Howard 
1987) indicate that compounds such as metyrapone, ligand to the sixth 
coordination position via the lone pair of electrons present on nitrogen 
atoms such as those of the pyridine rings in metyrapone. Since tertiary
6.5 Discussion.
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amines have a lone pair of electrons, then it is possible that they may
ligand to the haem if the substituent groups are not too bulky. This may
be supported by the fact that ethylhydroxy DME yields a reverse type I 
indicating that, as in the case of alcohols such as methanol and ethanol, 
it is the oxygen function that is liganding to the haem (Schenkman et  a l .  
1981). It appears that the methyl and ethyl groups not able interact with 
apoprotein so the nitrogen lone pairs interact with the iron. The 
inclusion of an hydroxyl function in the ethyl group allows this to
interact with the haem. However changing from ethyl to propyl increases
the length of the molecule sufficiently for it to interact with the 
cytochrome as a substrate and produce a type I spectral change.
The micro-equilibrium constants K3 and K4 obtained for the reconstit­
uted system show a slight correlation (r = 0.700, 0.02 > p >  0 .01) with
Ks obtained from the phenobarbital-induced hepatic microsomal fraction 
(table 6.6) indicating a link between these parameters. Comparison of the 
spectral binding data (Ks and % HS) obtained for a series of benzphetamine 
analogues in phenobarbital-induced hepatic microsomal fraction (Blanck et  
a l . 1983) and purified cytochrome P450 IIB4 (Pertzold e t  a l . 1985) showed 
differences in the rank order of the compounds when the different 
biological media were compared, hence it is not surprising that the 
spectral binding data for the 2-(2,4-dichlorophenoxy)-N-methylethanamines 
does not correlate when similar systems are compared. This may be a result 
of the purification process which although it produces a catalytically 
active enzyme may affect the tertiary structure and hence changes its 
affinity for a given substrate.
The trends observed for the binding of these molecules to cytochrome 
P450 IIB4 (section 6.4.4) indicate that either size or lipophilicity may 
play an important part in governing the strength of binding. Increasing 
the length and lipophilicity of the alkyl group results in stronger
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binding as does the inclusion of an aromatic system in the tail group. The 
exceptions to this are t-butyl DME and bis BME. The high values of the 
binding constants for t-butyl DME may be a result of the bulkiness of the 
tertiary butyl group not allowing a strong interaction with the enzyme. 
The low binding affinity of bis DME may be a result of this molecule being 
too large to interact with the binding site of the cytochrome.
Both propenyl and propynyl DME exhibited stronger binding than would 
be expected for compounds of their size and lipophilicity. The reason for 
this is not clear but may be related to the ability of these compounds to 
deactivate cytochrome P-450 by alkylating the porpyrin ring system.
The change in spin state of the haemoprotein from low to high spin on 
addition of a substrate, as measured by the micro-equilibrium constant K2, 
gave only a strong correlation with the percentage of the haemoprotein 
converted to its high spin form (% HS). This arises from the simple 
relationship between K2 and % HS:
% HS = K2/(l+K2) - Kx/(1+Kx)
since Kx is constant % HS is dependent on the part of the function 
containing K2. Over the small range of % HS values recorded in this study 
this approximates to a linear relationship between % HS and K2.
In general the values of K2 appear to increase as the molecule gets 
larger. This effect is reflected in the aromatic system with phenethyl and 
bis DME having the largest values, the straight chain alkyl group where 
pentyl DME has the largest value and the branched chain group where both 
isopropyl and t-butyl analogues have very similar values of K2. This 
suggests a link between the molecular size and the conversion of the 
haemoprotein from its low spin to its high spin form. A possible link 
between the size of the molecule and the spin state change was suggested 
by Fischer and Sligar (1987) who indicated that in the case of cytochrome
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P-450cam the increase in the high spin fraction was a result of the 
substrate molecule preventing the easy access of water to the active site 
and hence slowing down the H20/cytochrome P-450 recombination rate. It 
can be assumed that the larger the molecule the more water molecules it 
would prevent from entering the active site.
As with the spectrally determined constants, the kinetic constants 
Vma3C, Km and Vma3C/Km for the 2-(2,4-dichlorophenoxy)-N-methylethanamines 
being metabolised by purified cytochrome P450 IIB4 did not correlate with 
those obtained from the phenobarbital-induced hepatic microsomal fraction.
The values of VOTa3C for this series of molecules in a reconstituted 
system containing cytochrome P450 IIB4 showed no consistent trend (section 
6.4.2) The change of ethyl for d5-ethyl yielded no difference in the rate 
of metabolism confirming the result found in the hepatic microsomal
fraction that increased isotopic weight in the substituent group does not 
affect the rate of N-demethylation.
The lack of a consistent trends in the Vmax values for this series of 
molecules gives support to the suggestion that the maximum rate of 
substrate metabolism is related to the positioning of the nitrogen atom 
with respect to the 'active oxygen'. This is highlighted by the low rate 
of bis DME which had high values of K3 and K4 relative to the other
molecules with aromatic systems in the tail group. Thus both these 
findings may be attributable to the molecule not fitting in the binding 
site.
The formation of inhibitory complexes by the methyl, ethyl and
ethylhydroxy analogues may affect their overall rate of metabolism. No 
evidence of this existed for the methyl and ethyl analogues but the value 
of Vmax for the ethylhydroxy analogue is considerably lower than that of 
ethyl DME.
The values of Km for the 2-(2,4-dichlorophenoxy)-N-methylethanamine
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series obtained from the metabolism of these substrates by purified 
cytochrome P450 IIB4 did not correlate with those obtained from the 
metabolism of these substrates by phenobarbital-induced hepatic microsomal 
fraction.
The trend highlighted for the Km values of the n-alkyl substituents 
in section 6.4.2 indicates that the methyl and ethyl analogues have higher 
Km values than expected. This may be a-result of these molecules forming 
the inhibitory complexes with the haem of the cytochrome characterized by 
their type II binding spectra.
As with the Km values of these compounds determined using phenobar­
bital-induced hepatic microsomal fraction (section 5.4.4) the Km values 
did not correlate with Ks, K3 or K4. This supports the suggestion that the 
substrate/enzyme complex on which the I<m value depends is not the initial 
one formed and its strength is governed by features of the molecule 
different from those governing the strength of the initial sub­
strate/enzyme complex.
The ratio of Vma3C to Km which can be related to the intrinsic
clearance of the substrate from the incubation mixture can also be
,b3used as a measure of the efficiency/which the cytochrome metabolises the 
substrates.
As indicated in section 6.4.2 no consistent trend exists for the 
Vmax/Km ratio for the 2-(2,4-dichlorophenoxy)-N-methylethanamine series of 
molecules. However the data does indicate that in general molecules having 
either an unsaturated or aromatic system in the substituent group produced 
higher Vma3C/Km ratios. This suggests these groups provided a balance 
between the binding affinity and the rate of metabolism. This may arise 
because these functional groups are able to interact more strongly with 
amino acid residues in the active site that are closer to the 'active 
oxygen'.
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CHAPTER 7.
Quantitative structure-activity relationships.
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Quantitative structure-activity relationships (QSAR) attempt to find 
relationships between biological data and features of the molecules giving 
rise to this data.
In the present study QSAR's were sought for the 2-(2,4-dichlorophen­
oxy) -N-methy lethanamine series of tertiary amines between the binding, 
spin state and metabolism parameters detailed in chapter 5 for the hepatic 
microsomal fraction and chapter 6 for the purified protein and the 
physico-chemical and molecular mechanics data detailed in chapter 3.
Due to the lack of large variations between any of the data groups, 
linear and multi-linear relationships were sought between the biological 
data and the physico-chemical and molecular mechanical properties of the 
2-(2,4-dichlorophenoxy)-N-methylethanamines rather than using the loga­
rithm of the biological data.
Examination and interpretation of the equations produced may lead to 
an explanation of the variations seen in the biological parameters in this 
group of molecules in terms of gross parameters such as lipophilicity and 
pKa and also in terms of variations in charge or polarizabililty of key 
atoms.
7.1 Introduction
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All the biological, physico-chemical and molecular mechanical data 
for each of the compounds was stored on computer and each of the 
biological parameters examined for relationships between it and up to two 
of the physico-chemical and molecular mechanical variables. Two basic 
types of relationship were sought:-
i) linear relationships of the general form:
Y = m X + c
ii) multi-linear relationships of the form:
Y = a X  + b Z + c
where Y is the biological parameter and X and Z are physico-chemical 
and/or molecular mechanical parameters.
Multiple linear relationships were only sought if there were at least 
five observations for each variable used in the final equation.
All linear relationships found here were determined using the MINITAB 
package of programmes available on the University of Surrey Prime 750 
computer, all multi-linear relationships were determined by Dr D.F.V. 
Lewis on the CDC 7600 computer of the University of Manchester Regional 
Computer Center via a remote site link from the University of Surrey 
Prime computer.
The above systems generates many correlations the majority of which 
were of no value since the correlation coefficient was too low for any 
relationship between the variables to be meaningful. If in the case of 
multi-linear relationships the two variables were themselves highly corre­
7.2 Methods.
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lated then the relationship was ignored. Also three statistical criteria 
were used to determine if the relationship generated was of value:-
i) the correlation coefficient (r): in general all relationships with 
an r value of greater than 0.700 were examined.
ii) the standard deviation (s) of the Y values from the regression: 
in general relationships that had a low s value were chosen since this 
indicates that the Y values calculated from the regression equation were 
in good agreement.
iii) the variance ratios (F): in general relationships were chosen if 
they had high F values.
In the case of relationships involving biological parameters derived 
from the hepatic microsomal fraction isolated from phenobarbital-induced 
rats (chapter 5) the number of observations points used in deriving the 
equation was sixteen unless otherwise stated. In the case of relationships 
involving biological parameters derived from reconstituted systems cont­
aining purified rabbit cytochrome P450 IIB4 (chapter 6) the number of 
observations was fifteen for the metabolic results and eleven for the 
binding and spin state results.
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Each of the biological parameters was correlated with all the 
physico-chemical and molecular mechanics data and the correlations with a 
correlation coefficient greater than 0.7 are presented in turn below. The 
biological data obtained from the experiments using rat hepatic microsomal 
fraction (chapter 5) and that obtained using purified cytochrome P450 IIB4 
(chapter 6) were treated separately.
7.3.1 QSAR's obtained between the spectrally determined binding 
parameter (K«) from rat hepatic microsomal fraction.
Before attempting to find quantitative structure-activity relation­
ships for the binding of the 2-(2,4-dichlorophenoxy)-N-methylethanamines 
in terms of the micro-equilibrium constants K3 and K4, as defined in 
section 5.4.3 an attempt was made to correlate the spectrally determined
binding constant Ks with the physico-chemical and molecular mechanical
data determined in chapter 3.
A correlation was obtained between Ks and the volume of the molecule. 
This equation was a direct linear equation and is given below:
Ks = 112(+28) - 0.34(+0.12) volume
s = 8.54 r = 0.745 F = 8.96
This equation indicates that the relationship between the molecular volume 
and Ka is such that as the volume of the molecule is increased the 
numerical value of Ks is decreased implying stronger binding.
The relationship between Ka and the physico-chemical and molecular 
mechanical properties was then investigated for multi-linear expressions. 
This analysis yielded one equation:
7.3 Results
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Ka = 12.0(+2.9) pKa - 0.39(+0.08) volume + 21.08(+11.32) 
s = 12.97 r = 0.847 F = 15.90
This equation contains the same dependence of Ka on molecular volume but 
also has a a term for the pKa of the molecule. The dependence on the pKa 
indicates that as the pKa of the molecules is increased so the numerical 
value of Ka is increased which indicates a weaker binding.
7.3.2 QSARs obtained for the micro-equilibrium constants for the binding 
of a substrate to cytochrome P-450 (Ka and K4) determined in rat hepatic 
microsomal fraction.
Quantitative structure-activity relationships were sought between the 
the micro-equilibrium constants that describe the binding of a substrate 
to both the low and high spin forms of cytochrome P-450. These dissocia­
tion constants were defined in section 5.4.2 as K3 for the binding of a 
substrate to the low spin form and K4 for the binding of the substrate to 
the high spin form. Initially single linear regressions were sought 
between these parameters and the physico-chemical and molecular mechanical 
variables. This analysis yielded a dependence of both K3 and K4 on the 
molecular volume according to the following equations:
K3 = 102(+19) - 0.35(+0.08) volume 
s = 12.56 r = 0.762 F = 19.42
K4 = 78(+13) - 0.29(+0.06) volume 
s = 8.97 r = 0.806 F = 25.88
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These equations indicate that as the volume of the molecule increases the 
values of both K3 and K4 numerically decrease which indicates a stronger 
binding affinity.
These equations however only explain 58% of the variation in the case 
of K3 and 65% of the variation in the case of K4 so multi-linear 
expressions were sought that related K3 and K4 to molecular volume and one 
- other variable which explained a greater amount of the variation.
Both K3 and K4 yielded multi-linear correlations involving molecular 
volume and the polarizability of the N-methyl group {a N.METHYL) with 
that obtained for K4 being of higher statistical significance than that 
for K3. The correlation between the polarizability of the N-methyl group 
and molecular volume was poor (-0.303) hence these correlations were 
considered significant. Both equations for which are given below:
K3 = 78(+37) a N.METHYL - 0.30(+0.07) volume - 387(+231)
s = 11.23 r = 0.747 F = 17.69
K4 = 64(+25) a n_Methyl - 0.25(+0.05) volume - 320(+156)
s = 7.59 r = 0.876 F = 21.36
These equations again exhibit the negative dependence on the molecular
volume as in the normal linear equation but also they show a positive 
dependence on the polarizability of the N-methyl group indicating that as
this group becomes more polarizable the numerical values of both K3 and K4
increase leading to weaker binding.
Correlations were also obtained that relate both K3 and K4 to both 
the molecular volume and the pKa of the 2-(2,4-dichlorophenoxy)-N-methyl­
ethanamines. Both these equations represent an improvement on the original 
single linear correlations with molecular volume. As the correlation
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between molecular volume and pKa was poor (r = 0.07)> these equations were 
considered significant. Both equations are given below:
K3 = 5(+2) pKa - 0.3(+0.1) volume + 57(+27) 
s = 11.21 r = 0.813 F = 14.50
K4 = 3.5(+1.2) pKa - 0.36(+0.05) volume + 66(+20) 
s = 6.98 r = 0.902 F = 26.27
These correlations show the same relationship between K3, K4 and molecular 
volume and also a positive dependence on the estimated pKa of the 2—(2,4— 
dichlorophenoxy)-N-methylethanamine which suggests that as the pKa of the 
molecules increase the binding affinity, as expressed by K3 and K4, 
decreases.
Linear correlations also exist between both K3 and K4, and log D, the
partition coefficient of the compounds between octanol and buffer at pH
7.4. The correlation equations for this are given below:
K3 = 74(+13) - 18(+4) log D 
s = 12.90 r = 0.747 F = 17.69
K4 = 52(+10) - 14(+3) log D 
s = 10.10 r = 0.745 F = 17.46
These equations show a negative dependence of both K3 and K4 on log D.
Therefore for the 2 -(2,4-dichlorophenoxy)-N-methylethanamines to bind 
strongly to cytochrome P-450 they must have high values of log D. The 
relationship between log D, log P and pKa was explored in section 3.4.2
a high value of log D would require a large value of log P and a pKa value
approaching 7.4.
Further regression analysis was carried out to attempt to improve 
these correlations. In the case of K3 a correlation was found involving
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log D and the polarizability of the N-methyl function (a n-methyl)/ 
but this correlation was only a slight improvement on the original linear 
equation. In the case of K4, however, the same correlation was found with 
greater statistical significance. Both equations are detailed below:
K3 = 88(+48) a N.METHyL - 20(+4) log D - 210(+154) 
s = 11.91 r = 0.807 F = 12.10
K4 = 109(+29) a k.methyl - 17(+3) log D - 296(+94) 
s = 7.30 r = 0.886 F = 23.62
Both these correlations have the negative dependence on log D seen in the 
linear equation and the positive dependence on the polarizability of the 
N-methyl group seen in the relationship K3, K4 with molecular volume and 
the polarizability of the N-methyl group.
Examination of the correlation coefficients determined for the mole­
cular volume showed a correlation between the molecular volume and the 
lipophilicity of the compounds (r = 0.800). However no correlation was 
found between log P and K3 (r = -0.44) or K4 (r = -0.47). Therefore K3 and 
K4 were plotted against log P (Fig 7.1) to show if any correlation might 
exist between these parameters. Examination of both of these plots 
revealed that there is an relationship between both these binding para­
meters and the lipophilicity of the compounds. These relationships were 
not found previously due to the outlying compounds on each of the plots. 
The outliers present between K3 or K4 values of 0 and 20 and log P values 
of 2 and 3 are ethylhydroxy DME, propenyl DME and propynyl DME. When these 
compounds are excluded from the plot such that the only compounds 
considered are those that have alkyl chains, branched alkyl
CWn)
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Fig 7.1 Dependence of the spectral binding parameters K3 (A) and K4 (B) 
on the intrinsic lipophilicity (log P) for the 2-(2,4-dichlorophenoxy)-N- 
methylethanamine series.
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chains or a second aromatic system, then two essentially linear plots were 
obtained with correlation coefficients of -0.835 for K3 verses log P and 
-0.750 for K4 verses log P.
The relationships between both K3 and K4 and log P were negative 
indicating as for the molecular volume and log D that the strongest 
binding was obtained from the compounds with the highest values of log P.
Further examination of the plots revealed that there were optimum
values of log P for both K3 and K4. This led to the derivation of the
following quadratic expressions:
K3 = 9.7(+1.0) log P2 - 116(+11) log P + 346(+35)
s = 3.856 r = 0.984 F = 156.34
K4 = 8.8(+1.4) log P2 - 101(+14) log P + 288(+35)
s = 5.134 r = 0.956 F = 52.52
Both these equations reinforce the negative reliance of both K3 and 
K4 on log P since in each case the log P2 term does not outweigh negative 
effect of the log P term.
Values for both K3 and K4 were calculated from these expressions and
plotted against the observed values of K3 and K4. These plots are shown in
fig 7.2A for K3 and 7.2B for K4. The regression equations were generated 
between K3 observed and K3 calculated and K4 observed and K4 calculated 
are shown below:
K3 (Obs) = 0.98(+0.05) K3 (Calc) + 1.79(+1.51) 
s = 3.60 r = 0.985 F = 360.0
K4 (Obs) = 1.02(+0.08) K4 (Calc) - 2.48(+1.67) 
s = 4.24 r = 0.967 F = 157.4
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Fig 7.2 Correlation plots for the observed values of K3 verses the 
calculated values of K3 (A) and the observed values of K4 verses the 
calculated values of K4 (B).
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In ideal circumstances the gradient and intercept of each of these 
equations should be 1 and 0 respectively and the correlation coefficient 
(r) should be 1. Although the full quadratic curve is not present the K3/ 
K4 data does fit a quadratic function of log P.
7.3.3 QSARs determined for the spectrally determined shift in spin 
. equilibrium (% HS) of cytochrome P-450 obtained from rat hepatic
microsomes upon addition of substrate.
The maximum change in the spin state of cytochrome P-450 on spectral 
titration with a substrate was defined in section 5.4.2 as delta Amax» 
From this the percentage of cytochrome P-450 converted to the high spin 
form was determined using the type I extinction coefficient. The value of 
% HS for each of the 2-(2,4-dichlorophenoxy)-N-methylethanamines was then 
subjected to regression anaylsis.
Linear regression analysis yielded an equation for % HS involving log 
D. Log D was defined in section 3.3.2 as the partition coefficient of the 
compound between octanol and phosphate buffer at pH 7.4. The equation
relating these two quantities is given below:
% HS = 7(+6) + 9(+2) log D
s = 6.90 r = 0.751 F = 18.105
This expression indicates that the best conversion of the enzyme from low 
to high spin requires a compound of high log D which itself implies a 
compound with a high log P and a pKa close to 7.4.
Multi-linear analysis on % HS revealed another equation also invol­
ving log D:
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% HS = 12.5(+1.9) log D - 13.2(+3.8) sigma* - 15.2(+5.7)
s = 5.16 r = 0.873 F = 20.94
This represents a much more statistically significant expression for % HS 
with 76.3 % of the variation explained as opposed to only 56.4 % with the 
linear expression. This equation reveals the same dependence of % HS on 
log D but also reveals the negative dependence of % HS on sigma* the Taft
parameter which describes the inductive effect of the substituent groups
on the nitrogen atom in the 2-(2,4-dichlorophenoxy)-N-methylethanamine 
series.
No further equations were obtained between % HS and any of the other 
physico-chemical or molecular mechanical parameters.
7.3.4 QSARs for the micro-equilibrium constant which defines the sub­
strate induced conversion low spin cytochrome P-450 to high spin cyto­
chrome P-450 (Ka) obtained from rat hepatic microsomal fraction.
The values of K2 determined in section 5.4.3 were subjected to the 
same analysis as the values of % HS. This analysis yielded the same 
correlations as the analysis of % HS but in both cases the correlations 
were much weaker. Both correlations are detailed below:
K2 = -0.5(+1.3) + 1.0(+0.4) log D 
s = 1.25 r = 0.550 F = 6.08
K2 = 14(+6) log D - 21(+13) sigma* - 74(+19) 
s = 2.54 r = 0.749 F = 7.81
As detailed in section 5.4.6 although K2 appears linearly related to % HS
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(r = 0.897) this arises because K2 may only have values which as indicated 
in this section make the relationship appear linear. It appears, however, 
there is sufficient difference between the two sets of values to affect 
any correlations derived from them.
No further significant correlations were determined for K2 either of 
the linear or the multi-linear type.
7.3.5 QSARs obtained for the experimentally determined Km values for the 
2-(2,4-dichlorophenoxy)-N-methylethanamine series in rat hepatic micro­
somal fraction.
The values of Km for the 2-(2,4-dichlorophenoxy)-N-methylethanamine 
series obtained in section 5.4.4 were subjected to the linear and then 
multi-linear analysis.
The linear analysis of Km yielded no correlations that were deemed 
statistically significant. Multi-linear analysis however yielded two 
expressions which were statistically significant both involving the 
electrophilic superdelocalizability of the N-methyl group (Se n_Methyl)- 
One of the equations also involved the nucleophilic superdelocalizability 
of the alpha carbon atom on the substituent group (Sn a„c) and the other 
expression involved the radical superdelocalizability of the alpha carbon 
atom of the substituent group (Sr a_c)» Since the latter two parameters 
are highly correlated (r =0.983) only the equation involving the 
nucleophilic superdelocalizability of the alpha carbon atom on the sub­
stituent group is given here:
Km = 18.1(+7.2) Sn a_c - 282(+110) Se n-methyl - 4527(+2258) 
s = 50.89 r = 0.745 F = 8.08
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It should be noted that the values of the electrophilic 
superdelocalizability of the N-methyl group do not vary greatly.
This equation indicates that as both the electrophilic superdelocal­
izability of the N-methyl group and the nucleophilic superdelocalizability 
of the alpha carbon atom increases the value of Km decreases.
7.3.6 QSARs for the experimentally determined Vmax values for the 2-(2,4- 
dichlorophenoxy)-N-methylethanamine series in rat hepatic microsomal frac­
tion.
The values of Vma5C determined in section 5.4.4 were subjected to 
linear and multi-linear regression anaylsis.
Both linear and multi-linear analysis failed to find any correlations 
between Vmax and any of the physico-chemical and molecular mechanical 
properties of the 2-(2,4-dichlorophenoxy)-N-methylethanamines.
7.3.7 QSARs obtained for the ratio Vmax/Km for the 2-(2,4-dichloro­
phenoxy) -N-methy lethanamine series in rat hepatic microsomal fraction.
The ratio Vma2C/Km was obtained from the kinetic constants Vmax and Km 
in section 5.4.4. These values were subjected to both linear and multi­
linear analysis. The values of Vmajc/Km were multiplied by one thousand to 
make their handling in the regression analysis easier.
Linear analysis yielded relationships between Vmax/Km and the Taft 
parameter sigma* and the radical superdelocalizability of the nitrogen 
atom. These equations are given below:
Vmax/Km = 78(+12) + 118(+30) sigma* 
s = 45.92 r = 0.722 F = 15.23
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Vma^/Km = -4080(+750) - 150(+30) SrN 
s = 37.02 r = 0.829 F = 30.84
The relationship involving sigma* indicates that as the inductive
effect of the substituent group increases so does the Vmax/Km ratio. The 
second equation suggests that an increase in the Vmax/Km ratio may also be 
related to an increase in the radical superdelocalizability of the 
nitrogen atom.
Multi-linear analysis yielded two relationships; one related Vmax/Km 
to the charge on the alpha carbon atom of the substituent group (q a_c) 
and the Taft parameter (sigma*) and the other related Vma3C/Km to the 
charge on the nitrogen atom (q N) and the nucleophilic superdelocalizabi­
lity of the alpha carbon atom of the substituent group (Sn a_c):
Vma3C/Km = 1035 ( + 192) q a_c + 94( + 18) sigma* - 75 (+30)
s = 26.44 r = 0.918 F = 34.89
Vmax/Km = -7190(+1372) q N - 42(+14) Sn a_G - 3100(+460)
s = 29.25 r = 0.899 F = 27.50
These equations yielded a number of factors which affect the ratio 
Vma3c/Km. The first equation indicates that as the positive charge on the 
alpha carbon atom of the substituent group is increased the value of
Vma:>c/Km increases. This correlation also has a positive dependence on
sigma* which indicates that the Vma3C/Km ratio rises with increasing 
inductive effect of the substituent group. The second equation indicates 
that as the charge on the nitrogen atom becomes more negative so the ratio 
Vmaac/Km increases, and in conjunction with this the Vma3t/Km ratio also 
increases as the nucleophilic superdelocalizability of the alpha carbon 
atom of the substituent group increases.
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7.3.8 Correlations obtained for Vmasc, Km and Vmax/Km for the 2-(2,4- 
dichlorophenoxy)-N-methylethanamines determined in purified cytochrome 
P450 IIB4.
Linear and multi-linear correlations were sought between the values 
of Vmax, Km and Vmax/Km obtained for each of the 2-(2,4-dichlorophenoxy)- 
, N-methylethanamines in a reconstituted system containing cytochrome P450 
IIB4 (section 6.4.5) and the physico-chemical and molecular mechanical 
properties of these molecules. Linear regression of each of these para­
meters failed to produce any significant relationships. Multi-linear 
regression analysis of these parameters also failed to produce any 
correlations between the biological data and the physico-chemical and 
molecular mechanical properties of these molecules.
7.3.9 Correlations obtained for the spectral binding parameter K„ 
determined in a reconstituted system containing cytochrome P450 IIB4.
As stated in section 6.4.4 not all of the 2-(2,4-dichlorophenoxy)-N- 
methylethanamines exhibited type I spectral interactions with cytochrome 
P450 IIB4 in a reconstituted system. As a result of this it was possible 
to use the Ks values for only eleven compounds in the linear/multi-linear 
regression analysis. In the case of the multi-linear analysis there are 
only just sufficient observations to justify seeking correlations which 
contain two variables.
Linear regression analysis on the Ks values yielded the following 
relationship between Kg and the sum of the charges for all the atoms in 
the different substituent groups (Qr):
K3 = 7758(+1330) Qr + 503(+135)
s = 167 r = 0.889 F = 34.03
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substituent group increases so the value of Ks increases. In other words
as the substituent group becomes less charged then Kg decreases.
Investigation into multi-linear correlations for Ks resulted in two
correlations which involved the sum of the atomic charges on the sub­
stituent group. One of the correlations involved the charge on the alpha 
carbon atom of the substituent group (q a_c) and the other the ionisation 
energy (IE) of the molecule as calculated by molecular mechanics from the 
energy of the highest occupied molecular orbital. The equations are give 
below:
Ks = 7872(+1254) Q*. - 1784(+1215) q a_c -233(+224)
s = 156 r = 0.914 F = 20.28
Kg = 9916(+1209) Qr - 6505(+2687) IE + 53793(+22427) 
s = 134 r = 0.938 F = 29.14
Both these correlations, although representing an improvement in the 
correlation coefficient with respect to the linear correlation, did not 
improve with respect to the variance ratio.
Both equations show the same dependence of Ks on the sum of the
atomic charges on the substituent group. The correlation in the first 
equation is supplemented by the involvement of the charge on the alpha 
carbon atom. Since this charge is positive the equation indicates that 
stronger binding is obtained from compounds which have a less positively 
charged alpha carbon atom. There is no correlation between the sum of the 
atomic charges of the substituent group and the charge on the alpha carbon 
atom (r = 0.06). In the second equation the sum of the atomic charges on
This equation indicates that as the sum of the atomic charges on the
223
the substituent group is supplemented by a negative dependence on the 
ionisation energy of the molecules. This implies that as the energy 
required to remove an electron from the HOMO decreases so does the value 
of Kg.
7.3.10 Correlations obtained for the binding micro-equilibrium constants 
Ka and K4 determined in a reconstituted system containing cytochrome P450 
IIB4.
Linear regression analysis on K3 and K4 produced one equation for K4 
but no linear equations for K3. As with KS,K4 showed a linear dependence 
on the sum of the atomic charges in the substituent group (Qr).
K4 = 4595(+630) Qr - 313(+70) 
s = 79 r = 0.924 F = 52.64
As with the Kg-Q*. relationship this indicates a positive dependence on Qr 
which again suggests that as the substituent group becomes less charged
the strength of binding of the compound to the protein increases.
Both K3 and K4 yielded bilinear expressions which contained a term
involving the sura of the atomic charges on the substituent group. In the
case of K3 the expression also contained a term involving the polariz­
ability of the alpha carbon atom of the substituent group (a a_c) and in 
the case of K4 the expression also contained a term which involved the 
ionisation energy (IE) of the molecule as determined by molecular mech­
anics from the energy of the HOMO. Both expressions are given below:
K3 = 10670(+3200) Qr - 4700(+1800) a a_c + 14800(+5900) 
s = 397 r = 0.850 F = 10.39
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K4 = 5360(+490) Q„ - 3660(+1080) IE + 30200(+9000) 
s = 54 r = 0.970 F = 62.64
These equations contain all the terms that were involved in the Kg 
correlations determined in section 7.3.9. In both equations the dependence 
on Qr is the same as in the linear equation involving K4 and Qr. The 
bilinear equation produced for K3 indicates that as the alpha carbon atom 
of the substituent group becomes more polarizable the strength of binding 
(described by K3) increases. The bilinear equation involving K4 indicates 
that as the ionisation energy of the molecule decreases the strength of 
binding (described by K4) increases.
7.3.11 Correlations obtained for % HS determined in a reconstituted 
system containing cytochrome P450 IIB4.
Linear and multi-linear correlations were sought between the subst­
rate induced percentage conversion of low spin to high spin cytochrome P- 
450 (% HS) and the physico-chemical and molecular mechanical properties of 
the 2-(2,4-dichlorophenoxy)-N-methylethanamines.
No statistically significant linear relationships were determined for 
% HS. Multi-linear regression yielded one bilinear expression. This third 
expression involved the atomic charge on the alpha carbon atom of the 
substituent (q a_c) and the polarizability of the alpha carbon atom of the 
substituent group (a a_c) and is given below:
% HS = 413(+111) - 233(+57) q a_c - 106(+33) a a_c 
s = 7.1 r = 0.850 F = 10.41
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The expression involving the charge and polarizability of the alpha carbon 
atom indicate that the percentage high spin conversion is increased when 
the alpha carbon atom becomes less charged but more polarizable.
7.3.12 Correlations obtained between the micro-equilibrium constant 
describing the substrate induced conversion of low spin to high spin 
cytochrome P-450 (K2) determined in a- reconstituted system containing
cytochrome P450 IIB4.
As with the substrate induced conversion of low to high spin 
cytochrome P-450 in section 7.3.11 the micro-equilibrium constant 
describing this change (k2) yielded no linear expressions with the 
physico-chemical and molecular mechanical properties of the 2-(2 ,4- 
dichlorophenoxy)-N-methylethanamines. Multi-linear regression analysis 
produced one bilinear relationship involving the atomic charge on the 
alpha carbon atom (q a_c) and the polarizability of the alpha carbon atom 
(a a_c). This equation is detailed below:
K2 = 37(+7) - 15(+4) q a_c - 10(+2) a a_c 
s = 0.49 r = 0.890 F = 15.23
As with % HS this equation predicts that a increase in high spin 
conversion may be expected when the charge on the alpha carbon atom 
decreases but the polarizability on the same atom increases.
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Linear and multi-linear regression analysis has led to a number of
correlations between biological parameters which describe the binding to
cytochrome P-450 and rate of N-demethylation of the series of 2-(2,4- 
dichlorophenoxy)-N-methylethanamines, and the physico-chemical and mole­
cular mechanical properties of these molecules.
The binding of these substrate molecules to cytochrome P-450 has been 
characterised by the spectral binding parameter Ka. The values of Ks 
obtained from spectral titration of the 2-(2,4-dichlorophenoxy)-N-methyl­
ethanamines with the hepatic microsomal fraction isolated from rats 
pretreated with phenobarbital produced the correlations with molecular 
volume and both molecular volume and estimated pKa as indicated in section 
7.3.1. Correlations were also obtained between these variables and the 
micro-equilibrium constants describing the binding of the substrate to the 
low spin (K3) and the high spin (K4) form of cytochrome P-450. As
indicated in section 5.4 there are strong correlations between K3,K4 and
Ks, so for the purposes of this discussion the binding of the substrate to 
the enzyme will be referred to in terms of K3 and K4.
The correlations obtained between K3 and K4 and molecular volume 
(section 7.3.2) indicated that as the volume of the molecule increased 
the values of K3 and K4 decreased which in turn implies stronger binding. 
The lack of a good correlation between the lipophilicity as described by 
log P and the molecular volume suggests this effect is due to the 
molecular volume and has not arisen as a coincidence because of the 
correlation between molecular volume and log P. The idea that the size of 
a molecule may affect its interaction with cytochrome P-450 was investi­
gated by Lewis et a l . (1987 and 1989). These workers concluded that the 
binding of a molecule to cytochrome P-450 could be described in terms of 
the molecule's area / depth2 ratio. The present work indicates that
7.4 Discussion.
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molecular volume may also describe the binding of- a substrate to the 
enzyme.
A possible explanation of this correlation may lie in consideration 
of the three-dimensional structure of both the substrate and the active 
site of cytochrome P-450. It is generally accepted that substrates bind to 
microsomal cytochrome P-450 via a hydrophobic interaction. In the case of 
the 2-(2,4-dichlorophenoxy)-N-methylethanamine series of compounds changes 
in structure resulted in changes in both volume and log P. However, if the 
interaction between the cytochrome and the substrate is considered as a 
three-dimensional interaction then any increase in the molecular volume of 
the substrate increases the probability of more hydrophobic interactions 
forming. The more hydrophobic interactions between the substrate and the 
enzyme, the tighter the substrate is held in the active site.
The correlation between K3-K4 and molecular volume became more 
significant when either the polarizability of the N-methyl group or the 
pKa was included (section 7.3.2). The equation involving both the mole­
cular volume and the polarizability of the N-methyl group indicates that 
for strong binding (i.e. low values of K3 and K4) a molecule should have a 
large volume and a poorly polarizable N-methyl group. A low polarizability 
implies that the electron cloud is less easily distorted by an adjacent 
electric field, which in the case of hydrophobic binding means a weaker 
interaction. This equation seems to indicate that the strength of the 
hydrophobic interaction between these substrates and cytochrome P-450 is 
increased as the methyl group becomes less able to form strong inter­
actions with the protein.
The inclusion of the estimated pKa in the binding/molecular volume 
relationship also leads to a more statistically significant equation. The 
role of pKa in the N-demethylation of some tertiary amines has been
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investigated by Cho and Miwa (1973). This model is detailed in fig 7.3. 
These workers suggested a model in which the binding affinity of the 
compounds was related to the ionisation of the compound and its lipophili­
city consequently an equation which relates Kg to pKa is not unexpected.
If it is assumed that the concentration of the conjugate acid of 
these tertiary amines is present in the microsomal membrane at concent- 
, rations which are negligible compared to that of the free base then the 
Cho and Miwa model is simplified somewhat with the equilibrium constants- 
for the partitioning of the conjugate acid between the aqueous and the 
membrane phases disappearing. This leaves a model in which the binding of 
these tertiary amine substrates is dependent on their ionisation and 
lipophilicity. This is similar to the model suggested in section 3.3.2 for 
the distribution coefficient (log D). It is therefore not surprising that 
both K3 and K4 in the microsomal system were found to correlate with the 
log D values for these compounds. The linear equation derived indicated 
that as the log D of the compounds increased, the strength of binding of 
the compounds increased. In terms of the model detailed in fig 7.3 this 
indicates as the concentration of the free base in the microsomal membrane 
increases so does the strength of binding to the enzyme.
Investigation of the K3 and K4 versus log P plots led to a quadratic 
relationship between these parameters but only if ethylhydroxy, propenyl 
and propynyl DME were excluded. A quadratic correlation involving an 
affinity constant and log P has recently been highlighted by Devinsky and 
Gorrod (1987) who found this type of relationship between the Km for the 
N-oxidation of a series of long chain N,N-dimethylalkylamines and their 
lipophilicity as indicated by log P.
The fact that ethylhydroxy, propenyl and propynyl DME were not 
involved in the correlation indicates that the values of K3 and K4 
obtained were lower i e  the binding was tighter than would be expected of
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compounds with the same log P. This may imply that these compounds were 
interacting with a different portion of the apoprotein than those 
molecules with alkyl or aromatic substituents. Evidence from the studies 
using cytochrome P450 IIB4 in a reconstituted system showed that ethyl­
hydroxy DME interacts with the haem iron via its hydroxyl function 
(section 6.4.4). This effect is not dependent on the formation of a 
hydrophobic interaction and hence a relationship between the strength of 
binding and log P may not be observed. It is possible that this also 
occurs in the microsomal system but to a lesser extent such that 
overall a type I spectral interaction is seen.
The unusually strong binding seen for the propenyl and propynyl
analogues indicated that these compounds may have been forming a pi-pi
or
interaction with the protein the porphyrin system which was not
related to these compounds lipophilicity.
The correlations obtained with K3 and K4 determined in the microsomal 
fraction from rats pretreated with phenobarbital were not the same as 
those obtained from a reconstituted system containing purified cytochrome 
P450 IIB4. This is not surprising since it has already been shown that the 
two sets of data do not correlate (section 6.4.7). A possible explanation 
of this may be that although purifying the cytochrome retained its 
catalytic activity, there may have been changes in the tertiary structure 
of the enzyme which produce different interactions with the substrate. The 
correlations obtained for K3 and K4 were centred around the sum of the 
atomic charges on the substituent group. The equations predicted that as 
this charge decreased the strength of interaction with the enzyme 
increased. The nature of a hydrophobic interaction is such that charged 
species form very weak hydrophobic interactions. This equation may there­
fore be implying that the strength of binding is dependent on the ability 
of the substituent group to form hydrophobic bonds.
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In the case of the reconstituted system containing the purified 
enzyme, K3 and K4 produced two different multi-linear expressions. The 
expression for K3 contained a term for the sum of atomic charges on the 
substituent group and also a term which involved the polarizability of the 
alpha carbon atom of the substituent group. An involvement between the 
strength of binding and the electron density on the alpha carbon atom was 
suggested by Petzold et a l . (1985). These workers found a correlation 
between the spectral binding parameter Ks and the electron density on the 
alpha carbon atom of a series of benzphetamine analogues. They predicted 
that as the electron density on this atom increased the strength of 
binding decreased. The equation generated for K3 in this study predicts 
that as the polarizability of this atom increases, the strength of binding 
increases. The relationship between polarizability and lipophilicity has 
already been clearly defined (section 3.5.3) hence this equation indicates 
the involvement of this atom in the hydrophobic interaction between 
substrate and enzyme. The bilinear equation generated for K4 also included 
a term involving the ionisation energy of the molecule along with one 
involving the sum of the atomic charges in the substituent group. It is 
not clear what importance to give to this term since it is difficult to 
see how the ionisation energy can be related to binding. However the 
energy of the HOMO was one of the terms investigated by Lewis et  a l (1987 
and 1989) to describe the interaction of substrates with cytochrome P-450. 
The energy of the HOMO has also been investigated with respect to its 
involvement in the lipophilicity of compounds (Lewis, 1989). It was 
suggested that the energy of the HOMO may be related to the lipophilicity 
of a molecule since it is a function of how tightly the atomic nuclei are 
attracting the electrons. Situations where the nuclear attraction is low 
may result in a low energy HOMO and also an electron cloud which is more 
easily polarized and so the molecule is more able to form hydrophobic
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The amount of enzyme converted from low spin to high spin in the 
presence of substrate, whether expressed in terms of a percentage or as 
the micro-equilibrium constant K2, was found to correlate with log D 
(sections 7.3.3 and 7.3.4). In both these cases the correlation was 
positive indicating that the amount of high spin conversion increased with 
„ increasing log D. The explanation of this effect may again be associated 
with the assumption that the concentration of Sir* in the microsomal- 
membrane is negligible. Compounds with high values of log D such as phenyl 
DME (log D = 4.33) have a much greater concentration of the free base in 
the microsomal membrane which is able to interact with the enzyme and 
convert low spin enzyme to high spin enzyme.
The ability of a compound to convert low spin cytochrome P-450 to its 
high spin form may also lie in the inductive effect of the substituent 
group as predicted by the multi-linear correlations for both % HS and K2 
with log D and the Taft inductive parameter (sigma*). This equation 
suggests that substituent groups with large inductive effects are able to 
convert more enzyme to its high spin form. This implies there maybe some 
kind of electronic interaction between the substrate and the enzyme which 
facilitates the removal of the cytochrome P-450 sixth ligand and hence the 
conversion form low to high spin.
It was suggested that the low to high spin conversion induced in 
cytochrome P-450 by a homologous series of hydrocarbons was related to 
their lipophilicity and electron acceptor/donor properties (Lewis et  a l .  
1986). The findings of the present study are in accord with this, since in 
the case of tertiary amines in an aqueous/microsomal membrane environment 
the log D rather than lipophilicity becomes an important factor and sigma* 
may also be interpreted as being related to the electron 
donating/accepting properties of the molecule.
interactions.
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The substrate-induced low spin to high spin conversion parameters % 
HS and K2 obtained from a reconstituted system containing cytochrome P450 
IIB4 were found to correlate with both the charge on the alpha carbon atom 
and its polarizability. This equation predicted that an increase in low to 
high spin conversion could best be obtained from a decrease in the charge 
and an increase in polarizability of this atom. The reason for this 
- correlation is not clear, however the alpha carbon atom has been suggested 
as a key atom in the binding of these substrates to cytochrome P-450. This 
suggests a link between the spin state change and the binding of these 
compounds to the cytochrome. A possible explanation of this may be that 
when the substrate binds to the enzyme an allosteric change occures which 
results in the removal of the sixth ligand. The strength of binding may 
affect the magnitude of the allosteric change and hence the amount of low 
to high spin conversion.
Only one multi-linear correlation was found for the apparent Michae- 
lis constant Km (section 7.3.5). These results are in accord with the 
suggestion made in section 5.4 that the steady-state complex on which Km 
depends is not the initial one formed between the 2-(2,4-dichlorophenoxy)- 
N-methylethanamines and cytochrome P-450. The correlation obtained was a 
poor one but did indicate that the Km of these molecules may depend on the 
nucleophilic (or radical) superdelocalizabilty of the alpha carbon atom of 
the substituent group and the electrophilic superdelocalizability of the 
N-methyl group. The equation indicates that as the alpha carbon atom of 
the substituent group becomes more susceptible to nucleophilic (or 
radical) attack and the N-methyl group more susceptible to electrophilic 
attack the Km for the N-demethylation reaction increases. The implication 
of this equation in terms of the structure-activity relationship is 
unclear. However cytochrome P-450 is considered, in general, to metabolise 
molecules at their most electron rich position. This equation implies that
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as the N-methyl group becomes more electron rich, the Km for N-demethyl- 
ation increases. The equation also indicates that as the expected site of 
metabolic attack of the substituent group (the alpha carbon atom) becomes 
less electron rich the Km for N-demethylation decreases.
No corroboration of this suggestion was obtained from the Km values 
derived from similar kinetic studies carried out in a reconstituted system 
„ using purified cytochrome P450 IIB4. These studies failed to produce any 
correlation between the Km values and the physico-chemical and molecular 
mechanical parameters. This may again be explained by the fact that 
although the purified enzyme retains its catalytic activity it may not 
retain the exact conformation it had in the membrane. These differences in 
conformation may explain this lack of correlation.
The Vmax values obtained in both microsomal and reconstituted systems 
failed to correlate with any of the physico-chemical or molecular mechan­
ical properties of the 2-(2,4-dichlorophenoxy)-N-methylethanamines. This 
result confirms that found by White and McCarthy (1986). A possible 
explanation of this lies in consideration of the position of the molecules 
in the active site. For a molecule to have a high rate of metabolism it is 
logical to assume that the portion of the molecule being metabolised must 
be positioned close to the 'active oxygen' in cytochrome P-450. From this 
the Vma3C for a homologous series of compounds, such as the 2-(2,4- 
dichlorophenoxy)-N-methylethanamines, may depend on the relative positions 
of the site of metabolic attack and the 'active oxygen'. In the case of 
the 2-(2,4-dichlorophenoxy)-N-methylethanamines it is assumed that the 
site of metabolic attack is the nitrogen atom, the position of which may 
vary depending on how each of the molecules interacts with the cytochrome.
The Vmax/Km ratio was found to correlate with a number of the 
molecular mechanical variables in the hepatic microsomal fraction isolated 
from rats pretreated with phenobarbital (section 7.3.8). The linear
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equations obtained suggested that the Taft parameter (sigma*) and the 
radical superdelocalizability of the nitrogen atom all affected the 
Vma3C/Km ratio. These equations suggest that increases in all these 
parameters result in an increase in the Vmax / Km ratio. This indicates 
that the electronic structure of the nitrogen atom is having a large 
influence on this ratio. Increases in all the above parameters are 
- indicative of increases in electron density on the nitrogen atom. Increas­
es in the radical superdelocalizability of the nitrogen atom may increase 
the ability of a radical species to remove an electron from this atom. 
This would be in accordance with the suggested mechanism of N-dealkylation 
(section 1.14).
Multi-linear equations for Vma3C/Km were also generated that involved 
the charge on the alpha carbon atom and the Taft parameter and the charge 
on the nitrogen and the nucleophilic superdelocalizability of the alpha 
carbon atom. These equations suggest that increased inductive effect and 
decreased positive charge on the alpha carbon atom result in increased 
Vma3C/Km ratio. These two effects imply an increased electron density on 
the nitrogen. These findings may be related to the mechanism of N- 
dealkylation in as much as the first step of N-dealkylation has been 
suggested to involve the removal of one of the nitrogen lone pair 
electrons. This ionisation may be facilitated by increased electron 
density on the nitrogen atom. The second multi-linear equation supports 
this since it directly relates the charge on the nitrogen atom to the 
Vma3c/Km ratio. This equation also has a term involving the nucleophilic 
superdelocalizability of the alpha carbon atom indicating that as the 
alpha carbon atom becomes less susceptible to nucleophilic attack the 
Vma3C/Km ratio increases. In general cytochrome P-450 is considered to 
attack molecules in their most electron rich areas. An increase in the 
susceptiblity of a group to nucleophilic attack implies a increase in
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electron density. The Vmaoc/Ktn ratio for N-demethylation is possibly 
related to the Vma3C/Km ratio for other metabolic routes and as the other 
routes are rendered more unlikely by changes to the molecule, N-demethyl­
ation increases.
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CHAPTER 8.
General Discussion.
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It was the aim of this investigation to produce a series of compounds 
which could be used to probe the cytochrome P-450 N-dealkylation reaction 
and identify any physico-chemical and molecular mechanical properties of 
the molecules which affect the rate of this metabolic transformation. The 
, series of compounds synthesised for this task had 2-(2,4-dichlorophenoxy)- 
N-methylethanamine as their basic structure (chapter 2). These compounds 
were then characterised with regard to their physico-chemical and molecu­
lar mechanical properties (chapter 3).
Having produced a series of compounds to investigate N-dealkylation
o j-
by determining the effect/changing the substituent group has on the rate 
of N-demethylation, it was shown using a radio-labelled substrate (section
4.4.1) and a selected series of unlabelled substrates in conjunction with 
hplc-ms techniques (section 4.4.2 and 4.4.3) that N-demethylation was the 
major route of metabolism with N-dealkylation and mono-oxygenation present 
as very minor routes. This showed that these substrates could then be used 
to probe the effect of changing the substituent group on the rate of N~ 
demethylation without too much concern about interfering routes of 
metabolism.
Before any meaningful interpretation of data of enzyme binding, spin 
state change and rate of metabolism of the 2-(2,4-dichlorophenoxy)-N- 
methylethanamine could be attempted it was necessary to determine which 
enzyme system and which isoenzyme within this system was most effective in 
the expression of these biological parameters. Studies using cytochrome P- 
450 inducers (section 4.4.5) and inhibitors (section 4.4.6) indicated that 
the phenobarbital-inducible forms cytochrome P450 IIB1 and cytochrome P450 
IIB2, were responsible for the metabolism of these compounds. It was not 
clear which of these isoforms was responsible for majority of the
Discussion.
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metabolism of these compounds, however, the similarity between the metabo­
lism of the 2-(2,4-dichlorophenoxy)-N-methylethanamines with that of benz­
phetamine suggested that the majority of the metabolism was mediated by 
cytochrome P450 IIB1. This was confirmed by the results obtained for the 
metabolism of a number of selected 2-(2,4-dichlorophenoxy)-N-methyl­
ethanamines in a reconstituted system containing purified cytochrome P450 
, IIB4 (section 4.4.6).
Studies of the rates of metabolism (section 5.4.4) and spectral 
binding (sections 5.4.2 and 5.4.3) of these substrates by rat hepatic 
microsomal fraction yielded a number of biological parameters for each 
compound. Each of these parameters was examined and any differences in the 
biological parameters were related to the changes in structure of the 
molecules (section 5.5).
It was notable that no correlation was found between any of the 
spectral binding parameters and any of the parameters which describe the 
rate of N-demethylation. This finding is in opposition to that of Blanck 
et a l . (1983) although the series of compounds used by these workers was a 
very closely related group of benzphetamine analogues not as structurally 
diverse as the compounds used in this study.
No correlation was obtained between any of the spectral parameters 
which describe the binding of the substrate to the enzyme (Ks, K3 and K4) 
and the kinetically determined affinity constant Km determined in either 
the hepatic microsomal fraction of rats pretreated with phenobarbital or a 
reconstituted system containing cytochrome P450 IIB4. The implication of 
this is that the enzyme-substrate complex on which Km is dependent is not 
that initially formed between the 2-(2,4-dichlorophenoxy)-N-methylethan- 
amines and cytochrome P-450. Further confirmation of this was provided by 
the lack of any correlation between Km and the lipophilicity of these 
molecules. Since it is generally accepted that the binding of substrates
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to cytochrome P-450 is dependent on the lipophilicity of the molecule, 
which was supported by a correlation between K3, K4 and log P, then the 
enzyme-substrate complex on which Km is dependent cannot be the initial 
complex formed.
The quantitative relationships found for the Km values determined in
the hepatic microsomal fraction isolated from rats pretreated with pheno­
barbital indicated that for this series of compounds Km was a function of 
the nucleophilic (or radical) superdelocalizability of the alpha carbon 
atom of the substituent group and the electrophilic superdelocalizability 
of N-methyl group (section 7.3.5). This dependence of the Km values on the 
molecular mechanical properties of the alpha carbon atom of the substit­
uent group indicates that as this particular atom becomes more susceptible 
to nucleophilic attack the Km for the N-demethylation reaction decreases. 
The implication of this is that since cytochrome P-450 tends to metabolise 
compounds at their most electron rich atoms, and hence may be considered 
as an electrophile, that as this group becomes more susceptible to
nucleophilic attack it becomes less susceptible to metabolism by cyto­
chrome P-450.
This study indicates that the binding parameters Ks, K3 and K4
describe the interaction of the molecule with the enzyme without consider­
ation of the orientation of the molecule in the active site. When these 
tertiary amines bind to the active site they may either orientate 
themselves with the methyl group pointing at the haem or the substituent 
group pointing at the haem. It appears that the factor which governs the 
orientation of the molecules is Km, which appears to be related to the 
relative susceptibility of the substituent groups to attack by cytochrome 
P-450.
A number of qualitative relationships were noticed between the 
biological parameters and the molecular structure. Firstly there appeared
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to be a link between the size of the molecule and the strength of binding 
to the cytochrome (section 5.4). This was supported by a quantitative 
relationship between both K3 and K4 with the volume of the molecule 
(section 7.3.2). This relationship implies that as the molecular volume 
increases so the strength of binding increases. Although none were found, 
this relationship must have finite values otherwise it implies that the
, active site of cytochrome P-450 is infinitely large.
Restrictions on the binding of the 2-(2,4-dichlorophenoxy)-N-methyl­
ethanamines were imposed by the correlation determined between K3, K4 and 
the lipophilicity. The restriction imposed by the lipophilicity on K3 and 
K4 would reflect back on the molecular volume and hence indirectly 
restrict this parameter with respect to I<3 and K4.
In terms of structure-activity relationships it was clear that
increasing the number of aromatic nuclei in either the 2-(2,4-dichloro­
phenoxy) -N-methylethanamine or the N-substituted phenoxy-N,N-dimethyl- 
ethanamine series increased the strength of binding to cytochrome P-450.
A model for the active site of cytochrome P450 IIB1 has recently 
been suggested (Lewis e t  a l ., 1987). This model is based on two aromatic
amino acids separated by two other amino acids. If this model is
correct then any molecules with more than one aromatic or unsaturated
systems which was able to interact with these aromatic amino acids would
be expected to bind with higher affinity than molecules with alkyl or 
polar side chains. The current study supports this view with the exception 
of 2-(l-naphthyloxy)-N,N-dimethylethanamine. Because of the spatial 
arrangement of the fused aromatic rings in this compound it may be
impossible for this compound to form a tight interaction with both of
these aromatic amino acids.
Compounds with polar substituent groups such as ethylhydroxy and 
carboxymethyl DME would not interact strongly with aromatic amino acids
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and hence would bind weakly or not at all. However the binding of 
ethylhydroxy DME may be confused by the liganding of this compound to the 
haem via its hydroxyl function, as was found to be the case when this 
compound was spectrally titrated with purified cytochrome P450 IIB4 in a 
reconstituted system.
The quantitative analysis of K3 and K4 also produced a correlation 
, between these parameters and the octanol/water partition coefficient at pH
7.4 (log D). This correlation was interpreted to mean that only the free 
tertiary amine base present in the microsomal membrane bound to the enzyme 
and compounds that produce the greatest amounts of this species produced 
the tightest binding. In terms of the proposed mechanism of N-demethyl­
ation this is the species that would need to be present at the active site 
of the enzyme for metabolism to occur.
In overall terms, the size, lipophilicity and log D were found to 
determine the strength of binding of the 2-(2,4-dichlorophenoxy)-N-methyl- 
ethanamines to cytochrome P-450.
The interaction between the substrates and purified cytochrome P450 
IIB4 in a reconstituted system was found in qualitative terms to be 
similar to the situation in the microsomal system (section 6.4.4). The 
strength of binding appeared to be directly related to increasing chain 
length or number of aromatic/unsaturated systems. However, not all the 
compounds of varying chain length were examined since the shortest two 
members of this series produced type II interactions with the enzyme. This 
effect is assumed to be a result of the tail group of these compounds 
being too short to interact with the apoprotein which resulted in these 
compounds liganding to the haem via the nitrogen lone pair. The suggestion 
that these side chains are too small to interact with the apoprotein is 
given some support by ethylhydroxy DME which produced a reverse type I 
spectrum indicating that this compound was liganding to the haem via its
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In terms of quantitative relationships it was found that the two 
groups of biological data (i.e. microsomal and reconstituted purified 
protein) did not correlate (section 6.4.7) and hence different 
quantitative-structure activity relationships were obtained. However the 
two groups of relationships obtained both relate to hydrophobic inter- 
, actions between the substrate and the enzyme.
The substrate-induced low to high spin state change, represented by 
K2/ was also found to be related to the log D of the compounds. This 
suggests that the species which is responsible for the spin state change 
is the free tertiary amine base. This is the species that would need to be 
present at the active site for metabolism to occur since the lone pair of 
electrons on the nitrogen are free for metabolic attack by the cytochrome- 
oxygen complex.
In terms of structure, changing the nature of the aryloxy moiety had 
little effect on the high spin conversion (section 5.4.5) but changes in 
the variable N-substituent group did produce some changes in the 
substrate-induced low to high spin conversion (section 5.4.3). These 
changes seemed to be related to the size of the molecule since an increase 
in both % HS and K2 were noted as the length of the alkyl chain was 
increased. An explanation of this was offered in terms of the findings of 
Fischer and Sligar (1987). Their suggestion for the substrate-induced spin 
state change in the cytochrome P-450cam system was based on the ability of 
the substrate molecule to exclude water from the enzyme's active site and 
hence slow down the H20/cytochrome P-450 recombination rate. The nature of 
the sixth ligand of microsomal cytochrome P-450 is not known, however the 
likelihood is that it is either water or an hydroxylated amino acid (most 
probably serine). If this were the case, then this model would explain the 
structure-induced differences seen in the values of % HS and K2.
hydroxyl function.
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The Vma3c of the compounds, determined in both the hepatic microsomal 
fraction isolated from rats pretreated with phenobarbital (section 5.4.4) 
and a reconstituted system containing cytochrome P450 IIB4 (section
6.4.2), failed to correlate with any of the physico-chemical or molecular 
mechanical properties of the 2-(2,4-dichlorophenoxy)-N-methylethanamines 
(section 7.3.6 and 7.3.8). This again may highlight an indirect relation- 
, ship between the rate of metabolism and the binding of the substrate to 
the enzyme. When each of the substrates interacts with the enzyme it does- 
so preferentially in the strongest manner in which it is able. This may 
mean that in terms of the three dimensional space of the active site, the 
nitrogen atoms of the different compounds in the series may not reside in 
the same position with respect to the 'active oxygen' resident on the 
haem. The maximum rate of metabolism of a substrate by cytochrome P-450 
may be envisaged as a function of the distance between the site of 
metabolic attack and the 'active oxygen'.
For a compound which is cleared by metabolism the intrinsic clearance 
has been shown to be directly related to the Vmax/Km ratio. For compounds 
which have several metabolic routes this may only be obtained from data 
which relates to the loss of substrate. However, in the 2-(2,4-dichloro­
phenoxy) -N-methylethanamine series, the intrinsic clearance in both the 
hepatic microsomal fraction isolated from rats pretreated with pheno­
barbital and a reconstituted system containing cytochrome P450 IIB4, may 
be related to Vma3C/Km ratio for N-demethylation since this represents the 
major route of metabolism.
Examination of the ratios of the 2-(2,4-dichlorophenoxy)-N-
methylethanamines reveals that the compounds with the highest intrinsic 
clearance are benzyl and propynyl DME (table 5.3). Both compounds have an 
aromatic or unsaturated moiety separated from the nitrogen atom by one 
methylene unit. It may therefore be assumed that for the microsomal system
245
this structure represents the best compromise between strong binding and 
close proximity of the nitrogen atom to the 'active oxygen'. In the case 
of the reconstituted system containing purified cytochrome P450 IIB4 the 
picture is not as clear, however it is clear that compounds with unsatur­
ated or aromatic moieties in the substituent group have the highest 
intrinsic clearance (table 6.2).
The Vmax/Km ratio was quantitatively related to a number of the 
molecular mechanical parameters including the charge on the nitrogen atom, 
the charge on the alpha carbon atom of the substituent group, the 
inductive effect of the substituent group, and the nucleophilic super­
delocalizability of the alpha carbon atom of the substituent group. These 
quantitative results indicate that the i n  v i t r o  intrinsic clearance is 
determined by the properties of the molecule that influence its metabolism 
rather than properties such as lipophilicity which have been found to 
influence the i n  v ivo intrinsic clearance (Caccia et  a l . 1987).
This study has highlighted some of the properties which influence the 
binding and rate of metabolism of tertiary amines. It may be possible to 
use the correlations and trends determined here to design drugs containing 
tertiary amine functions which are more slowly metabolised by cytochrome 
P-450. This study indicated that this may be achieved by either preventing 
the compound binding to the cytochrome by changing its size or polarity or 
by making it so large that the site of metabolism is not close enough to 
the 'active oxygen' to facilitate rapid metabolism.
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To f u r t h e r  understand cytochrome P-450 m e d ia te d -N -d e a lk y la t io n  u s ing  
the 2 - ( 2 , 4-d ich lo rophenoxy)-N -m ethy le thanam ine  s e r ie s  o f  compounds the 
fo l lo w in g  approaches cou ld  be a p p l ie d :
The Vma3C o f  these  compounds cou ld  be in v e s t ig a te d  by r e l a t i n g  t h e i r
s t r u c tu re  to  th a t  o f  a compound such as te s to s te ro n e  which i s  m etabo lised
in  on ly  two p o s i t io n s  by cytochrome P450 IIB1 (and cytochrome P450 I IB 4 ) .  
Using these su b s t ra te s  to  i n h i b i t  c o m p e t i t iv e ly  the metabo lism  o f  t e s t ­
osterone and then comparing the  s u b s t ra te  s t r u c tu re s  w ith  th a t  o f  t e s t ­
oste rone  may y i e l d  in fo rm a t io n  about the  p o s i t io n  o f  the  n it ro g en  atom
r e l a t i v e  to  th a t  o f  the  16- carbon atom o f  te s to s te ro n e .
The ra te  o f  d isappearance  o f  these  su b s t ra te s  cou ld  be measured a t  
low su b s t ra te  c o n ce n t ra t io n s  when the r e a c t io n  r a t e  i s  f i r s t  o rde r.  T h is  
would produce an a l t e r n a t i v e  assessment o f  Vmax/Km. Both va lue s  f o r  Vma3C / 
Km cou ld  then be compared w ith  i n t r i n s i c  c le a ren ce  v a lu e s  ob ta ined  from 
pharm acok ine t ic  experiments to  determ ine any in vitro / in vivo 
c o r r e la t io n s .
In gen e ra l ,  the r a t  (and c e r t a i n l y  the  ph en o b a rb ita l- in d u ced  ra t )  i s ,
not a model r o u t i n l y  used by drug companies in  t h e i r  assessment o f  a
j ^
compound's metabo lism . I t  w ou ld /u se fu l th e re fo re  to  c a r r y  out s im i l a r  
s tu d ie s  to  those p resen ted  in  t h i s  t h e s i s  but u s ing  the  h e p a t ic  m icrosomal 
f r a c t i o n  from dogs o r  p o s s ib l y  from man. These s tu d ie s  in  conduct ion  w ith  
a knowledge o f  the  cytochrome P-450 isozymes p re sen t  i n  these  sp e c ie s ,  
would be more in fo rm a t iv e  w ith  re sp e c t  to  fu tu re  drug des ign .
Future Work
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Table 1. Log P, CMR and Andrews binding energies for the 2-(2,4-
dichlorophenoxy)-N-methylethanamines.
S u b s t i tu e n t log  P CMR Andrews B in d in g  Energy
Methy l 3.336 6.048 5.8
E th y l 3.785 6.512 5.9
n -P rop y l 4.234 6.976 6.0
Isop rop y l 4.014 6.976 6.7
n -B u ty l 4.683 7.440 6.1
t - B u t y l 4.333 7.440 7.5
n -P e n ty l 5.212 7.904 6.2
n-Hexy l 5.741 8.367 6.3
Phenyl 5.300 8.096 -1 .8
Benzy l 5.135 8.560 -1 .7
Phenethy l 5.273 9.023 8.7
B is 6.825 10.159 11.7
Propeny l 3.690 6.951 5.8
Propyny l 2.826 6.773 4.4
E thy lhyd roxy 2.632 6.665 7.0
E th y l  DMP 4.309 6.823 5.6
B is  = N ,N -B is  [ 2 - ( 2 , 4 -d ich lo rophenoxy )ethyl]methanamine 
E th y l  DMP = 3 - (2 ,4 -D ich lo ro pheny l) -N -e th y l-N -m e th y le th anam ine  
CMR = c a lc u la t e d  molar r e f r a c t i v i t y .
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Table 2. Length, surface area and volume of the 2-(2,4-dichlorophenoxy)-
N-methylethanamines
S u b s t i tu e n t Length
(A)
su r fa ce  area
(A2 )
volume
(A3 )
Methy l 10.54 1041.0 124.0
E th y l 11.07 1105.6 209.1
n -P ropy l 12.56 1201.0 225.3
Isop ropy l 11.05 1204.8 225.3
n -B u ty l 12.91 1298.8 241.5
t - B u t y l 11.52 1322.6 241.5
n -P en ty l 14.35 1402.2 257.7
n-Hexy l 14.38 1509.6 273.9
Phenyl 12.17 1306.7 246.5
Benzy l 13.22 1414.1 262.7
Phenethy l 12.46 1531.2 278.9
B is 14.53 1585.0 314.1
Propeny l 12.18 1104.5 219.7
Propyny l 12.25 1078.0 215.3
E thy lhyd roxy 12.30 1144.8 215.3
E th y l  DMP 11.18 1188.9 219.1
Bis = N,N-Bis [2-(2,4-dichlorophenoxy)ethylJmethanamine
Ethyl DMP = 3-(2,4-Dichlorophenyl)-N-ethyl-N-methylethanamine.
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Tab le  3. Atomic p a r t i a l  charges on the  n it ro g en ,  a lpha carbon atom o f  the 
s u b s t i tu e n t  group and the s u b s t i t u e n t  group.
S u b s t i tu e n t Nq A lpha  carbon S u b s t i tu e n t  group
Methy l -0.1607 0.1609 0.15
E th y l -0.1677 0.1559 0.09
n -P rop y l -0.1698 0.1534 0.20
Isop rop y l -0.1719 0.1537 0.10
n -B u ty l -0.1702 0.1523 0.09
t - B u t y l -0.1761 0.1378 0.11
n -P e n ty l -0.1680 0.1525 0.10
n-Hexy l -0.1678 0.1525 0.11
Phenyl -0.1486 0.1060 0.06
Benzy l -0 .1714 0.1628 0.10
Phenethy l -0.1648 0.1548 0.08
B is -0.1598 0.1130 0.05
Propeny l -0.1690 0.1794 0.07
Propyny l -0.1711 0.2628 0.08
E thy lhyd roxy -0.1609 0.1020 0.07
E th y l  DMP -0.1812 0.1605 0.09
Bis = N,N-Bis [2-(2,4-dichlorophenoxy)ethyljmethanamine
Ethyl DMP = 3-(2,4-Dichlorophenyl)-N-ethyl-N-methylethanamine.
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Tab le  4. P o l a r i z a b i l i t i e s  o f  the  N-methyl group, a lpha carbon atom o f the 
s u b s t i t u e n t  group and the  s u b s t i t u e n t  group.
S u b s t i tu e n t  N-methyl a lpha  carbon s u b s t i t u e n t  group
Methy l 6.1434 3.4004 6.145
E th y l 6.3991 3.2674 11.1744
n -P rop y l 6.0708 3.2954 16.3296
Isop rop y l 6.0741 3.1810 16.3052
n -B u ty l 6.0730 3.2952 21.4702
t - B u t y l 6.0843 3.1137 21.4896
n -P e n ty l 6.0768 3.2960 26.6179
n-Hexy l 6.0871 3.2946 31.8098
Phenyl 6.1495 3.3714 25.1822
Benzy l 6.0706 3.3115 30.3722
Phenethy l 6.0827 3.2921 35.6181
B is 6.0719 3.2875 40.5315
Propeny l 6,0692 3.2711 14.8417
Propyny l 6.0695 3.2142 13.7705
E thy lh yd roxy 6.0672 3.2876 13.2648
E th y l  DMP 6.1406 3.2856 11.2892
Bis = N,N-Bis [2-(2,4-dichlorophenoxy)ethyl]methanamine
Ethyl DMP = 3-(2,4~Dichlorophenyl)-N-ethyl-N-methylethanamine.
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Tab le  5. E l e c t r o p h i l i c ,  n u c le o p h i l i c  and r a d i c a l  s u p e r d e l o c a l i z a b i l i t i e s  
o f  the  s u b s t i t u e n t  group o f  the 2 - ( 2 , 4 -d ich lo rophenoxy ) -N -
m ethy le thanam ines.
S u b s t i tu e n t E l e c t r o p h i l i c N u c le o p h i l i c R a d ic a l
Methy l -19.69 -59.53 -39.53
E th y l -37.41 -63.93 -73.70
n -P ropy l -56.26 -160.57 -108.39
Isop rop y l -55.74 -163.12 -104.93
n -B u ty l -74.39 -210.34 -139.39
t - B u t y l -75.11 -214.50 -140.55
n -P e n ty l -93.27 -263.60 -178.43
n-Hexy l -111.61 -316.70 -214.15
Phenyl -105.51 -322.04 -213.78
Benzy l -121.05 -346.98 -234.38
Phenethy l -139.65 -398.55 -269.10
B is -155.23 -485.71 -320.47
Propeny l -54.51 -158.06 -106.28
Propyny l -61.83 -181.54 -121.68
E thy lh yd roxy -60.66 -135.69 -98.17
E th y l  DMP -38.00 -109.80 -73.90
B is  = N ,N -B is  [ 2 - ( 2 , 4 -d ich lo rophenoxy)e thy l]m ethanam ine
E th y l  DMP = 3 - ( 2 , 4 -D ich lo ropheny l) -N -e thy l-N -m e thy le thanam ine .
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Tab le  6. E l e c t r o p h i l i c ,  n u c le o p h i l i c  and r a d i c a l  s u p e r d e lo c a l i z a b i l i t e s  
o f  the  a lpha carbon atom o f the  s u b s t i tu e n t  group o f  the 2 - ( 2 ,4 -  
d ich lo rophenoxy ) -N -methy le thanam ines.
S u b s t i tu e n t E l e c t r o p h i l i c N u c le o p h i l i c R a d ic a l
Methy l -15.614 -49.603 -32.608
E th y l -15.003 -47.650 -31.327
n -P ropy l -15.327 -47.903 -31.615
Isop rop y l -14.680 -47.000 -30.840
n -B u ty l -15.300 -48.010 -31.652
t - B u t y l -14.593 -45.251 -29.922
n -P en ty l -15.322 -47.933 -31.627
n-Hexy l -15.343 -47.858 -31.601
Phenyl -15.904 -52.483 -34.193
Benzy l -15.576 -48.115 -31.845
Phenethy l -15.155 -49.264 -31.989
B is -14.946 -50.317 -32.632
Propeny l -15.145 -48.019 -31.582
Propyny l -14.508 -52.219 -33.363
E thy lhyd roxy -15.221 -48.179 -31.700
E th y l  DMP -15.249 -47.187 -31.218
Bis = N,N-Bis [2-(2,4-dichlorophenoxy)ethyl]methanamine
Ethyl DMP = 3-(2,4-Dichlorophenyl)-N-ethyl-N-methylethanamine.
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Table 7, Electrophilic, nucleophilic and radical superdelocalizabilities
of the N-methyl group of the 2-(2,4-dichlorophenoxy)-N-methylethanamines.
S u b s t i tu e n t E l e c t r o p h i l i c N u c le o p h i l i c R a d ic a l
Methy l -19.674 -60.465 -40.070
E th y l -19.542 -58.692 -39.117
n -P ropy l -19.554 -58.632 -38.928
Isop rop y l -19.614 -58.270 -38.941
n -B u ty l -19.580 -58.608 -39.094
t - B u t y l -19.710 -58.193 -39.061
n -P e n ty l -19.649 -58.454 -39.051
n-Hexy l -19.820 -58.309 -39.065
Phenyl -19.743 -60.107 -39.925
Benzy l -19.435 -58.725 -39.123
Phenethy l -19.558 -59.022 -39.290
B is -19.430 -59.870 -39.650
Propeny l -19.529 -58.843 -39.186
Propyny l -19.513 -59.117 -39.315
E thy lhyd roxy -19.562 -58.518 -39.040
E th y l  DMP -19.839 -58.761 -39.300
Bis = N,N-Bis [2-(2,4-dichlorophenoxy)ethylJmethanamine
Ethyl DMP = 3-(2,4-Dichlorophenyl)-N-ethyl-N-methylethanamine.
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Table 8. Ionisation energies and dipole moments of the 2-(2,4-
dichlorophenoxy)-N-methylethanamines.
S u b s t i tu e n t I o n is a t io n  Energy 
(eV)
D ipo le  Moment 
(Debyes)
Methy l 8.410 3.221
E th y l 8.378 (8.26) 3.355
n -P ro p y l 8.376 3.379
Isop rop y l 8.378 3.358
n -B u ty l 8.374 3.440
t - B u t y l 8.366 (8.32) 3.489
n -P e n ty l 8.373 3.453
n-Hexy l 8.375 3.401
Phenyl 8.331 (8.33) 3.065
Benzy l 8.378 (8.16) 3.505
Phenethy l 8.370 3.272
B is 8.333 5.918
Propeny l 8.382 (8.26) 3.334
P ropyny l 8.376 5.156
E thy lh yd roxy 8.411 3.062
E th y l  DMP 8.487 1.611
The va lue s  i n  parentheses a re  the  va lu e s  o f  the io n i s a t i o n  energy o f  the  
m o lecu les  determ ined by p h o to e le c t ro n  spectroscopy .
Bis = N,N-Bis [2-(2,4-dichlorophenoxy)ethyljmethanamine
Ethyl DMP = 3-(2,4-Dichlorophenyl)-N-ethyl-N-methylethanamine.
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Table 9. Log P, CMR and Andrews binding energies for the substituted
phenoxy-N,N-dimethylethanamine series.
S u b s t i tu e n t lo g  P CMR Andrews B ind ing  Energy 
(Kca l/mo l)
2 ,3 -D ic h lo ro 3.336 6.048 5.8
2,3-D im ethy l 3.278 5.993 4.8
1-Naphthyl 3.154 6.754 6.0
2-Methy l 2.629 5.529 4.0
2-P ro p y l 3.687 6.457 4.2
2-B u ty l 4.216 6.921 4.3
2 -Benzy l 4.197 8.041 6.8
DPH 2.932 8.041 6.8
DPH = Diphenhydramine.
CMR = c a l c u la t e d  molar r e f r a c t i v i t y .
